Yoshiki Tokura

Yoshiki Tokura's AcademicInfluence.com Rankings

Yoshiki Tokura

Medical

#1857

World Rank

#2236

Historical Rank

Dermatology

#29

World Rank

#41

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Yoshiki Tokura Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yoshiki Tokura's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma (2010) (379)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. (2018) (330)
Extrinsic and intrinsic types of atopic dermatitis. (2010) (285)
Possible pathogenic role of Th17 cells for atopic dermatitis. (2008) (269)
Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. (2010) (256)
CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. (2007) (241)
Interleukin‐10 expressed at early tumour sites induces subsequent generation of CD4+ T‐regulatory cells and systemic collapse of antitumour immunity (2001) (229)
Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. (2004) (228)
A randomized double-blind trial of intravenous immunoglobulin for pemphigus. (2009) (209)
Attempts to accelerate wound healing. (2014) (164)
Depletion of IL-10- and TGF-β-Producing Regulatory γδ T Cells by Administering a Daunomycin-Conjugated Specific Monoclonal Antibody in Early Tumor Lesions Augments the Activity of CTLs and NK Cells (1999) (147)
Epithelial-mesenchymal transition in the skin. (2011) (141)
What causes alopecia areata? (2013) (140)
IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. (2014) (140)
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report (2019) (127)
Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin (2006) (124)
Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. (2001) (122)
Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. (2010) (116)
NK-cell neoplasms in Japan (2005) (109)
Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. (2012) (107)
Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. (2000) (102)
Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. (1994) (101)
Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma. (2011) (100)
Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17 (2016) (97)
Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis. (2013) (97)
IgG4‐related skin disease (2014) (96)
Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. (1997) (95)
Augmented expression of programmed death‐1 in both neoplastic and non‐neoplastic CD4+ T‐cells in adult T‐cell leukemia/lymphoma (2007) (91)
Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. (1992) (91)
Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled, phase II study (2017) (90)
Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors (2007) (86)
E‐ and P‐cadherin expression during murine hair follicle morphogenesis and cycling (1999) (86)
Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. (2005) (86)
A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. (2012) (86)
Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens (1995) (82)
Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. (1990) (79)
Expression of toll‐like receptor 2, NOD2 and dectin‐1 and stimulatory effects of their ligands and histamine in normal human keratinocytes (2009) (78)
CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. (2013) (74)
Quinolone photoallergy: photosensitivity dermatitis induced by systemic administration of photohaptenic drugs. (1998) (73)
Hypersensitivity to Mosquito Bites Conceals Clonal Lymphoproliferation of Epstein‐Barr Viral DNA‐positive Natural Killer Cells (1997) (72)
Induction of eosinophil‐ and Th2‐attracting epidermal chemokines and cutaneous late‐phase reaction in tape‐stripped skin (2009) (70)
Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE‐high extrinsic and IgE‐normal intrinsic types of atopic dermatitis (2010) (70)
Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma. (1996) (69)
Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. (2008) (69)
TSLP Directly Interacts with Skin-Homing Th2 Cells Highly Expressing its Receptor to Enhance IL-4 Production in Atopic Dermatitis. (2015) (69)
The role of cytokines and chemokines in the T‐cell‐mediated autoimmune process in alopecia areata (2014) (67)
Increased circulating Th17 frequencies and serum IL‐22 levels in patients with acute generalized exanthematous pustulosis (2011) (67)
Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody‐mediated cytotoxicity (1999) (67)
Kallikrein-related Peptidase 5 Functions in Proteolytic Processing of Profilaggrin in Cultured Human Keratinocytes* (2013) (65)
Characterization of Drug-Specific T Cells in Phenobarbital- Induced Eruption (2002) (64)
Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes? (2006) (63)
Aberrant aquaporin 5 expression in the sweat gland in aquagenic wrinkling of the palms. (2008) (60)
Psoriasis and other Th17-mediated skin diseases. (2010) (60)
Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. (1998) (58)
Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. (2016) (58)
Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey (2017) (57)
Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine (2004) (57)
Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies. (1994) (55)
IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. (2009) (55)
CXCR4 engagement promotes dendritic cell survival and maturation. (2007) (53)
Assessment of Epidermal Barrier Function by Photoacoustic Spectrometry in Relation to Its Importance in the Pathogenesis of Atopic Dermatitis (2002) (51)
Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice. (1996) (50)
"Nagashima-type" keratosis as a novel entity in the palmoplantar keratoderma category. (2008) (50)
Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. (1999) (49)
Adult T‐cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte‐associated antigen‐4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells (2007) (49)
Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin. (2010) (48)
Ectopic extramammary Paget's disease: case report and literature review. (2010) (47)
Down-Regulation of Tumoricidal NK and NK T Cell Activities by MHC Kb Molecules Expressed on Th2-Type γδ T and αβ T Cells Coinfiltrating in Early B16 Melanoma Lesions (1998) (47)
Skin manifestations of adult T‐cell leukemia/lymphoma: Clinical, cytological and immunological features (2014) (46)
Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. (2000) (46)
Wells'syndrome: a pathogenic role for circulating CD4+CD7− T cells expressing interleukin‐5 mRNA (1997) (45)
Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites. (2005) (45)
Febrile ulceronecrotic Mucha-Habermann's disease managed with methylprednisolone semipulse and subsequent methotrexate therapies. (2003) (45)
Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid. (2000) (45)
Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course. (2019) (44)
The Mandatory Role of IL-10–Producing and OX40 Ligand-Expressing Mature Langerhans Cells in Local UVB-Induced Immunosuppression (2010) (44)
Subtypes of atopic dermatitis: From phenotype to endotype. (2021) (43)
T cell populations propagating in the peripheral blood of patients with drug eruptions. (2007) (43)
Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice. (1996) (43)
Potential application of in vivo imaging of impaired lymphatic duct to evaluate the severity of pressure ulcer in mouse model (2014) (43)
Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion. (2016) (42)
Photohaptenic Properties of Fluoroquinolones (1996) (42)
Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis. (2014) (41)
High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome. (2012) (41)
Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma. (2015) (41)
Lupus Erythematosus Associated with C1 Inhibitor Deficiency (2002) (38)
D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells. (2013) (38)
S–100 protein‐positive cells in hidrocystomas (1986) (38)
High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome. (2011) (37)
FTY720 regulates bone marrow egress of eosinophils and modulates late-phase skin reaction in mice. (2010) (37)
High frequencies of positive nickel/cobalt patch tests and high sweat nickel concentration in patients with intrinsic atopic dermatitis. (2013) (37)
Guidelines for the management of cutaneous lymphomas (2011): A consensus statement by the Japanese Skin Cancer Society – Lymphoma Study Group (2013) (36)
CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. (2003) (36)
Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells. (2002) (36)
Histological diagnostic criteria for accessory tragi (1990) (36)
Pathogenesis of cholinergic urticaria in relation to sweating. (2012) (36)
Serum interleukin‐22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis (2013) (35)
HTLV‐1‐associated infective dermatitis: updates on the pathogenesis (2012) (35)
Analysis of CXCL9 and CXCR3 expression in a case of intravascular large B-cell lymphoma. (2009) (35)
Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-gamma-producing CD8(+) T cells in IP-10 expression. (2002) (35)
TCRV beta 7+ Th2 cells mediate UVB-induced suppression of murine contact photosensitivity by releasing IL-10. (1996) (34)
Pathophysiology of Skin Resident Memory T Cells (2021) (34)
Production of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine by CCR4+ Adult T-Cell Leukemia Cells (2005) (34)
Ultraviolet light induces Stat3 activation in human keratinocytes and fibroblasts through reactive oxygen species and DNA damage (2010) (34)
Anti-allergic Psidium guajava extracts exert an antitumor effect by inhibition of T regulatory cells and resultant augmentation of Th1 cells. (2005) (34)
Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-gamma-treated keratinocytes and keratinocyte cell lines. (1995) (34)
Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo. (2011) (33)
Clinical and histopathological differential diagnosis of eosinophilic pustular folliculitis (2013) (33)
Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. (1999) (33)
Photocontact dermatitis and chloracne: two major occupational and environmental skin diseases induced by different actions of halogenated chemicals. (2003) (32)
Alopecia areata triggered or exacerbated by swine flu virus infection (2012) (32)
Modulation of semaphorin 3A expression by calcium concentration and histamine in human keratinocytes and fibroblasts. (2011) (31)
Chemical photoallergy: photobiochemical mechanisms, classification, and risk assessments. (2017) (31)
Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis. (2009) (31)
Cross-reactivity in murine fluoroquinolone photoallergy: exclusive usage of TCR Vbeta13 by immune T cells that recognize fluoroquinolone-photomodified cells. (1998) (30)
Involvement of Wnt signaling in dermal fibroblasts. (2010) (30)
Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma (2010) (30)
Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator‐blinded, controlled study (2016) (30)
Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma (2001) (30)
Clinical categories of exaggerated skin reactions to mosquito bites and their pathophysiology. (2016) (30)
Drug-induced CD30+ T cell pseudolymphoma. (2009) (30)
Necrobiosis lipoidica of the glans penis. (2003) (30)
Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals (2008) (30)
Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice. (2002) (30)
VEGF-A promotes IL-17A-producing γδ T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells. (2014) (30)
Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles. (1999) (30)
CD7-positive Sézary syndrome with a Th1 cytokine profile. (1996) (29)
Basal cell carcinoma of the scrotum with lymph node metastasis: report of a case and review of the literature (2005) (29)
Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology. (2010) (29)
A successful treatment with ustekinumab in a case of antilaminin‐γ1 pemphigoid associated with psoriasis (2013) (29)
Defective Epidermal Innate Immunity and Resultant Superficial Dermatophytosis in Adult T-cell Leukemia/Lymphoma (2012) (29)
Congenital self-healing reticulohistiocytosis presenting with hemorrhagic bullae. (2003) (28)
Platelets Regulate the Migration of Keratinocytes via Podoplanin/CLEC-2 Signaling during Cutaneous Wound Healing in Mice. (2016) (28)
Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. (2004) (28)
Induction of keratinocyte apoptosis by photosensitizing chemicals plus UVA. (2007) (28)
TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody. (2013) (28)
The localization of label-retaining cells in eccrine glands. (2009) (27)
Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders. (2012) (27)
The macrolide antibiotic, roxithromycin suppresses IFN-gamma-mediated immunological functions of cultured normal human keratinocytes. (1996) (27)
Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study (2016) (27)
Phase II study of i.v. interferon‐gamma in Japanese patients with mycosis fungoides (2014) (27)
Immune responses to photohaptens: implications for the mechanisms of photosensitivity to exogenous agents. (2000) (27)
Expression of Snail1 in the fibrotic dermis of postmenopausal frontal fibrosing alopecia: possible involvement of an epithelial–mesenchymal transition and a review of the Japanese patients (2010) (27)
Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T‐cell lymphomas (2017) (27)
Selective Expansions of T cells Expressing Vβ38 and Vβ13 in Skin Lesions of Patients with Chronic Cutaneous Lupus Erythematosus (1996) (26)
Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells. (2006) (26)
Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome. (2010) (26)
Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides. (2008) (25)
Formation and removal of 8-MOP-DNA photoadducts in keratinocytes: effects of calcium concentration and retinoids. (1990) (25)
Drug-induced papuloerythroderma: analysis of T-cell populations and a literature review. (2009) (25)
Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study (2020) (24)
M2 macrophages promote wound-induced hair neogenesis. (2018) (24)
AFLOQUALONE PHOTOSENSITIVITY. IMMUNOGENICITY OF AFLOQUALONE‐PHOTOMODIFIED EPIDERMAL CELLS (1994) (23)
Formation of antigenic quinolone photoadducts on Langerhans cells initiates photoallergy to systemically administered quinolone in mice. (2000) (23)
Generalized fixed drug eruption caused by pazufloxacin. (2011) (23)
Sparfloxacin phototoxicity: Potential photoaugmentation by ultraviolet A and B sources (2006) (23)
Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment. (2018) (23)
Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes (2007) (23)
Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma. (1996) (23)
Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometer. (2014) (23)
Solar urticaria: a case with good therapeutic response to cimetidine. (1986) (22)
Modulation of cytokine production by 8-methoxypsoralen and UVA. (1999) (22)
Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption. (2010) (22)
Drug eruption induced by IL‐6 receptor inhibitor tocilizumab (2010) (22)
Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid. (2015) (22)
Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides. (2005) (22)
Chronic actinic dermatitis associated with adult T-cell leukemia. (2005) (22)
Subacute and chronic prurigo effectively treated with recombination interferon-gamma: implications for participation of Th2 cells in the pathogenesis of prurigo. (1997) (22)
Vitiligo with raised inflammatory borders: involvement ofT cell immunity and keratinocytes expressing MHC class IIand ICAM-1 molecules (2000) (22)
Disseminated pagetoid reticulosis: need for long-term follow-up. (1994) (22)
Genetic control of contact photosensitivity to tetrachlorosalicylanilide. I. Preferential activation of suppressor T cells in low responder H-2k mice. (1990) (21)
Structural and Immunological Effects of Skin Cryoablation in a Mouse Model (2015) (21)
The anagen hair cycle induces systemic immunosuppression of contact hypersensitivity in mice. (1998) (21)
Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen. (2007) (21)
Ultraviolet-induced suppressor T cells and factor(s) in murine contact photosensitivity. I. Biological and immunochemical characterization of factor(s) extracted from suppressor T cells. (1987) (21)
Lupus Erythematosus Profundus with Unusual Skin Manifestation: Subcutaneous Nodules Coexisting with Eyelid Plaques (2001) (20)
Purpuric adult T‐cell leukaemia/lymphoma: expansion of unusual CD4/CD8 double‐negative malignant T cells expressing CCR4 but bearing the cytotoxic molecule granzyme B (2005) (20)
Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma. (2015) (20)
Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation (2018) (20)
Impaired initiation of contact hypersensitivity by FTY720. (2008) (20)
Lymphomatoid papulosis. Histologic and immunohistochemical studies in a patient with a scaly pigmented eruption. (1986) (20)
Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival. (2010) (20)
Genetic control of contact photosensitivity to tetrachlorosalicylanilide. II. Igh complex controls the sensitivity induced by photohapten-modified spleen cells but not epidermal cells. (1991) (19)
Papuloerythroderma of Ofuji induced by furosemide. (2008) (19)
Down-regulation of tumoricidal NK and NK T cell activities by MHC Kb molecules expressed on Th2-type gammadelta T and alphabeta T cells coinfiltrating in early B16 melanoma lesions. (1998) (19)
Tocilizumab-induced erythroderma. (2009) (19)
Enhanced T‐cell response to mosquito extracts by NK cells in hypersensitivity to mosquito bites associated with EBV infection and NK cell lymphocytosis (2005) (19)
Expression of SNAI1 and TWIST1 in the eccrine glands of patients with systemic sclerosis: possible involvement of epithelial–mesenchymal transition in the pathogenesis (2011) (19)
CD30‐positive T‐cell pseudolymphoma induced by amlodipine (2008) (19)
Disordered expression of inhibitory receptors on the NK1‐type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites (2000) (18)
Primary cutaneous amyloidosis of the auricular concha: Case report and review of published work (2006) (18)
Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms (2018) (18)
Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients (2021) (18)
Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: A randomized study (2011) (18)
Normolipaemic plane xanthomatosis associated with mycosis fungoides (2000) (18)
Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T‐cell leukemia‐lymphoma (2014) (18)
Hair cycle‐dependent expression of heat shock proteins in hair follicle epithelium (1997) (18)
Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata (2021) (18)
Vitiligo with inflammatory raised borders, associated with atopic dermatitis (2006) (18)
Formation of 8‐hydroxy‐2′‐deoxyguanosine in the DNA of cultured human keratinocytes by clinically used doses of narrowband and broadband ultraviolet B and psoralen plus ultraviolet A (2006) (18)
Calcipotriol increases hCAP18 mRNA expression but inhibits extracellular LL37 peptide production in IL-17/IL-22-stimulated normal human epidermal keratinocytes. (2014) (18)
Soluble intercellular adhesion molecule-1 (sICAM-1) in atopic dermatitis. (1994) (18)
A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor‐associated periodic syndrome (TRAPS) manifesting adult‐onset Still disease‐like skin eruptions: report of a case and review of the Japanese patients (2009) (17)
New Etiology of Cholinergic Urticaria. (2016) (17)
Plasmacytoid dendritic cells as a possible key player to initiate alopecia areata in the C3H/HeJ mouse. (2019) (17)
Erosive pustular dermatosis of the scalp and leg associated with myasthenia gravis: A possible pathogenetic role for neutrophil-stimulating cytokines and chemokines. (2010) (17)
Familial acanthosis nigricans with p.K650T FGFR3 mutation (2018) (17)
T-cell proliferation to superantigen-releasing Staphylococcus aureus by MHC class II-bearing keratinocytes under protection from bacterial cytolysin. (1997) (17)
Increased frequencies of Th17 cells in drug eruptions. (2014) (17)
Spontaneous hair follicle cycling may influence the development of murine contact photosensitivity by modulating keratinocyte cytokine production. (1997) (17)
Two cases of lichen planus pigmentosus inversus: possible causative role of tightly fitting underclothes. (2013) (17)
CD8+ CD56+ mycosis fungoides with an indolent clinical behaviour: case report and literature review. (2010) (17)
Ki-1+ cutaneous lymphoma. Gene rearrangement analysis of tumor cells in tissue and short-term culture of a patient. (1988) (17)
Preferential infiltration of interleukin‐4‐producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis (2014) (16)
Decreased expression of suprabasin induces aberrant differentiation and apoptosis of epidermal keratinocytes: Possible role for atopic dermatitis. (2019) (16)
Quinolone-photoconjugated major histocompatibility complex class II-binding peptides with lysine are antigenic for T cells mediating murine quinolone photoallergy. (2001) (16)
Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata. (2013) (16)
Erythrodermic cutaneous T‐cell lymphoma with CD8+CD56+ leukaemic T cells in a young woman (2003) (16)
Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells. (2003) (16)
Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometer (2016) (16)
Th2 cell fluctuation in association with reciprocal occurrence of bullous pemphigoid and psoriasis vulgaris (2006) (16)
Th2 suppressor cells are more susceptible to sphingosine than Th1 cells in murine contact photosensitivity. (1996) (16)
The Various Effects of Four H1‐Antagonists on Serum Substance P Levels in Patients with Atopic Dermatitis (2005) (16)
Downmodulatory Effects of the Antihistaminic Drug Bepotastine on Cytokine/Chemokine Production and CD54 Expression in Human Keratinocytes (2008) (16)
CD8+ cell changes in psoriasis associated with roxithromycin-induced clinical improvement. (2001) (15)
Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype. (2010) (15)
Prostaglandin E2 is critical for the development of niacin-deficiency-induced photosensitivity via ROS production (2013) (15)
Pemphigus vegetans associated with gastric cancer (2007) (15)
Photocontact dermatitis to ketoprofen presenting with erythema multiforme. (2008) (15)
Trichorhinophalangeal syndrome with low expression of TRPS1 on epidermal and hair follicle epithelial cells (2013) (15)
Anti-CCR4 Monoclonal Antibody, Mogamulizumab, Demonstrates Significant Improvement in PFS Compared to Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): Results from the Phase III MAVORIC Study (2017) (15)
Erosive pustular dermatosis of the scalp arising concomitantly with elevation of serum matrix metalloproteinase‐3 in a patient with rheumatoid arthritis (2015) (15)
Photosensitive drug eruption induced by flutamide. (1998) (15)
Inhibitory effect of melanin pigment on sensitization and elicitation of murine contact photosensitivity: mechanism of low responsiveness in C57BL/10 background mice. (1993) (15)
Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunization. (2014) (15)
Papuloerythroderma caused by aspirin. (2006) (14)
Circulating Th17 cell fluctuation in psoriatic patients treated with topical calcipotriol and betamethasone butyrate propionate (2011) (14)
Rothmund-Thomson syndrome with herpes encephalitis. (1999) (14)
Intrinsic atopic dermatitis shows high serum nickel concentration. (2015) (14)
Effects of oral antibiotic roxithromycin on quality of life in acne patients (2009) (14)
Acute generalized exanthematous pustulosis caused by sennoside in a patient with multiple myeloma (2008) (14)
Contact urticaria caused by a fish‐derived elastin‐containing cosmetic cream (2012) (14)
Skin application of ketoprofen systemically suppresses contact hypersensitivity by inducing CD4(+) CD25(+) regulatory T cells. (2009) (14)
Primary cutaneous anaplastic large cell lymphoma with fatal leukemic outcome in association with CLA and CCR4-negative conversion. (2007) (14)
Alterations of immune functions in barrier disrupted skin by UVB irradiation. (2003) (14)
Mechanisms of Local, Low‐dose UVB‐induced Immunosuppression in Contact Hypersensitivity (1992) (13)
Addition of UVA-absorber butyl methoxy dibenzoylmethane to topical ketoprofen formulation reduces ketoprofen-photoallergic reaction. (2012) (13)
Percutaneous Peptide Immunization via Corneum Barrier‐disrupted Murine Skin for Experimental Tumor Immunoprophylaxis (2001) (13)
Primary apocrine adenocarcinoma with neuroendocrine differentiation occurring on the pubic skin (2004) (13)
Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes. (2006) (13)
Analysis of 8-hydroxyguanine (8-OH-Gua) released from DNA by the formamidopyrimidine DNA glycosylase (Fpg) protein: a reliable method to estimate cellular oxidative stress. (2004) (13)
Elevated expression of activation-induced cytidine deaminase in T and NK cells from patients with chronic active Epstein-Barr virus infection. (2011) (13)
Tinea profunda cysticum caused by Trichophyton rubrum. (2006) (13)
Twist1 as a possible biomarker for metastatic basal cell carcinoma. (2012) (13)
Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia/lymphoma with skin involvement (2013) (13)
Lymphocyte stimulation test with drug-photomodified cells in patients with quinolone photosensitivity. (1999) (12)
A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22. (2010) (12)
Superficial Angiomyxoma on the Scrotum of a Child (2011) (12)
Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells. (1999) (12)
Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8 T cells. (2000) (12)
Defective epidermal induction of S100A7/psoriasin associated with low frequencies of skin-infiltrating Th17 cells in dermatophytosis-prone adult T cell leukemia/lymphoma. (2013) (12)
Prostaglandin E2-EP3 Axis in Fine-Tuning Excessive Skin Inflammation by Restricting Dendritic Cell Functions (2013) (12)
Percutaneous penetration via hand eczema is the major accelerating factor for systemic absorption of toluene and xylene during car spray painting (2007) (12)
Potential role of transforming growth factor‐beta 1/Smad signaling in secondary lymphedema after cancer surgery (2020) (12)
Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology. (2013) (12)
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma (2021) (12)
Skin application of the nonsteroidal anti‐inflammatory drug ketoprofen downmodulates the antigen‐presenting ability of Langerhans cells in mice (2008) (12)
Clear cell hidradenoma with whorl formation of squamoid cells: immunohistochemical and electron microscopic studies. (1989) (12)
Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris (2013) (12)
d‐penicillamine‐induced pemphigus successfully treated with combination therapy of mizoribine and prednisolone (2004) (12)
Vaccine therapy for cutaneous T-cell lymphoma. (2003) (12)
Solar urticaria as a manifestation of Churg–Strauss syndrome (2007) (12)
Mechanisms of contact photosensitivity in mice. VI. Oxygen intermediates are involved in contact photosensitization but not in ordinary contact sensitization. (1986) (12)
Retinoid augmentation of bioactive interleukin‐1 production by murine keratinocytes (1992) (12)
CXCR3 and CCR4 double positive tumor cells in granulomatous mycosis fungoides. (2006) (12)
Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201) (2019) (11)
Possible enhancement of BP180 autoantibody production by herpes zoster (2016) (11)
Topical cholecystokinin depresses itch-associated scratching behavior in mice. (2011) (11)
The role of low-density lipoprotein receptors in sensitivity to killing by Photofrin-mediated photodynamic therapy in cultured human tumor cell lines. (2005) (11)
Erythema annulare centrifugum associated with herpes zoster. (2008) (11)
Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. (1996) (11)
Pseudolymphomatous folliculitis presenting with multiple nodules. (2009) (11)
Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab. (2018) (11)
Drug photoallergy (2018) (11)
A case of cholinergic urticaria associated with acquired generalized hypohidrosis and reduced acetylcholine receptors: cause and effect? (2011) (11)
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with high‐risk cutaneous squamous cell carcinoma (2016) (11)
Efficacy of Using Pseudoceramide-containing Cream for the Treatment of Atopic Dry Skin in Comparison with Urea Cream. (2002) (11)
Toxic epidermal necrosis-like dermatosis induced by the first course of methotrexate. (2009) (11)
High levels of activation‐induced cytidine deaminase expression in adult T‐cell leukaemia/lymphoma (2011) (11)
Primary signet‐ring cell/histiocytoid carcinoma of the eyelid expressing androgen receptors and treated with bicalutamide (2017) (11)
Evaluation of photoallergic potential of chemicals using THP-1 cells. (2008) (11)
Measurement of cutaneous lymphatic flow rates in patients with skin cancer: area extraction method (2014) (11)
Efficacious treatment of psoriasis with low‐dose and intermittent cyclosporin microemulsion therapy (2014) (10)
Acicular, but not globular, titanium dioxide nanoparticles stimulate keratinocytes to produce pro‐inflammatory cytokines (2013) (10)
Connexin 26 (GJB2) mutations in keratitis–ichthyosis–deafness syndrome presenting with squamous cell carcinoma (2012) (10)
Sarcoid‐like reaction and vitiligo occurring after nivolumab therapy in a patient with metastatic melanoma (2019) (10)
Cholecystokinin Downregulates Psoriatic Inflammation by Its Possible Self-Regulatory Effect on Epidermal Keratinocytes (2019) (10)
Linear IgA bullous dermatosis following human papillomavirus vaccination. (2012) (10)
Emergence of Photosensitivity with Decreased Treg Cells in a Patient with Mycosis Fungoides Treated with Anti-CC Chemokine Receptor 4 Antibody Mogamulizumab. (2016) (10)
Possible involvement of T lymphocytes in the pathogenesis of Nagashima‐type keratosis palmoplantaris (2009) (10)
The contribution made by skin‐infiltrating basophils to the development of alpha‐gal syndrome (2019) (10)
Suprabasin-null mice retain skin barrier function and show high contact hypersensitivity to nickel upon oral nickel loading (2020) (10)
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with extramammary Paget's disease (2017) (10)
Skin infiltration of pathogenic migratory and resident T cells is decreased by Secukinumab treatment in psoriasis. (2020) (10)
Scabies‐induced acquired reactive perforating collagenosis (2007) (10)
Direct and indirect action modes of acetylcholine in cholinergic urticaria. (2020) (10)
Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol. (2016) (10)
Doripenem‐induced intertriginous drug eruption as a mild form of AGEP (2009) (10)
Oral allergy syndrome caused by raw fish in a Japanese sushi bar worker (2007) (10)
Increased number of dendritic epidermal T cells associated with induced anagen phase of hair cycles. (1994) (10)
Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3 (2016) (10)
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori (2016) (10)
Enhancement of adipogenesis induction by conditioned media obtained from cancer cells. (2008) (10)
ACCESSORY CELL ABILITY OF LANGERHANS CELLS FOR SUPERANTIGEN IS RESISTANT TO ULTRAVIOLET‐B LIGHT (1994) (10)
Angiolymphoid hyperplasia with eosinophilia occurring on the penis. (2010) (9)
What are the most promising strategies for the therapeutic immunomodulation of allergic diseases? Note (2001) (9)
Colonic involvement in Stevens-Johnson syndrome-like mucositis without skin lesions. (2015) (9)
Roxithromycin down-modulates antigen-presenting and interleukin-1 beta-producing abilities of murine Langerhans cells. (1998) (9)
Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus. (2013) (9)
Identification and Characterization of a Recessive Missense Mutation p.P277L in SERPINB7 in Nagashima-Type Palmoplantar Keratosis. (2016) (9)
14-MHz Ultrasonography as an Outcome Measure in Morphea (Localized Scleroderma) (2011) (9)
Development of a prominent granulomatous eruption after interferon-gamma therapy in a patient with mycosis fungoides. (2010) (9)
Telangiectasia macularis eruptiva perstans in polycythemia rubra vera. (2002) (9)
Hyporesponsiveness of peripheral blood lymphocytes to streptococcal superantigens in patients with guttate psoriasis: evidence for systemic stimulation of T cells with superantigens released from focally infecting Streptococcus pyogenes (1999) (9)
Decreased expression of homeostatic chemokine receptors in intravascular large B-cell lymphoma. (2012) (9)
Congenital woolly hair without P2RY5 mutation (2009) (9)
Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes. (2005) (9)
Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege (2014) (9)
Dramatic exacerbation of palmoplantar pustulosis following strongly positive nickel patch testing (2014) (9)
Reciprocal contribution of Th17 and regulatory T cells in severe drug allergy. (2016) (9)
High calcium induces heat shock proteins 72 and 60 in cultured human keratinocytes: comparative study with heat shock and sunlamp light irradiation. (1994) (9)
Ultraviolet-induced suppressor T cells and factor(s) in murine contact photosensitivity. III. Mode of action of T-cell-suppressor factor(s) and interaction with cytokines. (1990) (9)
Skin, drug and chemical reactions (2008) (9)
CD8+ Sézary syndrome with interleukin‐22 production modulated by bacterial sepsis (2013) (9)
Raynaud phenomenon, digital gangrene and hypergammaglobulinaemic purpura occurring in a patient with IgG4‐related disease (2011) (9)
Epidermolysis bullosa acquisita associated with psoriasis. (2010) (9)
Multiple pilomatricomas in association with 21‐hydroxylase deficiency (2010) (9)
Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine. (1999) (8)
Mechanisms of contact photosensitivity in mice. VII. Diminished elicitation by reserpine and defective expression in mast cell-deficient mice. (1986) (8)
The Vitamin D3 analogue calcipotriol suppresses CpG‐activated TLR9‐MyD88 signalling in murine plasmacytoid dendritic cells (2018) (8)
Downregulation of Innate and Acquired Antitumor Immunity by Bystander g d and a b T Lymphocytes with Th2 or Tr1 Cytokine Profiles (1999) (8)
Acute onset disseminated superficial porokeratosis associated with exacerbation of diabetes mellitus due to development of anti-insulin antibodies (2010) (8)
Kimura's disease presenting with a giant suspensory tumor and associated with membranoproliferative glomerulonephritis. (2009) (8)
Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus. (1996) (8)
An immunohistologic study on eccrine gland carcinoma. (1989) (8)
Atopic dermatitis as Th2 disease revisited (2018) (8)
Folliculotropic mycosis fungoides presenting as papuloerythroderma (2006) (8)
Acquired Idiopathic Generalized Anhidrosis (AIGA) and Its Complications: Implications for AIGA as an Autoimmune Disease (2021) (8)
Protective role of Galectin‐7 for skin barrier impairment in atopic dermatitis (2020) (8)
Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis (2016) (8)
Evaluation of toxicity and Stat3 activation induced by hydrogen peroxide exposure to the skin in healthy individuals. (2010) (8)
Augmentation of monocyte interleukin‐8 production by psoralen/UVA‐treated CD4+ T cells (2002) (8)
Rosacea-like demodicosis mimicking cutaneous lymphoma. (2012) (8)
High responses of peripheral lymphocytes to mosquito salivary gland extracts in patients with Wells syndrome. (2010) (8)
Cutaneous plasmacytosis as a skin manifestation of IgG4-related disease. (2013) (8)
Epidemiology of adult T‐cell leukemia‐lymphoma in Japan: An updated analysis, 2012‐2013 (2021) (8)
‘Nagashima‐type’ keratosis palmoplantaris in two siblings (2009) (8)
Angiolymphoid hyperplasia with eosinophilia on the leg successfully treated with T‐helper cell 2 cytokine inhibitor suplatast tosilate (2011) (8)
Development of novel in vitro photosafety assays focused on the Keap1–Nrf2–ARE pathway (2016) (7)
Dendritic Cells Promote the Spread of Human T-Cell Leukemia Virus Type 1 via Bidirectional Interactions with CD4+ T Cells. (2019) (7)
Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo (2010) (7)
Bullous pemphigoid, figurate erythema and generalized pigmentation with skin thickening in a patient with adenocarcinoma of the stomach. (1985) (7)
Alopecia universalis associated with impaired interleukin-4 production and low serum IgE level. (2007) (7)
Generalized eruptive xanthoma with prominent deposition of naked chylomicrons: evidence for chylomicrons as the origin of urate‐like crystals (2010) (7)
Hypersensitivity to mosquito bites in association with chronic Epstein–Barr virus infection and natural killer (NK) leukaemia/lymphoma with expansion of NK cells expressing a low level of CD56 (2002) (7)
Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes. (2007) (7)
Heparin serves as a natural stimulant of the inflammasome and exacerbates the symptoms of tumor necrosis factor receptor-associated periodic syndrome (TRAPS). (2012) (7)
Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum. (2012) (7)
Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
Deep cutaneous infection with Microsphaeropsis arundinis: report of two Japanese cases. (2015) (7)
Expression of Snail1 in the vimentin‐expressing squamous cell carcinoma mimicking atypical fibroxanthoma: possible involvement of an epithelial–mesenchymal transition (2010) (7)
Eruptive milium‐like syringoma showing eccrine duct origin of milia (2012) (7)
[The biological role of UVB-induced cutaneous immunosuppression]. (2012) (6)
RIFM fragrance ingredient safety assessment, coumarin, CAS Registry Number 91-64-5. (2019) (6)
Disseminated maculopapular eruption caused by leuprorelin acetate. (2008) (6)
Decreased responsiveness of T cells to toxic shock syndrome toxin-1 in patients with severe psoriasis at active stage (1997) (6)
Severe muscle weakness to necessitate rehabilitation in a case of trichorhinophalangeal syndrome type II (2009) (6)
Angiohistiocytoid papules associated with atopic dermatitis (2008) (6)
A case of laryngeal carcinoma in a young adult with dyskeratosis congenita (2010) (6)
Cutaneous T‐cell lymphoma with massive co‐infiltration of polyclonal B cells (1994) (6)
Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti‐desmoglein 3 serum antibodies by routine tests (2015) (6)
Expression of T-cell cytokines in challenged skin of murine allergic contact photosensitivity: low responsiveness is associated with induction of Th2 cytokines. (2000) (6)
Atopic Dermatitis: Common Extrinsic and Enigmatic Intrinsic Types (2016) (6)
Erythema multiforme‐like drug eruption caused by sennoside (2006) (6)
Successful differentiation of herpes zoster‐associated erythema multiforme from generalized extension of herpes by rapid polymerase chain reaction analysis (2014) (6)
Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer. (2015) (6)
Lichen spinulosus in an alcoholic patient. (2009) (6)
[Anti-microbial therapies for acne vulgaris: anti-inflammatory actions of anti-microbial drugs and their effectiveness]. (2007) (6)
Alopecia areata possibly induced by autoimmune reaction in a patient with human T‐cell lymphotropic virus‐1‐associated myelopathy (2013) (6)
RIFM fragrance ingredient safety assessment, acetophenone, CAS Registry Number 98-86-2. (2018) (6)
Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells (2009) (6)
Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis. (2017) (6)
Erythema multiforme-like eruption associated with contact dermatitis to cutting oil. (2001) (6)
Palmar pseudolymphoma associated with herpes simplex infection (2009) (6)
Eosinophilic pustular folliculitis successfully treated with sequential therapy of interferon-gamma and ciclosporin. (2006) (6)
[A case of dyshidrosiform pemphigoid]. (2011) (6)
Leukoderma in patients with atopic dermatitis (2015) (6)
Similarities of dermoscopic findings in alopecia areata between human and C3H/HeJ mouse. (2016) (6)
Sebaceous carcinoma arising at a chronic candidiasis skin lesion of a patient with keratitis–ichthyosis–deafness (KID) syndrome (2012) (6)
RIFM fragrance ingredient safety assessment, terpineol, CAS Registry Number 8000-41-7. (2017) (6)
Epstein–Barr virus‐associated T‐cell lymphoproliferative disorder affecting skin and lung in an elderly patient (2014) (6)
A Japanese case of Mal de Meleda with SLURP1 mutation (2014) (6)
UV Dose Measurements of Photosensitive Dermatosis Patients by Polycrystalline GaN–based Portable Self-data-acquisition UV Monitor¶ (2002) (6)
Identification and Characterization of a Recessive Missense Mutation p.P277L in SERPINB7 in Nagashima-Type Palmoplantar Keratosis. (2015) (5)
Successful treatment of chronic intractable pain with risperidone in a patient with acquired idiopathic generalized anhidrosis (2018) (5)
[Th17 cells and skin diseases]. (2012) (5)
Eruptive generalized granuloma annulare presenting with numerous micropapules (2010) (5)
Actinic reticuloid: an immunohistochemical study. (1987) (5)
Quadruple extra-mammary Paget's disease. (2007) (5)
Tuberculosis verrucosa cutis with elevation of circulating T‐helper 1 and 17 cells and their reductions after successful treatment (2012) (5)
Drug‐induced papuloerythroderma of Ofuji: Comment (2008) (5)
Immunological and molecular mechanisms of photoallergic contact dermatitis. (2003) (5)
Application of a three-microneedle device for the delivery of local anesthetics (2015) (5)
Alopecia universalis following two sequential traffic accidents: possible association with increased Th1 and Th17 cells and decreased Th2 cells. (2011) (5)
Identification of a novel mutation, c.686delAins18 (p.Asp229Glyfs*22), in the LIPH gene as a compound heterozygote with c.736T>A (p.Cys246Ser) in autosomal recessive woolly hair/hypotrichosis (2015) (5)
PD-1 expression defines epidermal CD8+CD103+ T cells preferentially producing IL-17A and using skewed TCR repertoire in psoriasis. (2021) (5)
Acute hepatic failure secondary to extensive hepatic replacement by metastatic amelanotic melanoma: an autopsy case report (2010) (5)
An intuitive explanation of dermoscopic structures by digitally reconstructed pathological horizontal top-down view images (2019) (5)
Scabies superimposed on skin lesions of adult T‐cell leukemia/lymphoma: case report and literature review (2008) (5)
Coincident two mutations and one single nucleotide polymorphism of the PTCH1 gene in a family with naevoid basal cell carcinoma syndrome. (2008) (5)
Loss of tumor cell CCR4 expression upon leukemic change in adult T-cell leukemia/lymphoma. (2009) (5)
Three‐microneedle device as an effective option for intralesional corticosteroid administration for the treatment of alopecia areata (2017) (5)
Successful control of severe eosinophilic granulomatosis with polyangiitis in a pregnancy and perinatal period: A use of mepolizumab (2019) (5)
A case of a long‐time survivor with chronic active Epstein–Barr virus infection (2004) (5)
Palmar hyperlinearity in early childhood atopic dermatitis is associated with filaggrin mutation and sensitization to egg (2019) (5)
Erythrokeratodermia variabilis: First Japanese case documenting GJB3 mutation (2013) (5)
Histiocytoid Sweet’s syndrome associated with t(9;22)(q34;q11)‐positive chronic myelogenous leukemia: immature granulocytic origin of histiocytic cells (2013) (5)
Pancytopenia in tuberous sclerosis. (2001) (5)
Development of an in vitro photosensitization test based on changes of cell-surface thiols and amines as biomarkers: the photo-SH/NH₂ test. (2016) (5)
RIFM fragrance ingredient safety assessment, cinnamaldehyde, CAS Registry Number 104-55-2. (2019) (5)
[S-100 protein-positive cells in sweat apparatus tumors]. (1985) (5)
Cryptococcosis: long-lasting presence of fungi after successful treatment. (2004) (5)
Identification of a novel heterozygous mutation in the first Japanese case of Marie Unna hereditary hypotrichosis (2013) (5)
Pustular psoriasis‐like lesions associated with hereditary lactate dehydrogenase M subunit deficiency without interleukin‐36 receptor antagonist mutation: long‐term follow‐up of two cases (2015) (5)
Methylmalonic aciduria presenting with recurrent multiple molluscum contagiosum lesions (2010) (5)
Artificial foreign body embolism after percutaneous cardiac catheterization. (2006) (4)
Digitally reconstructed top‐down view images provide intuitive understanding of the correlation between dermoscopy and histopathology: a good educational tool (2019) (4)
Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis (2021) (4)
Sterile suppurative folliculitis associated with acute myeloblastic leukaemia (2002) (4)
Folliculosebaceous cystic hamartoma presenting as a subcutaneous nodule on the thigh (2013) (4)
Drug eruption to clavulanic acid with sparing of cellulitis-affecting site. (2015) (4)
Therapeutic Effectiveness of Immunoradiotherapy on Brain-metastatic BRAF/MEK Inhibitor-resistant Melanoma with Balloon Cell Change. (2019) (4)
Determination of action spectrum for sparfloxacin‐photosensitized single‐strand breaks in plasmid pBR322 DNA (2005) (4)
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion. (2012) (4)
A case of idiopathic pure sudomotor failure associated with prolonged high levels of serum carcinoembryonic antigen (2016) (4)
Induction of contact photosensitivity to TCSA using photohapten-modified syngeneic spleen cells (2004) (4)
Facial Erythema and Pigmentation as an Initial Manifestation of Chronic Graft‐versus‐Host Disease (1994) (4)
Haemodialysis-induced pseudoporphyria successfully treated with glutathione. (2012) (4)
Erythema multiforme associated with Gardnerella vaginosis and elevated circulating CXCR3+ B cells (2008) (4)
A novel missense mutation in the PAX3 gene in a case of Waardenburg syndrome type I (2009) (4)
Development of a Three-Microneedle Device for Hypodermic Drug Delivery and Clinical Application (2012) (4)
Photodynamic DNA-breaking activity of serum from patients with various photosensitivity dermatoses (2004) (4)
Cutaneous pharmacokinetics of topically applied maxacalcitol ointment and lotion. (2008) (4)
Segmental lentiginosis and café au lait spots within naevoid hypopigmentation (2008) (4)
RIFM fragrance ingredient safety assessment, β-caryophyllene alcohol, CAS Registry Number 472-97-9. (2018) (4)
2020 guidelines for the diagnosis and treatment of prurigo (2021) (4)
RIFM fragrance ingredient safety assessment, ethylene brassylate, CAS Registry Number 105-95-3. (2016) (4)
Systematic mentoring on three continents. (2011) (4)
RIFM fragrance ingredient safety assessment, ethyl benzoate, CAS Registry Number 93-89-0. (2018) (4)
Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis (2004) (4)
Photocontact dermatitis : from basic photobiology to clinical relevance (2005) (4)
7th Drug hypersensitivity meeting: part two (2016) (4)
Paediatric acute generalized exanthematous pustulosis induced by paracetamol with high serum levels of interleukin-8 and -22: a case report. (2013) (4)
Dominant dystrophic epidermolysis bullosa pruriginosa with a COL7A1 exon 87 c.6898C>T mutation (2018) (4)
Soluble form of vascular cell adhesion molecule-1 in systemic lupus erythematosus and discoid lupus erythematosus. (1996) (4)
Subcutaneous granuloma annulare following influenza vaccination in a patient with diabetes mellitus (2014) (4)
Ultraviolet-induced suppressor T cells and factor(s) in murine contact photosensitivity. II. Igh-V restriction of T-cell-suppressor factor. (1989) (4)
Follicular cyst derived from hair matrix and outer root sheath (1989) (4)
TGFβ/SMAD4 signalling is inhibited in tumour cells and infiltrating lymphocytes of a patient with colon cancer‐associated dermatomyositis (2015) (4)
Detection of autoantibodies against the calcium‐dependent epitopes of desmoglein 3 by ethylenediaminetetraacetic acid‐treated enzyme‐linked immunosorbent assay with mammalian cell expression system (2015) (4)
RIFM fragrance ingredient safety assessment, cinnamyl alcohol, CAS Registry Number 104-54-1. (2020) (3)
Evaluation of ultraviolet-A protection by sunscreen agents using a mouse model of contact photoallergy. (1994) (3)
A novel missense mutation in the TRPS1 gene in a case of trichorhinophalangeal syndrome type I (TRPS1) with fish‐like malodour (2010) (3)
RIFM fragrance ingredient safety assessment, 2-undecanone, CAS Registry Number 112-12-9. (2019) (3)
RIFM fragrance ingredient safety assessment, decanoic acid, CAS Registry Number 334-48-5. (2020) (3)
Calcitriol-induced hypercalcemia in a patient with granulomatous mycosis fungoides and end-stage renal disease. (2013) (3)
RIFM fragrance ingredient safety assessment, benzyl benzoate, CAS Registry Number 120-51-4. (2020) (3)
Therapeutic efficacy of mizoribine for discoid lupus erythematosus with normalized frequency of circulating T helper 17 cells (2011) (3)
Granulocyte-colony stimulating factor-producing primary cutaneous anaplastic large cell lymphoma with cerebral metastasis. (2013) (3)
Coexistence of linear morphea and nodular mucinosis (2013) (3)
Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study (2019) (3)
Food-dependent anaphylaxis with serum IgE immunoreactive to dairy products containing high-molecular-weight proteins. (2010) (3)
Human T‐lymphotropic virus 1 (HTLV‐1)‐associated lichenoid dermatitis induced by CD8+ T cells in HTLV‐1 carrier, HTLV‐1‐associated myelopathy/tropical spastic paraparesis and adult T‐cell leukemia/lymphoma (2015) (3)
Infiltration of mast cells in pachydermia of pachydermoperiostosis (2017) (3)
Psychological aspects of patients with intrinsic atopic dermatitis (2014) (3)
RIFM fragrance ingredient safety assessment, p-mentha-1,8-dien-7-ol, CAS Registry Number 536-59-4. (2018) (3)
RIFM fragrance ingredient safety assessment, δ-3-carene, CAS Registry Number 13466-78-9. (2018) (3)
Simultaneous reactivation of cytomegalovirus in an adult patient with varicella (2015) (3)
RIFM fragrance ingredient safety assessment, caryophyllene oxide, CAS Registry Number 1139-30-6. (2020) (3)
Blocking of CTLA-4 on lymphocytes improves the sensitivity of lymphocyte transformation tests in a patient with nickel allergy. (2012) (3)
RIFM fragrance ingredient safety assessment, octanoic acid, CAS Registry Number 124-07-2. (2020) (3)
Influence of Th2 cells on hair cycle/growth after repeated cutaneous application of hapten (2014) (3)
Th1 Chemokine CXCL10 and Alopecia Areata: The Possible Target for the Treatment of Alopecia Areata (2016) (3)
Epidermal CD8+CD103+ skin resident memory T cells in psoriasis plaques are reduced in number but remain in the basement membrane zone after topical application of corticosteroid and vitamin D3. (2022) (3)
Corrigendum to "Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis" [J. Dermatol. Sci. 81 (2016) 153-164]. (2017) (3)
Case of renal metastasis of melanoma successfully controlled by a combination therapy of nivolumab and radiation (2018) (3)
Evidence for polyclonal infection of Epstein–Barr virus in a patient with primary cutaneous anaplastic large cell lymphoma (2004) (3)
Lymphatic transit rate as a novel predictive parameter for nodal metastasis in primary truncal skin cancers (2016) (3)
Cutaneous pseudolymphoma due to benidipine hydrochloride with massive infiltration of eosinophils (2011) (3)
Herpes zoster occurring as a solitary nodule on the index finger (2004) (3)
Second report of FLG R501X mutation in Japanese patients with atopic dermatitis (2013) (3)
[Chromoblastomycosis caused by Fonsecaea monophora]. (2011) (3)
Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma (2018) (3)
Transverse nasal crease with milia and comedones: Dermoscopic observation (2018) (3)
A case of suppurative granuloma induced by insulin injection. (2010) (3)
Multiple facial plaques of diffuse plane xanthoma arising from regressed tumours of folliculotropic mycosis fungoides (2020) (3)
Chondrodermatitis of the auricle in patients with atopic dermatitis. (2010) (3)
Spinal cord compression presumably due to metastasized cutaneous squamous cell carcinoma to the thoracic spine. (2010) (3)
Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages (2016) (3)
Churg-Strauss syndrome presenting with severe cutaneous and intestinal ulcers. (2012) (3)
RIFM fragrance ingredient safety assessment, p-cymene, CAS Registry Number 99-87-6. (2021) (2)
Unknown primary Merkel cell carcinoma responding well to first‐line treatment with avelumab (2019) (2)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-1,6-nonadien-3-ol, CAS Registry Number 10339-55-6. (2016) (2)
RIFM fragrance ingredient safety assessment, 2-octanone, CAS Registry Number 111-13-7. (2019) (2)
The potential of selected prostanoid receptors as targets in a new therapeutic strategy for allergy and immune diseases. (2007) (2)
Organizing pneumonia associated with multicentric reticulohistiocytosis (2015) (2)
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study (2022) (2)
Mixed tumor of the skin arising on the auricle (2009) (2)
RIFM fragrance ingredient safety assessment, hexyl butyrate, CAS Registry Number 2639-63-6. (2019) (2)
RIFM fragrance ingredient safety assessment, 3,5-dimethoxytoluene, CAS Registry Number 4179-19-5. (2019) (2)
RIFM fragrance ingredient safety assessment, myrcene, CAS Registry Number 123-35-3. (2020) (2)
Lymphocyte chemoattractive activity of soluble ICAM-1 from transformed human keratinocytes (1994) (2)
The human vermilion surface contains a rich amount of cholesterol sulfate than the skin. (2021) (2)
RIFM fragrance ingredient safety assessment, α-amylcinnamaldehyde dimethyl acetal, CAS Registry Number 91-87-2. (2021) (2)
RIFM fragrance ingredient safety assessment, menthyl acetate (isomer unspecified), CAS Registry Number 16409-45-3. (2017) (2)
RIFM fragrance ingredient safety assessment, 2-ethylbutyric acid, CAS Registry Number 88-09-5. (2020) (2)
Fexofenadine downmodulates antigen-presenting ability of murine epidermal Langerhans cells. (2008) (2)
Giant Suspensory Lipoma with Calcification (2004) (2)
RIFM fragrance ingredient safety assessment, l-carvone, CAS Registry Number 6485-40-1. (2022) (2)
RIFM fragrance ingredient safety assessment, isovaleric acid, CAS Registry Number 503-74-2. (2019) (2)
[Necessary number of dedicated industrial physicians in Japan: evaluated from the establishment and enterprise census]. (2010) (2)
Systemic cholesterol embolization syndrome in a patient positive for anti-cardiolipin antibody (2010) (2)
RIFM fragrance ingredient safety assessment, linalool, CAS Registry number 78-70-6. (2021) (2)
RIFM fragrance ingredient safety assessment, methyl anthranilate, CAS Registry Number 134-20-3. (2017) (2)
Wheat-dependent Exercise-induced Anaphylaxis Elicited by Danish Pastry: Requirement of Both Exercise and Aspirin for Provocation (2009) (2)
Trichophyton tonsurans‐induced kerion celsi with decreased defensin expression and paradoxically increased interleukin‐17A production (2019) (2)
Indolent multipapular adult T‐cell leukemia/lymphoma with phenotype of resident memory T cells (2020) (2)
RIFM fragrance ingredient safety assessment, citronellal, CAS Registry Number 106-23-0. (2021) (2)
RIFM fragrance ingredient safety assessment, butyric acid, CAS Registry Number 107-92-6. (2019) (2)
RIFM fragrance ingredient safety assessment, Hexyl acetate, CAS Registry Number 142-92-7. (2018) (2)
RIFM fragrance ingredient safety assessment, p-mentha-1,4-diene, CAS Registry Number 99-85-4. (2021) (2)
Secukinumab promotes engagement of cholecystokinin and its receptor in epidermal keratinocytes of psoriasis patients (2020) (2)
Cisplatin-induced acral erythema. (2009) (2)
[Seborrheic keratosis on the umbilicus: case report and review of Japanese literature]. (2009) (2)
A high serum concentration of chemerin in pustular dermatitis paradoxically induced by etanercept. (2012) (2)
Increment of circulating plasmacytoid dendritic cells in a patient with Kaposi's varicelliform eruption (2007) (2)
RIFM fragrance ingredient safety assessment, citral, CAS Registry Number 5392-40-5. (2020) (2)
Idiopathic segmental anhidrosis associated with varicella (2017) (2)
RIFM fragrance ingredient safety assessment, trans-2-Hexenol, CAS Registry Number 928-95-0. (2018) (2)
Recurrent Facial Erythema with Cytotoxic T Cell Infiltration as a Possible Reactive Eruption in a Human T-Cell Lymphotropic Virus Type 1 Carrier (2015) (2)
2020 guidelines for the diagnosis and treatment of cutaneous pruritus (2021) (2)
Acute generalized exanthematous pustulosis caused by fexofenadine (2018) (2)
RIFM fragrance ingredient safety assessment, dl-limonene (racemic), CAS Registry Number 138-86-3. (2021) (2)
RIFM fragrance ingredient safety assessment, ethyl pyruvate, CAS Registry Number 617-35-6. (2019) (2)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-6-octenoic acid, CAS Registry Number 502-47-6. (2019) (2)
RIFM fragrance ingredient safety assessment, dodecyldimethylamine oxide, CAS Registry Number 1643-20-5. (2020) (2)
RIFM fragrance ingredient safety assessment, nootkatone, CAS Registry Number 4674-50-4. (2020) (2)
RIFM fragrance ingredient safety assessment phenethyl isovalerate, CAS Registry Number 140-26-1. (2018) (2)
A missense mutation in exon 1 of the keratin 9 gene in a Japanese patient with "Vörner type" hereditary palmoplantar keratoderma. (2009) (2)
Gross Cystic Disease Fluid Protein 15 in Stratum Corneum Is a Potential Marker of Decreased Eccrine Sweating for Atopic Dermatitis (2015) (2)
RIFM fragrance ingredient safety assessment, 2-phenoxyethanol, CAS Registry Number 122-99-6. (2019) (2)
Multiple milia and comedones as a skin manifestation of systemic amyloidosis. (2011) (2)
A novel missense mutation in the PTCH1 gene in a premature case of nevoid basal cell carcinoma syndrome. (2009) (2)
Photoinduced histiocytoid Sweet's syndrome (2019) (2)
Successful treatment of postburn flexion contracture in fingers of early childhood with dynamic splint therapy after operation: long-term follow-up (2017) (2)
RIFM fragrance ingredient safety assessment, 4-(p-hydroxyphenyl)-2-butanone, CAS Registry Number 5471-51-2. (2019) (2)
Inhibitory effect of roxithromycin on the myeloperoxidase activity of peripheral polymorphonuclear leukocytes: Its evaluation in patients with psoriasis and pustulosis palmaris et plantaris. (1995) (2)
The hair follicle‐psoriasis axis: Shared regulatory mechanisms and therapeutic targets (2021) (2)
A Japanese Case of Typical Epstein‐Barr Virus Non‐Associated Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (2004) (2)
RIFM fragrance ingredient safety assessment, ethyl levulinate, CAS Registry Number 539-88-8. (2019) (2)
T cell‐rich angiomatoid polypoid pseudolymphoma arising after local injury on the lip of a pregnant woman (2019) (2)
Fluctuation of circulating plasmacytoid dendritic cells in a patient with psoriatic arthritis (2008) (2)
Tissue resident memory T cells in lesional and non‐lesional psoriatic skin on a scar (2020) (2)
RIFM Fragrance Ingredient Safety Assessment,(E,Z)-2,6-nonadien-1-ol acetate, CAS Registry Number 68555-65-7. (2019) (2)
RIFM fragrance ingredient safety assessment, longifolene, CAS Registry Number 475-20-7. (2019) (2)
Treatment of a patient with neutrophilic dermatoses with granulocyte and monocyte adsorption apheresis: effects on serum cytokine levels (2015) (1)
RIFM fragrance ingredient safety assessment, 4-ethylbenzaldehyde, CAS Registry Number 4748-78-1. (2020) (1)
Voriconazole‐photoinduced polyomavirus‐negative Merkel cell carcinoma (2019) (1)
Update to RIFM fragrance ingredient safety assessment, eugenol, CAS Registry Number 97-53-0. (2022) (1)
RIFM fragrance ingredient safety assessment, ethyl phenylacetate, CAS Registry Number 101-97-3. (2018) (1)
RIFM fragrance ingredient safety assessment, Fenchone, CAS Registry Number 1195-79-5. (2018) (1)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-3,6-octadienal, CAS Registry Number 55722-59-3. (2020) (1)
RIFM fragrance ingredient safety assessment, 3-methyldodecanonitrile, CAS Registry Number 85351-07-1. (2019) (1)
RIFM fragrance ingredient safety assessment, p-menth-8-en-2-one, CAS Registry Number 7764-50-3. (2019) (1)
RIFM fragrance ingredient safety assessment, 1-octen-3-ol, CAS registry number 3391-86-4. (2019) (1)
Capsule‐like naevus: digital 3D reconstruction of its steric structure (2020) (1)
Rapid growth of scalp melanoma in a pediatric patient (2018) (1)
RIFM fragrance ingredient safety assessment, menthyl isovalerate CAS Registry Number 16409-46-4. (2017) (1)
RIFM fragrance ingredient safety assessment, hexyl isobutyrate, CAS Registry Number 2349-07-7. (2019) (1)
RIFM fragrance ingredient safety assessment, isobutyl propionate, CAS Registry Number 540-42-1. (2019) (1)
RIFM fragrance ingredient safety assessment, methyl mercaptan, CAS Registry Number 74-93-1. (2020) (1)
RIFM fragrance ingredient safety assessment, levulinic acid, CAS Registry Number 123-76-2. (2020) (1)
RIFM fragrance ingredient safety assessment, 1,2-dimethoxybenzene, CAS Registry Number 91-16-7. (2019) (1)
RIFM fragrance ingredient safety assessment, ethyl acetoacetate, CAS Registry Number 141-97-9. (2019) (1)
RIFM fragrance ingredient safety assessment, geranic acid, CAS Registry Number 459-80-3. (2018) (1)
RIFM fragrance ingredient safety assessment, cyclohexyl acetate, CAS Registry Number 622-45-7. (2019) (1)
RIFM fragrance ingredient safety assessment, dodecane, CAS Registry Number 112-40-3. (2020) (1)
Pityriasis rotunda associated with acute myeloid leukemia (2018) (1)
Task-adaptive physical reservoir computing (2022) (1)
Plasmacytoid dendritic cells is a possible key player for the initiation of alopecia areata in the C3H/HeJ mouse (2017) (1)
RIFM fragrance ingredient safety assessment, Isoamyl octanoate, CAS Registry Number 2035-99-6. (2017) (1)
RIFM fragrance ingredient safety assessment, isobutyl alcohol, CAS Registry Number 78-83-1. (2019) (1)
An integrated manual for hematologists and dermatologists to access the guidelines for the management of adult T-cell leukemia-lymphoma (2014). (2014) (1)
RIFM fragrance ingredient safety assessment, acetic acid, (1-oxopropoxy)-, 1-(3,3-dimethylcyclohexyl)ethyl ester, CAS Registry Number 236391-76-7. (2020) (1)
RIFM fragrance ingredient safety assessment, isobutyl hexanoate, CAS Registry Number 105-79-3. (2019) (1)
Occupational skin cancer arising in a patient with a high frequency of circulating regulatory T cells (2012) (1)
RIFM fragrance ingredient safety assessment, ethyl 3-methyl-2-oxopentanoate, CAS Registry Number 26516-27-8. (2021) (1)
RIFM fragrance ingredient safety assessment, ethyl phenethyl ether, CAS Registry Number 1817-90-9. (2018) (1)
Extrinsic and Intrinsic Atopic Dermatitis (2018) (1)
A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Proactive Management in Pediatric Subjects with Moderate to Severe Atopic Dermatitis (2013) (1)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, [2-Isopropoxyethyl]benzene, CAS Registry Number 68039-47-4. (2018) (1)
RIFM fragrance ingredient safety assessment, methyl 2-nonenoate, CAS Registry Number 111-79-5. (2019) (1)
RIFM fragrance ingredient safety assessment, isocyclocitral, CAS Registry number 1335-66-6. (2019) (1)
RIFM fragrance ingredient safety assessment, 1,1-diethoxyheptane, CAS Registry Number 688-82-4. (2018) (1)
RIFM fragrance ingredient safety assessment, 1-nonanol, 2,4,6,8-tetramethyl-,acetate, CAS Registry Number 68922-14-5. (2020) (1)
Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis. (2015) (1)
RIFM fragrance ingredient safety assessment, 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol, CAS Registry Number 67801-20-1. (2018) (1)
Stasis ulcer and dermatitis caused by artificial arteriovenous fistula created 33 years previously for the treatment of poliomyelitis (2006) (1)
RIFM fragrance ingredient safety assessment, cis-5-octen-1-ol CAS Registry Number 64275-73-6. (2017) (1)
RIFM fragrance ingredient safety assessment, methyl 2-nonynoate, CAS Registry Number 111-80-8. (2019) (1)
Polyarteritis nodosa with ureteric stenosis (2018) (1)
RIFM fragrance ingredient safety assessment, methyl N-methylanthranilate, CAS Registry Number 85-91-6 (2021) (1)
Schwannomatosis presenting with large subcutaneous and retroperitoneal tumours (2011) (1)
RIFM fragrance ingredient safety assessment, hexyl benzoate, CAS Registry Number 6789-88-4. (2018) (1)
Journal of Dermatological Science. Greetings from the new Editor-in-Chief. (2013) (1)
RIFM fragrance ingredient safety assessment, decanal dimethyl acetal, CAS Registry Number 7779-41-1. (2017) (1)
RIFM fragrance ingredient safety assessment, glyceryl monooleate, CAS Registry Number 111-03-5. (2021) (1)
RIFM fragrance ingredient safety assessment, 2-methoxy-4-methylphenol, CAS Registry Number 93-51-6. (2021) (1)
Acicular, but not globular, titanium dioxide nanoparticles stimulate keratinocytes to produce cytokines independently of inflammasome (2013) (1)
RIFM fragrance ingredient safety assessment, δ-decalactone, CAS Registry Number 705-86-2. (2021) (1)
Erythrokeratodermia variabilis et progressiva with a rare GJB3 mutation (2020) (1)
RIFM fragrance ingredient safety assessment, myrtenol, CAS Registry Number 515-00-4. (2019) (1)
Unusual clinical manifestations of rubella in the elderly (2016) (1)
RIFM fragrance ingredient safety assessment, oxacyclotridecan-2-one, CAS Registry Number 947-05-7. (2019) (1)
IL-4 and IL-12 Polymorphisms are Associated with Response to Suplatast Tosilate, a Th2 Cytokine Inhibitor, in Patients with Atopic Dermatitis (2012) (1)
IL-4 and IL-12 Polymorphisms are Associated with Response to Suplatast Tosilate, a Th2 Cytokine Inhibitor, in Patients with Atopic Dermatitis (2012) (1)
RIFM fragrance ingredient safety assessment, benzeneacetaldehyde, 3,4-dimethyl-, CAS Registry Number 68844-97-3. (2018) (1)
RIFM fragrance ingredient safety assessment, γ-heptalactone, CAS Registry Number 105-21-5. (2019) (1)
The RIFM approach to evaluating Natural Complex Substances (NCS). (2021) (1)
RIFM fragrance ingredient safety assessment, 2-octyldodecan-1-ol, CAS Registry Number 5333-42-6. (2019) (1)
Induction of eosinophil-infiltrating drug photoallergy in mice. (2009) (1)
RIFM fragrance ingredient safety assessment, amyl butyrate, CAS Registry Number 540-18-1. (2020) (1)
RIFM fragrance ingredient safety assessment, terpinyl acetate (isomer mixture), CAS Registry number 8007-35-0. (2018) (1)
Keloid exacerbation associated with adult T-cell leukemia/lymphoma cell infiltration. (2011) (1)
RIFM fragrance ingredient safety assessment, α-pinene, CAS Registry Number 80-56-8. (2021) (1)
RIFM fragrance ingredient safety assessment, p-isopropylbenzyl alcohol, CAS Registry Number 536-60-7. (2020) (1)
RIFM fragrance ingredient safety assessment, hydroxycitronellal dimethyl acetal, CAS Registry Number 141-92-4. (2019) (1)
RIFM fragrance ingredient safety assessment, 4-hydroxy-3-methyloctanoic acid lactone, CAS Registry Number 39212-23-2. (2020) (1)
RIFM fragrance ingredient safety assessment, 3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, CAS Registry Number 107898-54-4. (2019) (1)
cis -urocanic acid up-regulates interleukin-1β production and UDP-glucose receptor P2RY14 expression: Possible danger sensor of UVB irradiation (2011) (1)
Abstracts of the 2014 Annual Meeting of the Society for Investigative Dermatology, May 7 - 10, 2014, Albuquerque, New Mexico. (2014) (1)
Effect of the H-2 and Igh complexes on the susceptibility to ultraviolet B-induced immunosuppression in murine contact sensitivity and contact photosensitivity. (1990) (1)
RIFM fragrance ingredient safety assessment, 3-phenylpropionic acid, CAS Registry Number 501-52-0. (2019) (1)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl cis-3-hexenoate, CAS Registry Number 61444-38-0. (2020) (1)
RIFM fragrance ingredient safety assessment, hydroxycitronellal diethyl acetal, CAS Registry Number 7779-94-4. (2019) (1)
RIFM fragrance ingredient safety assessment, butyl 10-undecenoate, CAS Registry Number 109-42-2. (2019) (1)
RIFM fragrance ingredient safety assessment, benzothiazole, CAS Registry Number 95-16-9. (2018) (1)
RIFM fragrance ingredient safety assessment, m-cresol, CAS Registry Number 108-39-4. (2021) (1)
Inhibitory effect of melanin pigment on sensitization and elicitation of murine contact photosensitivity: Mechanism of low responsiveness in C57BL10 mice (1993) (1)
CCR5 is a novel target for the treatment of experimental alopecia areata (2020) (1)
An approach to fabricate the polymer hollow microneedle that targets dermal lymphatic vessels in the skin (2013) (1)
RIFM fragrance ingredient safety assessment, phenylacetaldehyde glyceryl acetal, CAS Registry Number 29895-73-6. (2020) (1)
Enhanced PD‐L1 expression on tumor cells in primary cutaneous large T‐cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases (2020) (1)
Occupational contact dermatitis due to polyvinylamine (2008) (1)
RIFM fragrance ingredient safety assessment, 2,4,6-trimethyl-3-cyclohexene-1-methanol, CAS Registry Number 68527-77-5. (2019) (1)
Keratinocyte differentiation is induced by cell-permeant ceramides but inhibited by sphingosine (1993) (1)
RIFM fragrance ingredient safety assessment, anisyl alcohol, CAS registry number 105-13-5. (2019) (1)
RIFM fragrance ingredient safety assessment, 1-cyclohexene-1-propanal, 4-(1-methylethyl)-, (4R), CAS Registry Number 1378867-81-2. (2021) (1)
RIFM fragrance ingredient safety assessment, linalyl phenylacetate, CAS Registry Number 7143-69-3. (2018) (1)
An adolescent case of xeroderma pigmentosum variant confirmed by the onset of sun exposure‐related skin cancer during Crohn's disease treatment (2018) (1)
Lymphomatoid papulosis in children (2000) (1)
Cell-to-cell contact with HTLV-1-infected T cell reduces dendritic cell immune functions and contributes to infection in trans. (2017) (1)
RIFM fragrance ingredient safety assessment, n-furfurylpyrrole, CAS Registry Number 1438-94-4. (2020) (1)
RIFM fragrance ingredient safety assessment, α,2,2,3-tetramethylcyclopent-3-ene-1-butyraldehyde, CAS Registry Number 65114-03-6. (2020) (1)
RIFM fragrance ingredient safety assessment, dihydrocoumarin, CAS Registry Number 119-84-6. (2021) (1)
Galectin-7 is extracellularly released from epidermal keratinocytes in atopic dermatitis and serves as immunomodulator of Langerhans cells (2017) (1)
RIFM fragrance ingredient safety assessment, methyl ionone (mixture of isomers), CAS registry number 1335-46-2. (2019) (1)
Epileptic seizures and cholinergic urticaria with generalized hypohidrosis or anhidrosis. (2011) (1)
Intractable disseminated maculopapular eruption in a patient with granulocyte macrophage colony‐stimulating factor‐producing anaplastic thyroid carcinoma (2019) (1)
RIFM fragrance ingredient safety assessment, 3-(4-methylcyclohex-3-enyl)-3-butenyl acetate, CAS Registry Number 6819-19-8. (2019) (1)
Atopic dermatitis presenting as generalized poikiloderma with filaggrin gene mutation (2014) (1)
RIFM fragrance ingredient safety assessment, sclareolide, CAS Registry Number 564-20-5. (2022) (1)
RIFM fragrance ingredient safety assessment, cis-3-octenyl propionate, CAS Registry Number 94134-03-9. (2018) (1)
RIFM fragrance ingredient safety assessment, dihydroisocaryophyllene epoxide, CAS Registry Number 1209-61-6. (2021) (1)
RIFM fragrance ingredient safety assessment 2,4-dimethylbenzyl acetate, CAS Registry Number 62346-96-7. (2018) (1)
RIFM fragrance ingredient safety assessment, l-menthyl lactate, CAS Registry Number 59259-38-0. (2017) (1)
Lichen planus‐like keratosis emerging in a pediatric case of xeroderma pigmentosum group A (2017) (1)
RIFM fragrance ingredient safety assessment, p-mentha-1,8-dien-7-al, CAS Registry Number 2111-75-3. (2019) (1)
Intramuscular metastasis of malignant melanoma mimicking leg cellulitis. (2012) (1)
RIFM fragrance ingredient safety assessment, cis-jasmone, CAS registry number 488-10-8 (2021) (1)
[Changes of working responsibilities and intentions of industrial physicians who are graduates of University of Occupational and Environmental Health, Japan, in 2001 and 2008 questionnaire analyses]. (2009) (1)
Questionnaire Survey of Possible Association of Allergic Diseases with Adverse Reactions to SARS-CoV-2 Vaccination (2021) (1)
RIFM fragrance ingredient safety assessment, p-dimethoxybenzene, CAS Registry Number 150-78-7. (2019) (1)
RIFM fragrance ingredient safety assessment, cyclohexanone, 2-ethyl-4,4-dimethyl-, CAS Registry Number 55739-89-4. (2019) (1)
Calcipotriol Increases hCAP 18 mRNA Expression but Inhibits Extracellular LL 37 Peptide Production in IL-17 / IL-22-stimulated Normal Human Epidermal Keratinocytes (2014) (1)
Lymphatic transit rate as a predictive parameter for nodal metastasis in primary limb malignant melanoma. (2017) (1)
RIFM fragrance ingredient safety assessment, isopropyl acetate, CAS Registry Number 108-21-4. (2019) (1)
RIFM fragrance ingredient safety assessment, p-α,α-trimethylbenzyl alcohol, CAS Registry Number 1197-01-9. (2020) (1)
Panhypopituitarism in metastatic melanoma patient treated with ipilimumab and pembrolizumab (2019) (1)
RIFM fragrance ingredient safety assessment, p-tert-butylcyclohexanone, CAS Registry Number 98-53-3 (2021) (1)
Comparison of TP53 mutation analysis findings for tar pitch dermatopathy and ionizing radiation-related skin cancer (2021) (1)
Reset Therapy with Cyclosporine A in Psoriasis: A Preliminary Study (2007) (1)
Development of lichen planus following benralizumab treatment (2021) (1)
RIFM fragrance ingredient safety assessment, 2,6-nonadien-1-ol, CAS Registry Number 7786-44-9. (2018) (1)
An Erythema Multiforme‐like Eruption Caused by Exposure to 1‐Chloromethylnaphthalene (1998) (1)
RIFM fragrance ingredient safety assessment, β-caryophyllene, CAS Registry Number 87-44-5 (2021) (1)
RIFM fragrance ingredient safety assessment, ethyl acetate, CAS Registry Number 141-78-6. (2022) (1)
Development of IgA vasculitis after SARS‐CoV‐2 vaccination (2022) (1)
Complete type of pachydermoperiostosis with a novel mutation c.510G>A of the SLCO2A1 gene (2017) (1)
Segmental lichen aureus distributed along running directions of popliteal and small saphenous veins (2021) (1)
Development of Schamberg's disease after SARS‐CoV‐2 vaccination (2022) (1)
Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8+ T cells reactive with its night metabolite thiodiglycolic acid. (2021) (1)
RIFM fragrance ingredient safety assessment, 2,2,6-trimethylcyclohexanone, CAS Registry Number 2408-37-9. (2019) (1)
RIFM fragrance ingredient safety assessment, cyclopentadecanone, CAS Registry Number 502-72-7. (2021) (1)
Possible involvement of interleukin‐22‐producing CD103+CD8+ T cells in the epidermal hyperplasia of atopic dermatitis (2022) (1)
RIFM fragrance ingredient safety assessment, p-tolualdehyde, CAS Registry Number 104-87-0. (2021) (1)
RIFM fragrance ingredient safety assessment, p-mentha-1,3-diene, CAS Registry Number 99-86-5 (2021) (1)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, propyl phenethyl acetal, CAS Registry Number 7493-57-4. (2017) (1)
RIFM fragrance ingredient safety assessment, α-bisabolol, CAS registry number 515-69-5. (2020) (1)
Atopic dermatitis and allergic rhinitis (WS-054) Chairpersons: Hisahiro Yoshida, Michiko Oyoshi (2010) (1)
RIFM fragrance ingredient safety assessment, α-methylbenzyl alcohol, CAS registry number 98-85-1. (2017) (1)
RIFM fragrance ingredient safety assessment, (±) 3-methyl-γ-decalactone, CAS Registry Number 67663-01-8. (2020) (1)
Localized Multiple Epidermolytic Acanthoma (2004) (1)
A Keratotic Variant of Malignant Trichilemmoma (1988) (1)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT p-Methylanisole, CAS Registry Number 104-93-8. (2018) (1)
RIFM fragrance ingredient safety assessment, heptanal dimethyl acetal, CAS Registry Number 10032-05-0. (2018) (1)
RIFM fragrance ingredient safety assessment, hexanoic acid, 6-(acetyloxy)-, ethyl ester, CAS Registry Number 104986-28-9. (2020) (1)
CD40L from platelet, endothelial cell, and smooth muscle cell may contribute to the proliferation of tumor cell in intravascular large B cell lymphoma (2021) (1)
Ectopic Adipose Tissue with Vasculitis in the Calf Muscle Explaining Systemic Symptoms in Leg-limited Cutaneous Polyarteritis Nodosa. (2016) (1)
RIFM fragrance ingredient safety assessment, isobutyl acetate, CAS Registry Number 110-19-0. (2019) (1)
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3. (2018) (1)
RIFM fragrance ingredient safety assessment, 4-methyl-5-thiazoleethanol, CAS Registry Number 137-00-8. (2020) (1)
RIFM fragrance ingredient safety assessment, propyl propionate, CAS Registry Number 106-36-5. (2020) (1)
563 Skin-infiltrating Th17/Tc17 and Th1/Tc1cells are significantly decreased and IL-17+ CD103+ resident memory T cells partly remain after secukinumab treatment (2018) (1)
RIFM fragrance ingredient safety assessment, 2-methyl-3-(p-isopropylphenyl)propionaldehyde, CAS Registry Number 103-95-7. (2020) (1)
Necrobiosis lipoidica of the scrotum. (2011) (1)
RIFM fragrance ingredient safety assessment, cuminic aldehyde, CAS Registry Number 122-03-2. (2020) (1)
In vitro activation of immune lymph node cell proliferation by photohapten-modified cells in murine contact photosensitivity (2004) (1)
RIFM fragrance ingredient safety assessment, furfuryl thioacetate, CAS Registry Number 13678-68-7. (2020) (1)
RIFM fragrance ingredient safety assessment, dimethyl disulfide, CAS Registry Number 624-92-0. (2021) (1)
RIFM fragrance ingredient safety assessment, 2-ethyl-5-methoxybicyclo[2.2.1]heptane, CAS registry number 122795-41-9. (2019) (1)
RIFM fragrance ingredient safety assessment, octyl crotonate, CAS Registry Number 22874-79-9. (2019) (1)
RIFM fragrance ingredient safety assessment, 2-hexenoic acid, 2-methyl-, methyl ester, (2E)-, CAS Registry Number 16493-96-2. (2021) (1)
RIFM fragrance ingredient safety assessment, 4-pentenoic acid, 2-acetyl-4-methyl-, ethyl ester, CAS Registry Number 20962-70-3. (2018) (1)
Elevation of Thin Pudendal Artery Flap Using Fat Thickness Data in Vulvovaginal Reconstruction (2019) (1)
RIFM fragrance ingredient safety assessment, 1,1-dihexyloxyhexane, CAS Registry Number 33673-65-3. (2021) (1)
RIFM fragrance ingredient safety assessment, 4-Carvomenthenol, CAS Registry Number 562-74-3. (2017) (1)
RIFM fragrance ingredient safety assessment, 6-nonenenitrile, (Z)- (9CI), CAS Registry Number 80639-54-9. (2021) (1)
RIFM fragrance ingredient safety assessment, myristic acid, CAS Registry Number 544-63-8. (2019) (1)
RIFM fragrance ingredient safety assessment, 3,7-dimethyloctanenitrile, CAS Registry Number 40188-41-8. (2019) (1)
RIFM fragrance ingredient safety assessment, 2-nonanol, CAS Registry Number 628-99-9. (2021) (1)
Agaricus blazei Murill augments keratinocyte production of bioactive cytokines capable of promoting antigen‐presenting capacity (2008) (1)
RIFM fragrance ingredient safety assessment,2-mercaptopropionic acid, CAS Registry Number 79-42-5. (2021) (1)
RIFM fragrance ingredient safety assessment, p-(2,2-dimethoxyethyl)toluene, CAS Registry Number 42866-91-1. (2017) (1)
RIFM fragrance ingredient safety assessment, benzyl acetone, CAS Registry Number 2550-26-7. (2019) (1)
RIFM fragrance ingredient safety assessment, hexyl isovalerate, CAS Registry Number 10032-13-0. (2020) (1)
RIFM fragrance ingredient safety assessment, ethyl 2-methyl-1,3-dioxolane-2-acetate, CAS Registry Number 6413-10-1. (2018) (1)
RIFM fragrance ingredient safety assessment, cadinene, CAS Registry Number 29350-73-0. (2022) (1)
RIFM fragrance ingredient safety assessment, trans-2-hexenoic acid, CAS Registry Number 13419-69-7. (2018) (1)
RIFM fragrance ingredient safety assessment, phenylacetaldehyde diethyl acetal, CAS Registry Number 6314-97-2. (2017) (1)
RIFM fragrance ingredient safety assessment, 3-phenyl-1-propanol, CAS Registry Number 122-97-4. (2022) (1)
RIFM fragrance ingredient safety assessment, 2-methyldecanenitrile, CAS Registry Number 69300-15-8. (2021) (1)
Leukaemic mycosis fungoides in an atomic bomb survivor with lung and renal cancers (2009) (1)
RIFM fragrance ingredient safety assessment, 1-methoxyhexane, CAS Registry Number 4747-07-3. (2018) (1)
Alopecia areata with autoimmune polyglandular syndrome type 3 showing type 1/Tc1 immunological inflammation (2020) (1)
RIFM fragrance ingredient safety assessment, m-dimethoxybenzene, CAS Registry Number 151-10-0. (2019) (1)
RIFM fragrance ingredient safety assessment, p-t-butyl-α-methylhydrocinnamic aldehyde, CAS Registry Number 80-54-6. (2020) (1)
Analysis of human leukocyte antigen genotypes in pemphigus with antidesmoglein antibody profile shift (2016) (1)
Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs (2007) (1)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 2-Isobutyl-4-methyltetrahydro-2H-pyran-4-ol, CAS registry number 63500-71-0. (2019) (1)
RIFM fragrance ingredient safety assessment, 4-ethyloctanoic acid, CAS Registry Number 16493-80-4. (2019) (1)
650 Suprabasin-deficient mice show limited but discernible defective barrier in both skin and upper digestive tract (2018) (1)
Cutaneous lymphomatoid granulomatosis with long‐term absence of lung involvement (2018) (1)
RIFM fragrance ingredient safety assessment, 2-methylbutyric acid, CAS Registry Number 116-53-0. (2019) (1)
RIFM fragrance ingredient safety assessment, phenethyl butyrate, CAS Registry Number 103-52-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 1-spiro[4.5]dec-7-en-7-yl-4-penten-1-one, CAS Registry Number 224031-70-3. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, isopulegol, CAS Registry Number 89-79-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 4-hydroxybenzaldehyde, CAS registry number 123-08-0. (2023) (0)
RIFM fragrance ingredient safety assessment, 2-phenoxyethyl propionate, CAS Registry Number 23495-12-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 1-(2-tert-butyl cyclohexyloxy)-2-butanol, CAS Registry Number 139504-68-0 (2021) (0)
RIFM fragrance ingredient safety assessment, propyl isovalerate, CAS Registry Number 557-00-6. (2022) (0)
RIFM fragrance ingredient safety assessment, p-mentha-1,8-dien-7-yl acetate, CAS Registry Number 15111-96-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-octen-4-one, CAS Registry Number 4643-27-0. (2021) (0)
RIFM fragrance ingredient safety assessment, ethyl decanoate, CAS Registry Number 110-38-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,7-decadienenitrile, (2E,7Z)-, CAS Registry Number 1801275-26-2 (2021) (0)
RIFM fragrance ingredient safety assessment, 1H-indende-2-methanol, 2,3-dihydro-2,5-dimethyl-, CAS Registry Number 285977-85-7. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, 2,6-dimethyl-5-heptenal, CAS Registry Number 106-72-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 5-hydroxy-7-decenoic acid δ-lactone, CAS Registry Number 25524-95-2. (2022) (0)
RIFM fragrance ingredient safety assessment, guaiacyl phenylacetate, CAS Registry Number 4112-89-4. (2023) (0)
RIFM fragrance ingredient safety assessment, anisole, CAS Registry Number 100-66-3. (2021) (0)
RIFM fragrance ingredient safety assessment, β,4-dimethylcyclohex-3-ene-1-propan-1-al, CAS Registry Number 6784-13-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,3,4-trimethyl-3-pentanol, CAS Registry Number 3054-92-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 4-(2,6,6-trimethyl-2-cyclohexen)-2-methylbutanal, CAS Registry Number 65405-84-7. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl 4(or 1)-isopropyl-1(or 4)-methylbicyclo[2.2.2]oct-5-ene-2-carboxylate, CAS Registry Number 68966-86-9. (2021) (0)
RIFM fragrance ingredient safety assessment, phenylethyl isoamyl ether, CAS Registry Number 56011-02-0. (2022) (0)
RIFM fragrance ingredient safety assessment, d-8-p-menthene-1,2-epoxide, CAS Registry Number 1195-92-2. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl butyrate, CAS registry number 623-42-7. (2022) (0)
RIFM fragrance ingredient safety assessment, oxacyclohexadecen-2-one, CAS registry number 34902-57-3. (2022) (0)
RIFM fragrance ingredient safety assessment, isocedranone, CAS Registry Number 13794-73-5. (2021) (0)
RIFM fragrance ingredient safety assessment, terpinolene, CAS Registry Number 586-62-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 12-oxahexadecanolide, CAS Registry Number 6707-60-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 3-octen-2-one, CAS Registry Number 1669-44-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 3,5-dimethylcyclohexene-1-methanol, CAS Registry Number 67634-16-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6,6-trimethyl-1-cyclohexen-1-acetaldehyde, CAS Registry Number 472-66-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-methyloctanal, CAS Registry Number 7786-29-0. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, β-patchoulene, CAS Registry Number 514-51-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,3,5-trimethylpyrazine, CAS registry number 14667-55-1. (2022) (0)
RIFM fragrance ingredient safety assessment, δ-octalactone, CAS Registry Number 698-76-0. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, trans-, CAS registry number 23250-42-2. (2022) (0)
RIFM fragrance ingredient safety assessment, p,α-dimethylstyrene, CAS Registry Number 1195-32-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-[(3,3,5-trimethylcyclohexyl)acetyl]cyclopentan-1-one, CAS Registry Number 84642-57-9. (2021) (0)
RIFM fragrance ingredient safety assessment, phenylacetaldehyde dimethyl acetal, CAS Registry Number 101-48-4. (2022) (0)
RIFM fragrance ingredient safety assessment, ethanol, 2-(4-methylphenoxy)-1-(2-phenylethoxy)-, CAS Registry Number 72987-59-8. (2022) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl isobutyrate, CAS Registry Number 41519-23-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 10-undecenal, CAS Registry Number 112-45-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6-dimethyl-2-heptanol, CAS Registry Number 13254-34-7. (2022) (0)
RIFM fragrance ingredient safety assessment, (2-endo,3-exo)-ethyl 3-(1-methylethyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate, CAS registry number 116044-44-1. (2021) (0)
RIFM fragrance ingredient safety assessment, dihydromyrcenyl acetate, CAS Registry Number 53767-93-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 4-cyclopentadecen-1-one, CAS Registry Number 35720-57-1. (2021) (0)
RIFM fragrance ingredient safety assessment, isodecyl acetate, CAS Registry Number 69103-24-8. (2022) (0)
RIFM fragrance ingredient safety assessment, phenethyl propionate, CAS Registry Number 122-70-3. (2022) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-2-(p-tolyloxy)-2H-pyrane, CAS Registry Number 13481-09-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-acetylthiophene, CAS registry number 88-15-3. (2023) (0)
RIFM fragrance ingredient safety assessment, undecenal, CAS Registry Number 1337-83-3. (2022) (0)
RIFM fragrance ingredient safety assessment, diphenylmethane, CAS Registry Number 101-81-5. (2023) (0)
RIFM fragrance ingredient safety assessment, geraniol, CAS registry number 106-24-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-undecenenitrile, CAS Registry Number 22629-48-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,4,6-trimethyl-4-phenyl-1,3-dioxane, CAS Registry Number 5182-36-5. (2022) (0)
RIFM fragrance ingredient safety assessment, cresol (mixed isomers), CAS Registry Number 1319-77-3. (2021) (0)
RIFM fragrance ingredient safety assessment, ethyl p-anisate, CAS registry number 94-30-4. (2023) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-2-butenyl salicylate, CAS Registry Number 68555-58-8 (2021) (0)
RIFM fragrance ingredient safety assessment, carvyl acetate, CAS registry number 97-42-7. (2021) (0)
RIFM fragrance ingredient safety assessment, 1-(3,3-dimethylcyclohexyl)ethan-1-one, CAS Registry Number 25304-14-7. (2022) (0)
RIFM fragrance ingredient safety assessment, α-methylbenzyl propionate, CAS Registry Number 120-45-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 6,6-dimethoxy-2,5,5-trimethylhex-2-ene, CAS registry number 67674-46-8. (2023) (0)
Update to RIFM fragrance ingredient safety assessment, ethyl phenethyl ether, CAS Registry Number 1817-90-9. (2022) (0)
RIFM fragrance ingredient safety assessment, trans-2-octenal, CAS registry number 2548-87-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 4-methoxy-α-methylbenzenepropanal, CAS Registry Number 5462-06-6. (2022) (0)
RIFM fragrance ingredient safety assessment, phenethyl phenylacetate, CAS Registry Number 102-20-5. (2021) (0)
RIFM fragrance ingredient safety assessment, 1,3-dimethyl-3-butenyl salicylate, CAS Registry Number 80118-10-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 3(2H)-furanone, 5-ethyl-4-hydroxy-2-methyl-, CAS Registry Number 27538-09-6. (2021) (0)
RIFM fragrance ingredient safety assessment, p-methoxybenzaldehyde, CAS Registry Number 123-11-5. (2022) (0)
RIFM fragrance ingredient safety assessment, trans-methylgeranate, CAS Registry Number 1189-09-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 6,10-dimethylundeca-5,9-dien-2-one, CAS registry number 689-67-8. (2021) (0)
RIFM fragrance ingredient safety assessment, 8-isopropyl-6-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde, CAS Registry Number 67845-30-1. (2021) (0)
RIFM fragrance ingredient safety assessment, nonanal, 5-ethyl-2-methyl-, CAS Registry Number 68141-14-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 5(or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-ene-2-carbaldehyde, CAS Registry Number 68259-31-4. (2021) (0)
RIFM fragrance ingredient safety assessment, 5-(2,2,3-trimethyl-3-cyclopentenyl)-3-methylpentan-2-ol, CAS Registry Number 65113-99-7. (2022) (0)
RIFM fragrance ingredient safety assessment,2-methyl-2-propanol, CAS registry number 75-65-0. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl hexanoate, CAS Registry Number 106-70-7. (2021) (0)
RIFM fragrance ingredient safety assessment, n-butyl 2-methylbutyrate, CAS Registry Number 15706-73-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,4,4,7-Tetramethyl-6-octen-3-one, CAS Registry Number 74338-72-0. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, 3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, CAS Registry Number 107898-54-4. (2022) (0)
RIFM fragrance ingredient safety assessment, o-tolylethanol, CAS Registry Number 19819-98-8. (2022) (0)
RIFM fragrance ingredient safety assessment, p-tolyl octanoate, CAS Registry Number 59558-23-5. (2021) (0)
RIFM fragrance ingredient safety assessment, ethyl 3,7-dimethylocta-2,6-dienoate, CAS Registry Number 13058-12-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-tert-butylcyclohexanone, CAS Registry Number 1728-46-7. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-(1,1-dimethylethyl)-4-methylcyclohexan-1-ol, CAS Registry Number 67634-11-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 1-methyl-4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde, CAS registry number 52475-86-2. (2022) (0)
RIFM fragrance ingredient safety assessment, β-sinensal, CAS Registry Number 60066-88-8. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, 2,4-dimethylbenzyl acetate, CAS Registry Number 62346-96-7. (2022) (0)
RIFM fragrance ingredient safety assessment, cyclohexaneacetic acid, α-methyl-, ethyl ester, CAS Registry Number 2511-00-4. (2021) (0)
RIFM fragrance ingredient safety assessment, 6-methoxy-2,6-dimethylheptan-1-al, CAS Registry Number 62439-41-2. (2022) (0)
RIFM fragrance ingredient safety assessment, butyl acetate, CAS Registry Number 123-86-4. (2022) (0)
RIFM fragrance ingredient safety assessment, phenethyl benzoate, CAS Registry Number 94-47-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 9-decenal, CAS Registry Number 39770-05-3. (2022) (0)
RIFM fragrance ingredient safety assessment, benzoic acid, 2-[(1-hydroxy-3-phenylbutyl)amino], methyl ester, CAS Registry Number 144761-91-1. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-ethylhexanal, CAS Registry Number 123-05-7. (2022) (0)
RIFM fragrance ingredient safety assessment, hydroxycitronellal, CAS Registry Number 107-75-5. (2022) (0)
RIFM fragrance ingredient safety assessment, tetrahydromuguol, CAS Registry Number 41678-36-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6-dimethoxyphenol, CAS Registry Number 91-10-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 5-methyl-2-hepten-4-one, CAS Registry Number 81925-81-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-cyclopentene-1-acetic acid, ethyl ester, CAS Registry Number 15848-49-4. (2022) (0)
RIFM fragrance ingredient safety assessment, octyl isovalerate, CAS Registry Number 7786-58-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6-octadienal, 3,6,7-trimethyl-, CAS Registry Number 1891-67-4. (2021) (0)
RIFM fragrance ingredient safety assessment, isopentyl 2-methylcrotonate (E), CAS Registry Number 41519-18-0. (2022) (0)
RIFM fragrance ingredient safety assessment, tetrahydromyrcenol, CAS Registry Number 18479-57-7. (2022) (0)
RIFM fragrance ingredient safety assessment, citronellyl formate, CAS Registry number 105-85-1. (2021) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl formate, CAS registry number 33467-73-1. (2021) (0)
RIFM fragrance ingredient safety assessment, ethyl heptanoate, CAS Registry Number 106-30-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 4-thujanol, CAS Registry Number 546-79-2. (2022) (0)
RIFM fragrance ingredient safety assessment, guaiacol, CAS Registry Number 90-05-1. (2022) (0)
RIFM fragrance ingredient safety assessment, (+-)-ethyl 3-mercapto-2-methylbutanoate, CAS Registry Number 888021-82-7. (2022) (0)
RIFM fragrance ingredient safety assessment, cyclooct-4-en-1-yl methyl carbonate, CAS registry number 87731-18-8. (2021) (0)
RIFM fragrance ingredient safety assessment, sabinene, CAS Registry Number 3387-41-5. (2022) (0)
RIFM fragrance ingredient safety assessment, myristo nitrile, CAS Registry Number 629-63-0. (2022) (0)
RIFM fragrance ingredient safety assessment, bisabolene, CAS registry number 495-62-5. (2022) (0)
RIFM fragrance ingredient safety assessment, ethyl laurate, CAS Registry Number 106-33-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 5,8-methano-2H-1-benzopyran, 6(or 7)-ethylideneoctahydro-, [4aR,5S,8S,8aS(or 4aR,5R,8S,8aR)]-rel-, CAS Registry Number 943723-15-7. (2021) (0)
RIFM fragrance ingredient safety assessment, N-[(ethoxycarbonyl)methyl)-p-menthane-3-carboxamide, CAS Registry Number 68489-14-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 5,9-undecadienal, 2,6,10-trimethyl- (dihydroapofarnesal), CAS registry number 24048-13-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-3-(1-oxopropoxy)-4H-pyran-4-one, CAS Registry Number 68555-63-5. (2023) (0)
RIFM fragrance ingredient safety assessment, isoeugenyl methyl ether, CAS Registry Number 93-16-3. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, 3,7-dimethyl-1,6-nonadien-3-ol, CAS Registry Number 10339-55-6. (2022) (0)
RIFM fragrance ingredient safety assessment, α-cyclohexylidene benzeneacetonitrile, CAS Registry Number 10461-98-0 (2021) (0)
RIFM fragrance ingredient safety assessment, citronellyl isobutyrate, CAS Registry Number 97-89-2. (2021) (0)
RIFM fragrance ingredient safety assessment, N-isobutyldeca-trans-2-trans-4-dienamide, CAS Registry Number 18836-52-7. (2022) (0)
RIFM fragrance ingredient safety assessment, benzyl valerate, CAS Registry Number 10361-39-4. (2022) (0)
RIFM fragrance ingredient safety assessment, methoxycitronellal, CAS Registry Number 3613-30-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 1,2,3,3a,4,5,6,8a-octahydro-4,8-dimethyl-2-(1-methylethylidene)-6-azulenol, CAS Registry Number 89-88-3. (2022) (0)
RIFM fragrance ingredient safety assessment, cis-3-Heptenyl acetate, CAS Registry Number 1576-78-9. (2021) (0)
RIFM fragrance ingredient safety assessment, cyclohexanecarboxylic acid, 2,2,6-trimethyl-, ethyl ester, (1R,6S)-rel-, CAS Registry Number 22471-55-2. (2022) (0)
RIFM fragrance ingredient safety assessment, citronellyl tiglate, CAS Registry Number 24717-85-9. (2023) (0)
RIFM fragrance ingredient safety assessment, tetrahydrolinalyl acetate, CAS Registry Number 20780-48-7. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, ethylene brassylate, CAS Registry Number 105-95-3. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, methyl dihydrojasmonate, CAS Registry Number 24851-98-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one, CAS Registry number 76-22-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6-nonadienenitrile, CAS Registry Number 67019-89-0. (2022) (0)
RIFM fragrance ingredient safety assessment, farnesyl acetate, CAS Registry Number 29548-30-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-cyclohexylidene-2-o-tolylacetonitrile, CAS Registry Number 916887-53-1. (2021) (0)
Corrigendum to “RIFM fragrance ingredient safety assessment, 2,2,6-trimethylcyclohexanone, CAS Registry Number 2408-37-9” [Food Chem. Toxicol. 134 Supplement 1 2019 110723 ISSN 0278–6915] (2022) (0)
RIFM natural complex substance (NCS) fragrance ingredient safety assessment, petitgrain Mandarin oil, CAS registry number 8014-17-3, RIFM ID: 250-E2.12. (2022) (0)
RIFM fragrance ingredient safety assessment, nonen acid nitrile, CAS Registry Number 29127-83-1. (2022) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl isovalerate, CAS Registry Number 35154-45-1. (2021) (0)
RIFM fragrance ingredient safety assessment, octahydro-8,8-dimethylnaphthalene-2-carbaldehyde, CAS Registry Number 68738-94-3. (2021) (0)
RIFM fragrance ingredient safety assessment, hexadecanolide, CAS Registry Number 109-29-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,11-dodecadienal, (E)- (9CI), CAS registry number 118635-60-2. (2023) (0)
Update to RIFM fragrance ingredient safety assessment, borneol, CAS Registry Number 507-70-0. (2022) (0)
A ug 2 00 5 C hange in lattice m odulation upon gigantic m agnetoelectric transition in G dM (2022) (0)
RIFM fragrance ingredient safety assessment, 2,2-dimethyl-3-(3-methyl-2,4-pentadienyl)oxirane, CAS Registry Number 69103-20-4. (2021) (0)
RIFM fragrance ingredient safety assessment, ethyl hexanoate, CAS Registry Number 123-66-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 3,5,5-trimethylhexanal, CAS Registry Number 5435-64-3. (2022) (0)
RIFM fragrance ingredient safety assessment, menthol, CAS Registry Number 89-78-1. (2022) (0)
RIFM fragrance ingredient safety assessment, eucalyptol, CAS Registry Number 470-82-6. (2021) (0)
RIFM fragrance ingredient safety assessment,4-allylphenol, CAS Registry Number 501-92-8. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, 3-methylpentyl 2-methylisocrotonate, CAS Registry Number 53082-58-9. (2022) (0)
RIFM fragrance ingredient safety assessment, o-(Methylthio)-phenol, CAS Registry Number 1073-29-6. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl furfuryl disulfide, CAS Registry Number 57500-00-2. (2021) (0)
RIFM fragrance ingredient safety assessment, 5-cyclohexadecen-1-one, CAS Registry Number 37609-25-9. (2021) (0)
RIFM fragrance ingredient safety assessment, carvyl propionate, CAS Registry Number 97-45-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,10-Tetradecadienenitrile, (2E,10Z)-, CAS Registry Number 1958026-97-5. (2022) (0)
RIFM fragrance ingredient safety assessment, nopol, CAS Registry Number 128-50-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 8H-indeno(4,5-B)furan,2,3,3a,4,5,5a,6,7,8a,9-decahydro-2,6,6,7,8,8-hexamethyl (mixture of isomers), CAS Registry Number 338735-71-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-isopropyl-5-methyl-2-hexenal, CAS Registry Number 35158-25-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 2,6-dimethylpyrazine, CAS registry number 108-50-9. (2023) (0)
RIFM fragrance ingredient safety assessment, 2-methoxy-4-vinylphenol, CAS Registry Number 7786-61-0. (2022) (0)
RIFM fragrance ingredient safety assessment, ethyl propionate, CAS Registry Number 105-37-3. (2022) (0)
RIFM fragrance ingredient safety assessment, (-)-(R)-α-phellandrene, CAS Registry Number 4221-98-1. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, 1-(1,2,3,4-tetrahydro-4,4-dimethyl-1-naphthyl)propan-1-one, CAS Registry Number 74499-60-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6,10-trimethyl-9-undecenal, CAS Registry Number 141-13-9. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, oxacyclotridecan-2-one, CAS Registry Number 947-05-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 3,7-dimethyloct-6-en-3-ol, CAS registry number 18479-51-1 (2021) (0)
RIFM fragrance ingredient safety assessment, phenoxyacetaldehyde, CAS Registry Number 2120-70-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-5-(methylthio)furan, CAS Registry Number 13678-59-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 6-methyl-5-hepten-2-one, CAS registry number 110-93-0. (2021) (0)
RIFM fragrance ingredient safety assessment, undecen-1-ol, CAS Registry Number 112-43-6. (2022) (0)
RIFM fragrance ingredient safety assessment, isohexenyl cyclohexenyl carboxaldehyde, CAS registry number 37677-14-8. (2022) (0)
RIFM fragrance ingredient safety assessment, methoxycyclododecane, CAS Registry Number 2986-54-1. (2022) (0)
RIFM fragrance ingredient safety assessment, p-cresol, CAS Registry Number 106-44-5. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, linalyl phenylacetate, CAS Registry Number 7143-69-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6-octadienal, (2E,6Z)-, CAS registry number 76917-23-2. (2021) (0)
RIFM fragrance ingredient safety assessment, α-amyl cinnamic aldehyde diethyl acetal, CAS Registry Number 60763-41-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 10-oxahexadecanolide, CAS Registry Number 1725-01-5. (2022) (0)
RIFM fragrance ingredient safety assessment, myrtenyl acetate, CAS Registry Number 1079-01-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,7-decadienenitrile, CAS Registry Number 1801275-25-1. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, p-(2,2-dimethoxyethyl)toluene, CAS Registry Number 42866-91-1. (2022) (0)
RIFM fragrance ingredient safety assessment, ethyl nonanoate, CAS Registry Number 123-29-5. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methoxy-3(5 and 6)-isopropylpyrazine, CAS Registry Number 25773-40-4. (2023) (0)
RIFM fragrance ingredient safety assessment, 3-decen-2-one, CAS Registry Number 10519-33-2. (2021) (0)
RIFM fragrance ingredient safety assessment, 4,7-decadienal, CAS registry number 934534-30-2. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, 3-methylbutyl 2-methylpropanoate, CAS Registry Number 2050-01-3. (2022) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-4-methyl-2-propyl-2H-pyran-4-yl acetate, CAS Registry Number 131766-73-9. (2022) (0)
RIFM fragrance ingredient safety assessment, α-methylcinnamic alcohol, CAS Registry Number 1504-55-8. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methyltetrahydrofuran-3-one, CAS Registry Number 3188-00-9. (2022) (0)
RIFM fragrance ingredient safety assessment, citronellyl butyrate, CAS Registry number 141-16-2. (2021) (0)
RIFM fragrance ingredient safety assessment, 4,9-dodecadienal, (4Z,9Z)-, CAS Registry Number 1801275-28-4. (2021) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-6-(3-pentenyl)-2H-pyran-2-one, CAS Registry Number 32764-98-0 (2021) (0)
mRIFM fragrance ingredient safety assessment, 4-t-amylcyclohexanone, CAS Registry Number 16587-71-6. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, hexyl isovalerate, CAS Registry Number 10032-13-0. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, benzyl butyrate, CAS Registry Number 103-37-7. (2022) (0)
RIFM fragrance ingredient safety assessment, cinnamyl butyrate, CAS Registry Number 103-61-7. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-hexenyl 2-methylbutanoate, CAS registry number 10094-41-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-2-pentenal, CAS Registry Number 623-36-9. (2021) (0)
RIFM fragrance ingredient safety assessment, citronellyl propionate, CAS registry number 141-14-0. (2021) (0)
RIFM fragrance ingredient safety assessment, alcohols, C9-11-iso-, C10-rich, CAS Registry Number 68526-85-2. (2022) (0)
RIFM fragrance ingredient safety assessment, carveol, CAS Registry Number 99-48-9. (2022) (0)
RIFM fragrance ingredient safety assessment, benzoic acid, CAS Registry Number 65-85-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-pentadecanone, CAS Registry Number 2345-28-0. (2022) (0)
RIFM fragrance ingredient safety assessment, eugenyl phenylacetate, CAS Registry Number 10402-33-2. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, α-irone, CAS registry number 79-69-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 1,3-dimethyl-3-butenyl salicylate, CAS Registry Number 80118-10-1. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, fenchyl alcohol, CAS Registry Number 1632-73-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 9-cycloheptadecen-1-one, CAS Registry Number 542-46-1. (2021) (0)
RIFM fragrance ingredient safety assessment, methyl p-methylbenzoate, CAS Registry Number 99-75-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 5-heptenenitrile, 2,6-dimethyl-, CAS Registry Number 54088-65-2 (2021) (0)
RIFM fragrance ingredient safety assessment, 2,2,3-trimethyl-3-cyclopentene-1-acetaldehyde, CAS Registry Number 4501-58-0. (2022) (0)
RIFM fragrance ingredient safety assessment, myrcenyl acetate, CAS Registry Number 1118-39-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-propionaldehyde, CAS Registry Number 33885-51-7. (2021) (0)
RIFM fragrance ingredient safety assessment, 4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one, CAS Registry Number 67801-38-1. (2022) (0)
RIFM fragrance ingredient safety assessment, benzyl phenylacetate, CAS Registry Number 102-16-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-tridecanone, CAS Registry Number 593-08-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-pentylcyclopentan-1-ol, CAS Registry Number 84560-00-9. (2022) (0)
RIFM fragrance ingredient safety assessment, phenylacetic acid, CAS Registry Number 103-82-2. (2022) (0)
RIFM fragrance ingredient safety assessment, (4-tert-butylphenyl)acetonitrile, CAS Registry Number 3288-99-1. (2022) (0)
RIFM fragrance ingredient safety assessment, cyclohexanepropanol, α-ethyl-2,2,6-trimethyl-, CAS registry number 60241-52-3. (2021) (0)
RIFM fragrance ingredient safety assessment, citronellyl acetate, CAS Registry Number 150-84-5. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-methylbutyl 2-methylbutanoate, CAS Registry Number 27625-35-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 3-Cyclohexene-1-carboxaldehyde, 1-ethenyl-, CAS Registry Number 1049017-63-1. (2022) (0)
RIFM fragrance ingredient safety assessment, heptanal, 6-hydroxy-2,6-dimethyl-, CAS Registry Number 62439-42-3. (2021) (0)
RIFM fragrance ingredient safety assessment, 1-[5(Or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-en-2-yl]ethan-1-one, CAS Registry Number 68259-33-6. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-1-cyclopentadecanone, CAS Registry Number 541-91-3. (2021) (0)
RIFM fragrance ingredient safety assessment, caryophyllene acetylated, CAS Registry Number 75975-83-6. (2021) (0)
RIFM fragrance ingredient safety assessment, phenethyl formate, CAS Registry Number 104-62-1. (2022) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl propionate, CAS Registry Number 33467-74-2. (2021) (0)
RIFM fragrance ingredient safety assessment, p-propylanisole, CAS Registry Number 104-45-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 3-phenylpropionaldehyde, CAS Registry Number 104-53-0. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,5,5-trimethyl-2-phenyl-1,3-dioxane, CAS Registry Number 5406-58-6. (2022) (0)
RIFM fragrance ingredient safety assessment, allyl phenoxyacetate, CAS Registry Number 7493-74-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-trans-6-cis-dodecadienal, CAS Registry Number 21662-13-5. (2021) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-2-isobutyl-4-methyl-2H-pyrane, CAS Registry Number 13477-62-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-tridecenal, CAS registry number 7774-82-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 8aH-2, 4a-methanonaphthalen-8a-ol, octahydro-1,1,5,5-tetramethyl-(2S,4aR,8aS)-, CAS Registry Number 57566-26-4. (2022) (0)
RIFM fragrance ingredient safety assessment, (Z)-non-6-enyl acetate, CAS Registry Number 76238-22-7. (2022) (0)
RIFM fragrance ingredient safety assessment, propyl acetate, CAS Registry Number 109-60-4. (2022) (0)
RIFM fragrance ingredient safety assessment, octanenitrile, CAS Registry Number 124-12-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 7-methoxy-3,7-dimethyloct-1-ene, CAS Registry Number 53767-86-5. (2022) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl butyrate, CAS Registry Number 16491-36-4 (2021) (0)
RIFM fragrance ingredient safety assessment, 3-methoxy-5-cresol, CAS Registry Number 3209-13-0. (2022) (0)
RIFM fragrance ingredient safety assessment, tridecene-2-nitrile, CAS Registry Number 22629-49-8. (2021) (0)
RIFM fragrance ingredient safety assessment, formaldehyde cyclododecyl ethyl acetal, CAS Registry Number 58567-11-6. (2021) (0)
RIFM fragrance ingredient safety assessment, 9-decen-1-ol, CAS Registry Number 13019-22-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 4-heptenal diethyl acetal, CAS Registry Number 18492-65-4. (2022) (0)
RIFM fragrance ingredient safety assessment, phenethyl acetate, CAS Registry Number 103-45-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6-dimethyl-10-methylene-2,6,11-dodecatrienal, CAS registry number 17909-77-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 4,8-undecadienal, (4Z,8Z)-, CAS Registry Number 1882830-62-7. (2021) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl lactate, CAS Registry Number 61931-81-5. (2022) (0)
RIFM fragrance ingredient safety assessment, ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-3,8,8-trimethyl-2-naphthalenyl)-, CAS Registry Number 93963-23-6 (2021) (0)
RIFM fragrance ingredient safety assessment, nona-2-trans-6-cis-dienal, CAS registry number 557-48-2. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl vanillyl ether, CAS Registry Number 5533-03-9. (2021) (0)
RIFM fragrance ingredient safety assessment, acetoin, CAS Registry Number 513-86-0. (2022) (0)
RIFM fragrance ingredient safety assessment, myraldyl acetate, CAS Registry Number 72403-67-9. (2021) (0)
RIFM fragrance ingredient safety assessment, trans-3-heptenyl 2-methylpropanoate, CAS Registry Number 67801-45-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-hexyl-1,3-dioxolane, CAS Registry Number 1708-34-5. (2021) (0)
RIFM fragrance ingredient safety assessment, styrene, CAS Registry Number 100-42-5. (2022) (0)
RIFM fragrance ingredient safety assessment, anethole (isomer unspecified), CAS Registry Number 104-46-1. (2021) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl tiglate, CAS Registry Number 67883-79-8. (2021) (0)
RIFM fragrance ingredient safety assessment, sodium benzoate, CAS Registry Number 532-32-1. (2021) (0)
RIFM fragrance ingredient safety assessment, cis-3-hexenyl methyl carbonate, CAS Registry Number 67633-96-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 11-tridecen-6-one, 8,12-dimethyl-, CAS Registry Number 68141-18-4. (2021) (0)
RIFM fragrance ingredient safety assessment, acetanilide, CAS Registry Number 103-84-4. (2022) (0)
RIFM fragrance ingredient safety assessment, acetanisole, CAS Registry Number 100-06-1. (2022) (0)
RIFM fragrance ingredient safety assessment, isobutyl isobutyrate, CAS Registry Number 97-85-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-octenoic acid, 4-ethyl-, (2E)-, CAS Registry Number 60308-76-1. (2023) (0)
RIFM fragrance ingredient safety assessment, 3-phenylpropyl acetate, CAS Registry Number 122-72-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 4-ethylguaiacol, CAS Registry Number 2785-89-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,7-decadienal, (2E,7Z)-, CAS Registry Number 52711-52-1. (2021) (0)
RIFM fragrance ingredient safety assessment, isoeugenyl acetate, CAS Registry Number 93-29-8. (2022) (0)
RIFM fragrance ingredient safety assessment, 1-menthyl methylether, CAS Registry Number 1565-76-0. (2022) (0)
RIFM fragrance ingredient safety assessment, ethyl butyrate, CAS registry number 105-54-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, CAS Registry Number 28219-60-5 (2021) (0)
RIFM fragrance ingredient safety assessment, 1-formyl-1-methyl-4-(4-methyl-pentyl)-3-cyclohexene, CAS Registry Number 66327-54-6. (2022) (0)
RIFM fragrance ingredient safety assessment, guaiacwood acetate, CAS Registry Number 61789-17-1. (2022) (0)
RIFM fragrance ingredient safety assessment, phenylpropionaldehyde dimethyl acetal, CAS Registry Number 90-87-9. (2022) (0)
RIFM fragrance ingredient safety assessment, citronelloxyacetaldehyde, CAS Registry Number 7492-67-3. (2022) (0)
Technical Report of ISSP Ser. A: Number 3041 (1995) (0)
RIFM fragrance ingredient safety assessment, (+/-)-4-ethyloctanal, CAS Registry Number 58475-04-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-thujopsanone, CAS Registry Number 25966-79-4. (2021) (0)
RIFM fragrance ingredient safety assessment, 4,8-undecadienal, (4Z,8E)-, CAS Registry Number 1958027-16-1 (2021) (0)
RIFM fragrance ingredient safety assessment, oxacyclopentadec-10-en-2-one, 13-methyl-, CAS Registry Number 329925-33-9. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, phenylacetaldehyde diethyl acetal, CAS Registry Number 6314-97-2. (2022) (0)
RIFM fragrance ingredient safety assessment, cinnamyl acetate, CAS Registry Number 103-54-8. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, 4-(3,4-methylenedioxyphenyl)-2-butanone, CAS Registry Number 55418-52-5. (2022) (0)
RIFM fragrance ingredient safety assessment, cinnamic acid, CAS Registry Number 621-82-9. (2022) (0)
RIFM fragrance ingredient safety assessment, isopropyl 2-methylbutyrate, CAS Registry Number 66576-71-4. (2022) (0)
RIFM fragrance ingredient safety assessment, cis-3-nonenyl acetate, CAS Registry Number 13049-88-2. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, 4-carvomenthenol, CAS Registry Number 562-74-3. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, benzyl acetate, CAS Registry Number 140-11-4. (2022) (0)
RIFM fragrance ingredient safety assessment, skatole, CAS Registry Number 83-34-1. (2022) (0)
RIFM fragrance ingredient safety assessment, citronellal methylanthranilate Schiff base, CAS Registry Number 67845-42-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,3-dethylpyrazine, CAS registry number 15707-24-1. (2023) (0)
RIFM fragrance ingredient safety assessment, ethyl octanoate, CAS Registry Number 106-32-1. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, α-methylbenzyl acetate, CAS Registry Number 93-92-5. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, methyl hexyl oxo cyclopentanone carboxylate, CAS Registry Number 37172-53-5. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, α,2,2,3-tetramethylcyclopent-3-ene-1-butyraldehyde, CAS Registry Number 65114-03-6. (2022) (0)
RIFM fragrance ingredient safety assessment, formic acid, CAS Registry Number 64-18-6. (2020) (0)
Update to RIFM fragrance ingredient safety assessment, benzyl methyl ether, CAS Registry Number 538-86-3. (2022) (0)
RIFM fragrance ingredient safety assessment, hexanoic acid, 4-methyl-, CAS Registry Number 1561-11-1. (2018) (0)
RIFM fragrance ingredient safety assessment, hexahydro-3H-benzofuran-2-one, CAS Registry Number 6051-03-2. (2018) (0)
RIFM fragrance ingredient safety assessment, 1-(5,6,7,8-tetrahydro-2-naphthalenyl)ethanone, CAS Registry Number 774-55-0. (2020) (0)
RIFM fragrance ingredient safety assessment, acetylpyrazine, CAS Registry Number 22047-25-2. (2019) (0)
218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata (2016) (0)
RIFM fragrance ingredient safety assessment, terpinyl propionate, CAS Registry Number 80-27-3. (2018) (0)
RIFM fragrance ingredient safety assessment, isoamyl alcohol CAS Registry Number 123-51-3. (2017) (0)
RIFM fragrance ingredient safety assessment, isopulegyl acetate, CAS Registry Number 57576-09-7. (2021) (0)
RIFM fragrance ingredient safety assessment, phenylethyl anthranilate, CAS Registry Number 133-18-6. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-prenylcyclopentanone, CAS Registry Number 2520-60-7. (2021) (0)
Anti heat shock protein antibody dependent keratinocyte damages in the pathogenesis of lepromatous leprosy (1998) (0)
RIFM fragrance ingredient safety assessment dihydro-β-terpinyl acetate, CAS Registry Number 26252-11-9. (2018) (0)
RIFM fragrance ingredient safety assessment, phenethyl tiglate, CAS Registry Number 55719-85-2. (2018) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-pseudo-ionone, CAS Registry Number 1322-58-3. (2021) (0)
UV Dose Measurements of Photosensitive Dermatosis Patients by Polycrystalline GaN–based Portable Self‐data‐acquisition UV Monitor ¶ (2002) (0)
A Case of Giant Sebaceous Carcinoma Occurring on the Scalp and Invading Dura Mater (2005) (0)
RIFM fragrance ingredient safety assessment, ethyl methacrylate, CAS Registry Number 97-63-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 3,6-dihydro-4-methyl-2-phenyl-2H-pyran, CAS Registry number 60335-71-9. (2020) (0)
RIFM fragrance ingredient safety assessment, naphtho[2,1-b]furan, dodecahydro-3a,6,6,9a-tetramethyl-, (3aR,5aS,9aS,9bR)-, CAS Registry Number 6790-58-5. (2021) (0)
Plasma cytoid dendritic cells as a key player in the induction of alopecia areata (2016) (0)
RIFM fragrance ingredient safety assessment, ethyl trans-2-butenoate, CAS Registry Number 623-70-1. (2018) (0)
Langerhans cell histiocytosis presenting as a nodule beneath the clitoral hood (2014) (0)
RIFM fragrance ingredient safety assessment, pulegone, CAS Registry Number 89-82-7. (2021) (0)
RIFM fragrance ingredient safety assessment, bis(hydroxymethyl)tricyclo[5.2.1.02,6]decane, CAS Registry Number 26160-83-8. (2018) (0)
RIFM fragrance ingredient safety assessment, 2,2-dimethyl-3-methyl-3-butenyl propanoate, CAS Registry Number 104468-21-5. (2020) (0)
RIFM fragrance ingredient safety assessment, isobutyl benzoate, CAS registry number 120-50-3. (2018) (0)
RIFM fragrance ingredient safety assessment, hexyl formate, CAS Registry Number 629-33-4. (2018) (0)
RIFM Fragrance ingredient safety assessment, 3-ethylhexahydro-2(3H)-benzofuranone, CAS Registry Number 54491-17-7. (2018) (0)
RIFM fragrance ingredient safety assessment, methyl 2-octynoate, CAS Registry Number 111-12-6. (2019) (0)
Surface magnetism of L[lc]a(2-2x)S[lc]r(1+2x)M[lc]n2O7 investigated by low temperature photoemission microscopy (LT-PEEM) (2002) (0)
RIFM fragrance ingredient safety assessment, allyl sulfide, CAS Registry Number 592-88-1. (2020) (0)
RIFM fragrance ingredient safety assessment, 1-(5,5-dimethyl-1-cyclohexen-1-yl)pent-4-en-1-one, CAS Registry Number 56973-85-4. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-(4-methyl-3-pentenyl)-3-cyclohexene-1-carbonitrile, CAS registry number 68084-04-8. (2020) (0)
RIFM fragrance ingredient safety assessment, N-(2-(pyridin-2-yl)ethyl)-3-p-menthanecarboxamide, CAS Registry Number 847565-09-7. (2020) (0)
RIFM fragrance ingredient safety assessment, 4-methyl-3-penten-2-one, CAS Registry Number 141-79-7. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-ethylhexyl acetate, CAS Registry Number 103-09-3. (2018) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-methylbutyrate, CAS Registry Number 7452-79-1. (2018) (0)
RIFM fragrance ingredient safety assessment, 6-methyl-3,5-heptadien-2-one, CAS Registry Number 1604-28-0. (2019) (0)
[Etiological mechanism and management of light hypersensitivity]. (2007) (0)
RIFM fragrance ingredient safety assessment, 4-methylpentanoic acid, CAS Registry Number 646-07-1. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl 2,4-dimethyldioxolane-2-acetate, CAS Registry Number 6290-17-1. (2019) (0)
RIFM fragrance ingredient safety assessment, α-methyl-cyclohexanepropanol, CAS Registry Number 10528-67-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-acetylthiazole, CAS Registry Number 24295-03-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-methylheptanoic acid, CAS Registry Number 1188-02-9. (2018) (0)
Squamous Cell Carcinoma of the Skin Shows a Distinct MicroRNA Profile Modulated by UV Radiation (2010) (0)
SENSITIVITY TO KILLING BY PHOTOFRIN II-MEDIATED PHOTODYNAMIC THERAPY IS RELATED TO THE EXPRESSION OF THE LOW-DENSITY LIPOPROTEIN RECEPTORS IN CULTURED HUMAN TUMOR CELL LINES (2000) (0)
Indeterminate cell histiocytosis presenting as a single nodule of the nose (2018) (0)
RIFM fragrance ingredient safety assessment, γ-methyldecalactone, CAS Registry Number 7011-83-8. (2020) (0)
RIFM fragrance ingredient safety assessment, methyl-2,2-dimethyl-6-methylene-1-cyclohexanecarboxylate, CAS Registry Number 81752-87-6. (2020) (0)
RIFM fragrance ingredient safety assessment, methyl benzoate, CAS Registry Number 93-58-3. (2018) (0)
147 Cross-reactivity of quinolones in T-cell responses to quinolone-photomodified cells (1996) (0)
RIFM fragrance ingredient safety assessment, 5-hydroxy-4-methylhexanoic acid δ-lactone, CAS Registry Number 10413-18-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-butanone, phenylhydrazone, CAS Registry Number 1129-62-0. (2018) (0)
RIFM fragrance ingredient safety assessment, 4,4a,6,7,8,8a-hexahydro-1,4-methanonaphthalen-5(1H)-one, CAS Registry Number: 51519-65-4. (2018) (0)
RIFM fragrance ingredient safety assessment, 2,6,6-trimethylcyclohexa-1,3-dienyl methanal, CAS Registry Number 116-26-7. (2020) (0)
A case of symmetrical linear scleroderma arising on the bilateral upper limbs (2010) (0)
RIFM fragrance ingredient safety assessment, 4,8-dimethyl-7-nonen-2-ol, CAS Registry Number 40596-76-7. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-propyl heptanenitrile, CAS Registry Number 208041-98-9. (2020) (0)
Epidemic occurrence of an acute, erythematous eruptionmimicking contact dermatitis: a new disease? (2000) (0)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-2,6-nonadienenitrile, CAS Registry Number 61792-11-8. (2017) (0)
Responses to mite antigen and superantigens of peripheral blood mononuclear cells in patients with atopic dermatitis (1993) (0)
Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus (2016) (0)
RIFM fragrance ingredient safety assessment, 6-isopropyl-2(1H)-octahydronaphthalenone, CAS Registry Number 34131-98-1. (2019) (0)
Greeting from the President of the Japanese Society for Investigative Dermatology (JSID): on achieving internationalization and educating young researchers. (2009) (0)
New Year's Greetings (2013) (0)
RIFM fragrance ingredient safety assessment, acetaldehyde, diphenethyl acetal, CAS Registry Number 122-71-4. (2017) (0)
RIFM fragrance ingredient safety assessment, 1-(3,3-dimethylbicyclo[2.2.1]hept-2-yl)ethane-1-one, CAS Registry Number 42370-07-0. (2018) (0)
RIFM fragrance ingredient safety assessment, methyl N-acetylanthranilate, CAS Registry Number 2719-08-6. (2017) (0)
Induction of plasmablasts by follicular helper T cell-CXCL13 axis upon occurrence of herpes zoster. (2018) (0)
RIFM fragrance ingredient safety assessment, 3-phenylbutanal, CAS Registry Number 16251-77-7. (2020) (0)
[Pathophysiology and treatment of photo allergy]. (2006) (0)
RIFM fragrance ingredient safety assessment, (+/-)2-mercapto-2-methylpentan-1-ol, CAS Registry Number 258823-39-1. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-cyclohexylpropanal, CAS Registry Number 2109-22-0. (2019) (0)
Regulation of keratinocyte proliferation by podoplanin during cutaneous wound healing in mice (2013) (0)
RIFM fragrance ingredient safety assessment, decyl acetate, CAS Registry Number 112-17-4. (2019) (0)
RIFM fragrance ingredient safety assessment, cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1a,2a,5b)-, CAS Registry Number 2230-87-7. (2019) (0)
RIFM fragrance ingredient safety assessment, propanal diethyl acetal, CAS registry number 4744-08-5. (2019) (0)
RIFM fragrance ingredient safety assessment, n-hexyl 2-butenoate, CAS Registry Number 19089-92-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-methylundecanal dimethyl acetal, CAS Registry Number 68141-17-3. (2018) (0)
RIFM fragrance ingredient safety assessment, 4-phenyl-3-buten-2-ol, CAS Registry Number 17488-65-2. (2020) (0)
RIFM fragrance ingredient safety assessment, hexyl 2-hydroxypropionate, CAS Registry Number 20279-51-0. (2020) (0)
RIFM fragrance ingredient safety assessment, γ-octalactone, CAS Registry Number 104-50-7. (2019) (0)
RIFM fragrance ingredient safety assessment, 1,4-cineole, CAS Registry Number 470-67-7. (2020) (0)
Resignation as JSID President. (2012) (0)
RIFM fragrance ingredient safety assessment, 1,3-dimethylbut-3-enyl isobutyrate, CAS Registry Number 80118-06-5. (2018) (0)
RIFM fragrance ingredient safety assessment, ethyl 3(2-furyl)propanoate, CAS Registry Number 10031-90-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 1-ethynylcyclohexyl acetate, CAS Registry Number 5240-32-4. (2019) (0)
RIFM fragrance ingredient safety assessment, p-tolyl acetate, CAS Registry Number 140-39-6. (2019) (0)
RIFM fragrance ingredient safety assessment, 5-hexen-2-one, CAS Registry Number 109-49-9. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-furanmethanethiol formate, CAS Registry Number 59020-90-5. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl trans-4-decenoate, CAS Registry Number 76649-16-6. (2021) (0)
RIFM fragrance ingredient safety assessment, α-amylcinnamyl alcohol, CAS Registry Number 101-85-9. (2019) (0)
RIFM fragrance ingredient safety assessment, 3-(methylthio)propanol, CAS Registry Number 505-10-2. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-(p-menth-1-ene-10-yl)cyclopentanone, CAS Registry Number 95962-14-4. (2018) (0)
RIFM fragrance ingredient safety assessment, p-isobutyl-α-methyl hydrocinnamaldehyde, CAS Registry Number 6658-48-6. (2020) (0)
Genetic control of contact photosensitivity to TCSA: Preferential activation of suppressor T cells in low responder H-2k mice (1990) (0)
RIFM fragrance ingredient safety assessment, octahydro-7-methyl-1,4-methanonaphtalen-6(2H)-one, CAS registry number 41724-19-0. (2021) (0)
Three‐dimensional histological explanation of the dermoscopy patterns in acral melanocytic lesions (2021) (0)
RIFM fragrance ingredient safety assessment, N-lactoyl ethanolamine, CAS Registry Number 5422-34-4. (2020) (0)
RIFM fragrance ingredient safety assessment, cis-4-decenol, CAS Registry Number 57074-37-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-hexen-1-ol (isomer unspecified), CAS Registry Number 544-12-7. (2017) (0)
RIFM fragrance ingredient safety assessment, 3-methylpentanoic acid, CAS Registry Number 105-43-1. (2020) (0)
RIFM fragrance ingredient safety assessment, 1,1-diethoxyisooctane, CAS Registry Number 69178-43-4. (2018) (0)
RIFM fragrance ingredient safety assessment, dihydro-4-methyl-5-pentylfuran-2(3H)-one, CAS Registry Number 33673-62-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 1-(2-methylprop-2-enoloxy)-2,2,4-trimethylpentan-3-ol, CAS Registry Number 526218-21-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 4-heptanol, 2,6-dimethyl-,acetate, CAS Registry Number 10250-45-0. (2019) (0)
RIFM fragrance ingredient safety assessment, benzenepropanenitrile, 4-ethyl-.α.,.α.-dimethyl, CAS Registry Number 134123-93-6. (2017) (0)
RIFM fragrance ingredient safety assessment,1-octene, CAS Registry Number 111-66-0. (2021) (0)
RIFM fragrance ingredient safety assessment, cyclopropanemethanol, 1-methyl-2-[[(1R,3R)-2,2,3-trimethylcyclopentyl]methyl]-, (1R,2R)-, CAS Registry Number 1181244-95-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 1,5-dimethylhexyl acetate, CAS Registry Number 67952-57-2. (2019) (0)
PHENOTYPE OF ATOPIC DERMATITIS. (2017) (0)
RIFM fragrance ingredient safety assessment, methyl isobutyrate, CAS Registry Number 547-63-7. (2018) (0)
RIFM fragrance ingredient safety assessment, allyl disulfide, CAS Registry Number 2179-57-9. (2020) (0)
Preservative and surgical interventions to treat ingrown nail and pincer nail (2018) (0)
Viewpoint 2 (2006) (0)
RIFM fragrance ingredient safety assessment, cyclohexanemethanol, 4-(acetyloxy)-α,α,4-trimethyl-, acetate, CAS Registry Number 20009-20-5. (2018) (0)
RIFM fragrance ingredient safety assessment, 2H-Inden-2-one, 1,3-dihydro-, CAS Registry Number 615-13-4. (2018) (0)
RIFM fragrance ingredient safety assessment, 4-methyl-2-pentanone, CAS Registry Number 108-10-1. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-methoxy-4-propylphenol, CAS Registry Number 2785-87-7. (2020) (0)
RIFM fragrance ingredient safety assessment, cyclohexanemethanol, 2,4-dimethyl-, CAS Registry Number 68480-15-9. (2019) (0)
Co-localization of kallikrein5 and profilaggrin in keratohyalin granules and reduction of filaggrin monomers by kallikrein5 downmodulation (2013) (0)
TSLP and IL-4 interact to promote mutual receptor expression on CD4+ T cells in atopic dermatitis (2016) (0)
Free Posterior Interosseous Artery Flap for Treatment of First Web Space Contracture: Methods of Venous Anastomosis (2019) (0)
Recalcitrant mycosis fungoides in a young woman. (2002) (0)
RIFM fragrance ingredient safety assessment, 2-furancarboxylic acid, tetrahydro-, ethyl ester, CAS Registry Number 16874-34-3. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-cyclohexene-1-carboxylic acid, 2,6,6-trimethyl-, methyl ester, CAS registry number 815580-59-7. (2019) (0)
RIFM fragrance ingredient safety assessment, isopentylamine, CAS Registry Number 107-85-7. (2020) (0)
Th2 nature of ultraviolet B-induced suppressor T cells in murine contact photosensitivity (1993) (0)
RIFM fragrance ingredient safety assessment, Ethyl 2,3,6-trimethylcyclohexyl carbonate, CAS Registry Number 93981-50-1. (2017) (0)
Molecular mapping of lymph node metastases by real‐time reverse transcription polymerase chain reaction in two melanoma patients (2011) (0)
Calcipotriol Versus Steroid Ointment in Combination with Narrowband Ultraviolet B in the Treatment of Psoriasis Vulgaris (2005) (0)
RIFM fragrance ingredient safety assessment, 2,2,3-trimethylcyclopent-3-enylacetonitrile, CAS Registry Number 15373-31-6. (2019) (0)
RIFM fragrance ingredient safety assessment, 1-oxaspiro[4.5]decan-2-one, 8-ethyl-, trans-, CAS Registry Number 91069-40-8. (2018) (0)
RIFM fragrance ingredient safety assessment, Amylcyclohexyl acetate (mixed isomers), CAS Registry Number 67874-72-0. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-(1,1,2,3,3-pentamethylindan-5-yl)-1-propanol, CAS Registry Number 1217-08-9. (2021) (0)
RIFM fragrance ingredient safety assessment, ω-pentadecalactone, CAS Registry Number 106-02-5. (2020) (0)
RIFM fragrance ingredient safety assessment, hexyl hexanoate, CAS Registry Number 6378-65-0. (2020) (0)
RIFM fragrance ingredient safety assessment, benzyl formate, CAS Registry Number 104-57-4. (2018) (0)
RIFM fragrance ingredient safety assessment, cyclopropanemethanol, 1-methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]hex-3-yl)methyl]-, CAS Registry Number 198404-98-7. (2021) (0)
RIFM fragrance ingredient safety assessment, Citronellyl nitrile, CAS Registry Number 51566-62-2. (2017) (0)
RIFM fragrance ingredient safety assessment, 3-hepten-1-ol, (3Z)-, CAS Registry Number 1708-81-2. (2020) (0)
RIFM fragrance ingredient safety assessment, isoamyl phenylacetate, CAS Registry Number 102-19-2. (2019) (0)
Vitamin D3 analogue depresses cutaneous inflammation-inducing activities of plasmacytoid dendritic cells (DCs) but not inflammatory DCs (2016) (0)
RIFM fragrance ingredient safety assessment, 9-decenyl acetate CAS Registry Number 50816-18-7. (2018) (0)
RIFM fragrance ingredient safety assessment, acetic acid, anhydride, reaction products with 1,5,10-trimethyl-1,5,9-cyclododecatriene, CAS registry number 144020-22-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-formyl-6,6-dimethylbicyclo(3.1.1)hept-2-ene, CAS Registry Number 564-94-3. (2018) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, butanoic acid, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl ester, CAS Registry Number 113889-23-9. (2018) (0)
Bacterial superantigen, staphylococcal enterotoxin B (SEB) induces the synthesis of ICAM-1 molecules on IFN-γ treated human keratinocytes via mobilizing intracellular calcium following SEB binding to HLA-DR molecules (1994) (0)
Predominant activation of ????T cells but not ????T cells in murine B16 melanoma lesions: 500 (1997) (0)
RIFM fragrance ingredient safety assessment, benzyl cinnamate, CAS Registry Number 103-41-3. (2020) (0)
Merkel cell carcinoma of unknown primary origin phenotypically mimicking rhabdomyosarcoma: A case report (2020) (0)
Plasma exchange is a therapeutic option in severe cases of pemphigus (0)
RIFM fragrance ingredient safety assessment 2-Benzylheptanol, CAS Registry Number 92368-90-6. (2018) (0)
RIFM fragrance ingredient safety assessment, terpinyl isobutyrate, CAS Registry Number 7774-65-4. (2018) (0)
RIFM fragrance ingredient safety assessment, 1-oxaspiro[4.5]decan-2-one, 8-methyl-, CAS Registry Number 94201-19-1. (2018) (0)
RIFM fragrance ingredient safety assessment, 3-(p-tert-butylphenyl)-2-methylpropanol (Lysmerol), CAS Registry Number 56107-04-1. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 1-Methyl-2-(1-methylpropyl)cyclohexyl acetate, CAS Registry Number 72183-75-6. (2018) (0)
RIFM fragrance ingredient safety assessment, pentyl benzoate, CAS Registry Number 2049-96-9. (2018) (0)
RIFM fragrance ingredient safety assessment, carbonic acid, 2-hydroxyethyl 5-methyl-2-(1-methylethyl)cyclohexyl ester, CAS Registry Number 156679-39-9. (2020) (0)
RIFM fragrance ingredient safety assessment, 1-oxaspiro[4.5]deca-3,6-diene, 6-ethyl-2,10,10-trimethyl-, CAS Registry Number 79893-63-3. (2020) (0)
RIFM fragrance ingredient safety assessment, cyclopentanol, 2-methyl-5-(1-methylethyl)-, 1-propanoate, CAS Registry Number 1245725-35-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 3,5-dimethylcyclohex-3-ene-1-methyl acetate, CAS Registry Number 67634-25-7. (2020) (0)
RIFM fragrance ingredient safety assessment, lauryl acetate, CAS Registry Number 112-66-3. (2018) (0)
ESDR and JSID Collegiality Was not Built in a Day. (2020) (0)
RIFM fragrance ingredient safety assessment, isononyl acetate (isomer unspecified), CAS Registry Number 40379-24-6. (2018) (0)
RIFM fragrance ingredient safety assessment, 2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d]-1,3-dioxin, CAS Registry Number 27606-09-3. (2019) (0)
RIFM fragrance ingredient safety assessment, 1-cyclohexene-1-acetic acid, CAS Registry Number 18294-87-6. (2019) (0)
205 Potential involvement of ceramide in IFN-γ-induced ICAM-1 and HLA-DR expression on cultured normal human epidermal keratinocytes (1995) (0)
Merkel cell carcinoma presenting with a giant suspensory tumor on the upper arm (2010) (0)
RIFM fragrance ingredient safety assessment, p-ethylphenol, CAS Registry Number 123-07-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-(4-methylphenoxy)-N-(1H-pyrazol-3-yl)-N-(thiophen-2-ylmethyl)acetamide, CAS Registry Number 1374760-95-8. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, Terpinyl butyrate, CAS Registry Number 2153-28-8. (2018) (0)
A Case of Eccrine Porocarcinoma (2005) (0)
RIFM fragrance ingredient safety assessment, pyridine, 4-ethenyl-, reaction products with 3a,4,7,7a-tetrahydrodimethyl-4,7-methano-1H-indene, CAS Registry Number 125352-06-9. (2020) (0)
RIFM fragrance ingredient safety assessment, methyl acetoacetate, CAS Registry Number 105-45-3. (2019) (0)
RIFM fragrance ingredient safety assessment, pentanedioic acid, 1,5-dimethyl ester, CAS Registry Number 1119-40-0. (2018) (0)
RIFM fragrance ingredient safety assessment, methyl cyclohexadiene (mixture of isomers), CAS Registry Number 30640-46-1. (2020) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, coumarin, CAS registry number 91-64-5" [Food Chem. Toxicol. 130 (Suppl. 1) (2019) 110522]. (2020) (0)
Plasmacytoid dendritic cells as a key player in the initiation phase of alopecia areata-induced C3H/HeJ mouse (2016) (0)
RIFM Fragrance ingredient safety assessment, 2-nonen-1-ol, CAS registry number 22104-79-6. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4-(camphenyl-8)-cyclohexanone, CAS Registry Number 68901-22-4. (2020) (0)
Epitope reduction of anti-desmoglein 1 autoantibodies in pemphigus foliaceus patients sera during clinical stages (2016) (0)
Controversies in Experimental Dermatology (2006) (0)
RIFM fragrance ingredient safety assessment, 2-isopropyl-4-methylanisole, CAS Registry Number 31574-44-4. (2017) (0)
CD7-positive Sezary syndrome with a TH1 cytokine profile (1994) (0)
RIFM fragrance ingredient safety assessment, 3-methylbutyraldehyde, CAS Registry Number 590-86-3. (2021) (0)
RIFM fragrance ingredient safety assessment, oxacyclohexadecane-2,13-dione, CAS Registry Number 38223-29-9. (2017) (0)
RIFM fragrance ingredient safety assessment, diethyl tartrate, CAS Registry Number 87-91-2. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4-phenylbutyraldehyde, CAS Registry Number 40654-82-8. (2018) (0)
RIFM fragrance ingredient safety assessment, spiro[bicyclo[4.1.0]heptane-2,5'-[1,3]dioxane], 2',2',3,7,7-pentamethyl-, (1α,3α,6α)-, CAS Registry number 121251-67-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-(3,7-dimethyl-2,6-octadienyl)cyclopentanone, CAS Registry Number 68133-79-9. (2020) (0)
RIFM fragrance ingredient safety assessment, benzyl trans-2-methyl-2-butenoate, CAS Registry Number 37526-88-8. (2021) (0)
Cross-reactivity in murine quinolone photoallergy: exclusive usage of T cell receptor Vβ13 by immune T cells that recognize fluoroquinolone-photomodified cells (1998) (0)
RIFM fragrance ingredient safety assessment, o-cresol, CAS Registry Number 95-48-7. (2021) (0)
RIFM fragrance ingredient safety assessment, hexyl phenylacetate, CAS Registry Number 5421-17-0. (2019) (0)
RIFM fragrance ingredient safety assessment, 5- and 6-decenoic acid, CAS Registry Number 72881-27-7. (2021) (0)
RIFM fragrance ingredient safety assessment, cis-3-octen-1-ol, CAS Registry Number 20125-84-2. (2017) (0)
Three Cases of Mycosis Fungoides Presenting with Purpura Pigmentosa Chronica (2008) (0)
Inflammatory granuloma mimicking lacrimal sac abscess (2020) (0)
Welcome all international dermatology researchers to the 34th Annual Meeting of the Japanese Society of Investigative Dermatology (JSID) and the JSID-Asia-Oceania-Forum on Hair Research and Stem Cells December 4-6, 2009, in Fukuoka City, Kyushu, Japan (2009) (0)
RIFM fragrance ingredient safety assessment, 4'-methylacetophenone, CAS Registry Number 122-00-9. (2018) (0)
RIFM fragrance ingredient safety assessment, 3,4,4a,5,8,8a(Or 3,4,4a,7,8,8a)-hexahydro-3,3,6,7-tetramethyl-1H-2-benzopyran, CAS Registry Number 72429-08-4. (2020) (0)
RIFM fragrance ingredient safety assessment, Methyl octanoate, CAS Registry Number 111-11-5. (2021) (0)
Recurrent herpes zoster on a fixed thigh site: Its possible association with lymphoma cell invasion to femoral nerve (2014) (0)
Cholinergic urticaria with angioedema successfully treated with omalizumab (2019) (0)
RIFM fragrance ingredient safety assessment, 1-octen-3-yl acetate, CAS Registry Number 2442-10-6. (2019) (0)
RIFM fragrance ingredient safety assessment, isoamyl cinnamate, CAS Registry Number 7779-65-9. (2021) (0)
RIFM fragrance ingredient safety assessment, anisyl phenylacetate, CAS Registry Number 102-17-0. (2019) (0)
RIFM fragrance ingredient safety assessment, 2,4,4,7-tetramethylnona-6,8-dien-3-one, CAS Registry Number 81782-89-0. (2018) (0)
E1-3 Drug eruptions associated with telaprevir(English Session 1) (2012) (0)
RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate, CAS registry number 67634-20-2. (2018) (0)
RIFM fragrance ingredient safety assessment, isoamyl benzoate, CAS registry number 94-46-2. (2019) (0)
RIFM fragrance ingredient safety assessment, propenylguaethol, CAS Registry Number 94-86-0. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, Butyl phenylacetate, CAS Registry Number 122-43-0. (2018) (0)
RIFM fragrance ingredient safety assessment, γ-dodecalactone, CAS Registry Number 2305-05-7. (2019) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, 4-(isopropyl)-β-methylcyclohexanethanol, CAS Registry Number 67634-03-1"[Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110713]. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-ethoxy-4-methylphenol, CAS Registry Number 2563-07-7. (2020) (0)
Dyshidrosiform palmoplantar pemphigoid with low‐titer autoantibodies against BP180 NC16A (2018) (0)
RIFM fragrance ingredient safety assessment, benzaldehyde, CAS Registry Number 100-52-7. (2019) (0)
RIFM fragrance ingredient safety assessment, 1,1-diethoxyhexane, CAS Registry Number 3658-93-3. (2019) (0)
RIFM fragrance ingredient safety assessment, ethyl 3-methylthiopropionate, CAS Registry Number 13327-56-5. (2020) (0)
RIFM fragrance ingredient safety assessment, S-(1-methylpropyl) 3-methylbut-2-enethioate, CAS Registry Number 34322-09-3. (2021) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, 3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, CAS Registry Number 107898-54-4" [Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110715]. (2020) (0)
Topical application of vitamin D3 analogue to psoriatic skin preferentially suppresses Th17 cells by both direct and indirect mechanisms (2017) (0)
RIFM fragrance ingredient safety assessment, α-methyl-1,3-benzodioxole-5-propionaldehyde, CAS Registry Number 1205-17-0. (2020) (0)
RIFM fragrance ingredient safety assessment, γ-nonalactone, CAS Registry Number 104-61-0. (2019) (0)
Three dimensional real-time analysis of Rho/Rho kinase pathway in cultured endothelial cells by low-coherent quantitative phase microscope (2016) (0)
Dual effects of 5α-reductase inhibitor dutasteride on androgenetic alopecia and acne vulgaris (2019) (0)
Successful preoperative intervention of dupilumab in high‐risk surgery in a patient with severe atopic dermatitis (2019) (0)
NK Cells Lesions Augments the Activity of CTLs and Monoclonal Antibody in Early Tumor Daunomycin-Conjugated Specific T Cells by Administering a δγ Regulatory-Producing β Depletion of IL-10-and TGF-Egawa (1999) (0)
RIFM fragrance ingredient safety assessment, methyl cis-5-octenoate, CAS Registry Number 41654-15-3. (2020) (0)
Correlation Between Palmar Hyperlinearity and Early Childhood Atopic Dermatitis with Filaggrin Gene Null Mutations (2015) (0)
RIFM fragrance ingredient safety assessment, theaspirane, CAS Registry Number 36431-72-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 3-(methylthio)-1-hexanol, CAS Registry Number 51755-66-9. (2021) (0)
CD8+ mycosis fungoides with optic nerve and central nervous system involvement (2021) (0)
RIFM fragrance ingredient safety assessment, tricyclodecenyl propionate, CAS Registry Number 17511-60-3. (2018) (0)
RIFM fragrance ingredient safety assessment, vanillyl butyl ether, CAS Registry Number 82654-98-6. (2021) (0)
RIFM fragrance ingredient safety assessment, 4-heptanone, CAS Registry Number 123-19-3. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-1-ol, CAS Registry Number 104864-90-6. (2021) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-4-methyl-2-(2-methylpropen-1-yl)pyran, CAS Registry Number 16409-43-1. (2017) (0)
RIFM fragrance ingredient safety assessment, (Z)-4-hepten-1-ol, CAS Registry Number 6191-71-5. (2018) (0)
RIFM Fragrance ingredient safety assessment, cis-3-Hexenyl anthranilate, CAS Registry Number 65405-76-7. (2019) (0)
RIFM fragrance ingredient safety assessment, dipropyl disulfide, CAS Registry Number 629-19-6. (2020) (0)
RIFM fragrance ingredient safety assessment, α-methylcinnamaldehyde, CAS Registry Number 101-39-3. (2019) (0)
RIFM fragrance ingredient safety assessment, 3-(cis-3-hexenyloxy)propanenitrile, CAS Registry Number 142653-61-0. (2018) (0)
RIFM fragrance ingredient safety assessment, 2(10)-pinen-3-ol, CAS Registry Number 5947-36-4. (2018) (0)
RIFM fragrance ingredient safety assessment, vanillyl ethyl ether, CAS Registry Number 13184-86-6. (2021) (0)
RIFM fragrance ingredient safety assessment, cyclopropanecarboxylic acid, (3Z)-3-hexenyl ester, CAS Registry Number 188570-78-7. (2020) (0)
Filaggrin deficiency and T‐helper 17 development (2016) (0)
324 A potential role of galectin-7 as a stabilizer for IL-4/IL-13-induced barrier disruption in atopic dermatitis (2019) (0)
RIFM fragrance ingredient safety assessment, thiogeraniol, CAS registry number 39067-80-6. (2020) (0)
IL-10 producing plasma blasts that increase at an acute phase of herpes zoster (2017) (0)
RIFM fragrance ingredient safety assessment, 5-phenylhex-3-en-2-one, CAS Registry Number 60405-50-7. (2020) (0)
RIFM fragrance ingredient safety assessment, dimethyl adipate, CAS Registry Number 627-93-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-Hexylcyclopentanone, CAS Registry Number 13074-65-2. (2018) (0)
RIFM fragrance ingredient safety assessment, octahydro-4,7-methano-1H-indenemethyl formate, CAS Registry Number 68039-78-1. (2018) (0)
RIFM fragrance ingredient safety assessment 2-methyl-trans-2-butenoic acid, CAS Registry Number 80-59-1. (2018) (0)
Downmodulatory effects of cetirizine and levocetirizine on cytokine/chemokine production and CD54 expression in keratinocytes (2007) (0)
264 Patients with pemphigus foliaceus may retain antibody reactivity against calcium dependent epitopes of desmoglein 1 in remission (2016) (0)
Drugs acting on T lymphocytes for the treatment of atopic dermatitis. (1999) (0)
T cell expansion study using the lesional skin provides evidence for the role of drug-specific Tc1 and Th17 cells in severe drug eruptions (2016) (0)
RIFM fragrance ingredient safety assessment, 4-tert-butyltoluene, CAS Registry Number 98-51-1. (2020) (0)
Confusion in determination of two types of cutaneous adverse reactions to drugs, maculopapular eruption and erythema multiforme, among the experts: A proposal of standardized terminology (2019) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, cinnamaldehyde, CAS Registry Number 104-55-2" [Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110710]. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-methylpentyl 2-methylisocrotonate, CAS Registry Number 53082-58-9. (2019) (0)
RIFM fragrance ingredient safety assessment, 4-methoxybenzoic acid, CAS Registry Number 100-09-4. (2019) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-methyl-4-pentenoate, CAS Registry Number 53399-81-8. (2021) (0)
Unilateral widespread lichen planus following Blaschko's lines after Mycoplasma pneumoniae infection (2013) (0)
RIFM fragrance ingredient safety assessment, 4,7,7-trimethyl-6-thiabicyclo[3.2.1]oct-3-ene, CAS Registry Number 6784-08-3. (2019) (0)
RIFM fragrance ingredient safety assessment, isopropyl cinnamate, CAS Registry Number 7780-06-5. (2021) (0)
Congenital nail clubbing (2018) (0)
RIFM fragrance ingredient safety assessment, cis-5-octenal, CAS Registry Number 41547-22-2. (2021) (0)
RIFM fragrance ingredient safety assessment, isobutyl N-methylanthranilate, CAS Registry Number 65505-24-0. (2017) (0)
RIFM fragrance ingredient safety assessment, Alcohols, C11-14-iso-, C13-rich, CAS Registry Number 68526-86-3. (2017) (0)
RIFM fragrance ingredient safety assessment, 2,4-dimethyl-4-phenyltetrahydrofuran, CAS Registry Number 82461-14-1. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, acetaldehyde ethyl phenylethyl acetal, CAS Registry Number 2556-10-7. (2017) (0)
Remitting seronegative symmetrical synovitis with pitting oedema syndrome with oedematous skin histopathologically characterized by granulomatous change (2016) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-methyl-3-pentenoate, CAS Registry Number 1617-23-8. (2018) (0)
Clinical Features of Patients with Filaggrin Gene Mutations in Childhood Atopic Dermatitis (2015) (0)
Welcome to the Journal of Dermatology and greetings from the new Editor‐in‐Chief (2011) (0)
RIFM fragrance ingredient safety assessment, hexen-2-al, CAS Registry Number 6728-26-3. (2021) (0)
RIFM fragrance ingredient safety assessment, pentyl phenylacetate, CAS Registry Number 5137-52-0. (2018) (0)
RIFM Fragrance Ingredient Safety Assessment, Butyl anthranilate, CAS Registry Number 7756-96-9. (2017) (0)
RIFM fragrance ingredient safety assessment, 9-decenoic acid, CAS Registry Number 14436-32-9. (2020) (0)
New technology in immunology (PP-063) (2010) (0)
Acquired poikiloderma associated with primary biliary cirrhosis. (2011) (0)
RIFM fragrance ingredient safety assessment, methylallyl isobutyrate, CAS Registry Number 816-73-9. (2020) (0)
Langerhans Cells and Prostaglandins: Contribution to the Etiology and Pathogenesis of Atopic Dermatitis and Related Disorders (2008) (0)
RIFM fragrance ingredient safety assessment, β,β,3-trimethyl benzenepropanol, CAS Registry Number 103694-68-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 1,6-heptadien-3-one, 2-cyclohexyl-, CAS Registry Number 313973-37-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 2,5,7-octatrien-1-ol, 2,6-dimethyl-, 1-acetate, CAS Registry Number 197098-61-6. (2020) (0)
RIFM fragrance ingredient safety assessment 5,8-Methano-2H-1-benzopyran-2-one, 6- ethylideneoctahydro-, CAS Registry Number 69486-14-2. (2018) (0)
RIFM fragrance ingredient safety assessment, butyl methacrylate, CAS Registry Number 97-88-1. (2020) (0)
Questionnaire Survey of Female Patients with Atopic Dermatitis Regarding Genital Skin Condition (2010) (0)
RIFM fragrance ingredient safety assessment, nonane, CAS Registry Number 111-84-2. (2020) (0)
232 Ultraviolet B light-induced suppressor T cells in murine contact photosensitivity to TCSA are tcrvβ7-bearing TH2 cells (1995) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-ethyl-3,6,6-trimethylcyclohexenecarboxylate, CAS Registry Number 94333-50-3. (2019) (0)
RIFM fragrance ingredient safety assessment, butyl benzoate, CAS registry number 136-60-7. (2018) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 1,2,3,4,4a,5,6,7-octahydro-2,5,5-trimethyl-2-naphthalenol, CAS Registry number 41199-19-3. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-propanol, 1,1',1',1'-(1,2-ethanediyldinitrilo)tetrakis-, CAS Registry Number 102-60-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-tert-butylcyclohexyl acetate, CAS Registry Number 31846-06-7. (2018) (0)
RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydromethoxy-4,7-methano-1H-indene (isomer unspecified), CAS Registry Number 27135-90-6. (2018) (0)
RIFM fragrance ingredient safety assessment, 1,2-cyclopentanedione, 3,4,4-trimethyl-, CAS Registry Number 33079-56-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 1,2,3,4,5,6,7,8,9,10-decahydro-5,9-methanobenzocycloocten-11-one, CAS Registry Number 22690-27-3. (2018) (0)
RIFM fragrance ingredient safety assessment, decyl methyl ether, CAS Registry Number 7289-52-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-Methylbutanal diethyl acetal, CAS Registry Number 3842-03-3. (2017) (0)
RIFM fragrance ingredient safety assessment, dimethyl sulfide, CAS Registry Number 75-18-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-5-cyclopentadecen-1-one, CAS registry number 63314-79-4. (2021) (0)
RIFM fragrance ingredient safety assessment,2-acetylpyridine, CAS Registry Number 1122-62-9. (2020) (0)
RIFM fragrance ingredient safety assessment, 4-(2-butenylidene)-3,5,5-trimethylcyclohex-2-en-1-one, CAS registry number 13215-88-8. (2020) (0)
RIFM fragrance ingredient safety assessment, butyl alcohol, CAS Registry Number 71-36-3. (2019) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, 4,8-dimethyl-4,9-decadiena", CAS registry number 71077-31-1 [Food Chem. Toxicol. 130, Suppl. 1 (2019) 110648]. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-nonanone, CAS Registry Number 821-55-6. (2020) (0)
RIFM fragrance ingredient safety assessment, cis-3-nonen-1-ol, CAS Registry Number 10340-23-5. (2020) (0)
Spindle cell hemangioma in an elderly patient: Uncommon benign vascular neoplasm (2016) (0)
Mechanism of Action Efficacy and Safety of the Topical Combination of Active Vitamin D3 and Steroid in Psoriasis Pathology (2019) (0)
RIFM fragrance ingredient safety assessment, 4,6-dimethyl-2H-pyran-2-one, CAS Registry Number 675-09-2. (2020) (0)
RIFM fragrance ingredient safety assessment, butyl sulfide, CAS Registry Number 544-40-1. (2019) (0)
Therapeutic Effects of Olopatadine Hydrochloride on Blood Substance P Levels and Circulating Th17 Cell Numbers in Patients with Atopic Dermatitis (2010) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-5-phenylpentanenitrile, CAS Registry Number 54089-83-7. (2018) (0)
Novel gene mutations in Chédiak–Higashi syndrome with hyperpigmentation (2019) (0)
RIFM fragrance ingredient safety assessment, (Z)-Octadec-9-enol, CAS Registry Number 143-28-2. (2018) (0)
RIFM fragrance ingredient safety assessment, 1-octen-3-one, CAS Registry Number 4312-99-6. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-decanone, CAS Registry Number 693-54-9. (2020) (0)
RIFM fragrance ingredient safety assessment, 1α,5α-dihydroguaiol, CAS Registry Number 3526-75-8. (2019) (0)
314 Infiltration of MDR-1-expressing T cells including Th17 in psoriasis lesional skin and their association with corticosteroid resistance (2017) (0)
RIFM fragrance ingredient safety assessment, 2-(1-methylpropyl)-1-vinylcyclohexyl acetate, CAS Registry Number 37172-02-4. (2020) (0)
Anti-HMGB1 antibody attenuates vascular hyperpermeability and promotes wound healing during ischemia-reperfusion injury model in mouse skin (2013) (0)
RIFM fragrance ingredient safety assessment, 3-octanone, CAS Registry Number 106-68-3. (2019) (0)
RIFM fragrance ingredient safety assessment, ethylene dodecanedioate, CAS registry number 54982-83-1. (2017) (0)
RIFM fragrance ingredient safety assessment, methyl 3-hexenoate, CAS Registry Number 2396-78-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-octanol, CAS Registry Number 589-98-0. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl 10-undecenoate, CAS Registry Number 692-86-4. (2020) (0)
RIFM fragrance ingredient safety assessment, dihydro-α-terpineol, CAS Registry Number 498-81-7. (2017) (0)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-1,3,6-octatriene, CAS Registry Number 13877-91-3. (2021) (0)
Corrigendum to “Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer” [J. Dermatol. Sci. 78 (2015) 153–155] (2016) (0)
RIFM fragrance ingredient safety assessment, 4-methylnonanoic acid, CAS Registry Number 45019-28-1. (2018) (0)
A case of sclerosing perineurioma (2006) (0)
RIFM fragrance ingredient safety assessment, cyclohexaneethyl acetate, CAS Registry Number 21722-83-8. (2020) (0)
A steric structure of tufted hair folliculitis. (2019) (0)
Pigmented dermatofibrosarcoma protuberans associated with dermal melanocytosis (2018) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4-phenyl-1,3-dioxolane, CAS Registry Number 33941-99-0. (2019) (0)
RIFM fragrance ingredient safety assessment, hexyl propionate, CAS registry number 2445-76-3. (2018) (0)
RIFM fragrance ingredient safety assessment, tricyclo[5.2.1.02,6]decan-8-one, CAS Registry Number 13380-94-4. (2021) (0)
A lymphocytic papular eruption associated with primary human immunodeficiency virus infection (2000) (0)
RIFM fragrance ingredient safety assessment, 1,4-dimethoxy-2-tert-butylbenzene, CAS Registry Number 21112-37-8. (2019) (0)
Erratum (2010) (0)
178 Acute barrier disruption by acetone before sensitization augments murine contact hypersensitivity to dnfb but not FITC (1995) (0)
RIFM fragrance ingredient safety assessment, 2,2,6-trimethyl-6-vinyltetrahydropyran, CAS registry number 7392-19-0. (2020) (0)
LesionsCoinfiltrating in Early B 16 Melanoma T Cells βα T and δγ Expressed on Th 2-Type MoleculesbT Cell Activities by MHC K Down-Regulation of Tumoricidal NK and NK Masahiro (1998) (0)
RIFM fragrance ingredient safety assessment, 4-Hexen-1-ol, (4Z)-, CAS Registry Number 928-91-6. (2018) (0)
RIFM fragrance ingredient safety assessment, spiro[5.5]undec-8-en-1-one, 2,2,7,9-tetramethyl-, CAS Registry Number 502847-01-0. (2019) (0)
RIFM fragrance ingredient safety assessment, ethyl (E)hex-3-enoate, CAS Registry Number 26553-46-8. (2020) (0)
RIFM fragrance ingredient safety assessment, methyl 2,6,6-trimethylcyclohex-2-ene-1-carboxylate, CAS Registry Number 28043-10-9. (2020) (0)
RIFM fragrance ingredient safety assessment, nonanoic acid, CAS Registry Number 112-05-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 4-methyl-1-oxaspiro[5.5]undecene, CAS Registry Number 68228-06-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 4H-4a,9-methanoazuleno[5,6-d]-1,3-dioxole, octahydro-2,2,5,8,8,9a-hexamethyl-, (4aR,5R,7aS,9R)-, CAS Registry Number 211299-54-6. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-tert-butylcyclohexyl propionate, CAS Registry Number 40702-13-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-(3-phenylpropyl)tetrahydrofuran, CAS Registry Number 3208-40-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 6,7-dihydro-1,1,2,3,3-pentamethyl-4(5H)-indanone, CAS Registry Number 33704-61-9. (2020) (0)
RIFM fragrance ingredient safety assessment, butyl butyrate, CAS Registry Number 109-21-7. (2020) (0)
RIFM fragrance ingredient safety assessment, benzonitrile, CAS Registry Number 100-47-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-ethylfuran, CAS Registry Number 3208-16-0. (2021) (0)
RIFM fragrance ingredient safety assessment, cyclohexanone diethyl ketal, CAS Registry Number 1670-47-9. (2021) (0)
173 Stimulation of peripheral blood lymphocytes with skincolonized bacteria: Superantigenic and nonsuperantigenic machanisms (1995) (0)
RIFM fragrance ingredient safety assessment, methyl isovalerate, CAS Registry Number 556-24-1. (2018) (0)
RIFM fragrance ingredient safety assessment, Methylcyclooctyl carbonate, CAS Registry Number 61699-38-5. (2017) (0)
RIFM fragrance ingredient safety assessment, isopropyl butyrate CAS Registry Number 638-11-9. (2019) (0)
RIFM fragrance ingredient safety assessment, 4-(isopropyl)-β-methylcyclohexanethanol, CAS Registry Number 67634-03-1. (2019) (0)
RIFM fragrance ingredient safety assessment, benzenepropanol, α, γ, γ-trimethyl-, CAS Registry Number 2035-93-0. (2019) (0)
RIFM fragrance ingredient safety assessment, 1-methyl-3-methoxy-4-isopropylbenzene, CAS Registry Number 1076-56-8. (2017) (0)
RIFM fragrance ingredient safety assessment, cis-4-(isopropyl)cyclohexanemethanol, CAS Registry Number 13828-37-0. (2020) (0)
36 Modulatory effects of cell-permeable sphingosine and ceramides on cellular kinetics of T cells: Th2 suppressor cells are more susceptible to sphingosine than Th1 cells in murine delayed-type hypersensitivity (1996) (0)
RIFM fragrance ingredient safety assessment, propyl alcohol, CAS Registry Number 71-23-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 10-dodecen-3-one, 5-hydroxy-7,11-dimethyl-, CAS registry number 68922-12-3. (2019) (0)
RIFM fragrance ingredient safety assessment, cyclohexanol,4-(3-methylbutyl)-, CAS Registry Number 830322-14-0. (2019) (0)
AhR-dependent COX-2 upregulation is involved in the mechanisms underlying voriconazole-induced UV-associated skin cancer development (2016) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-2-butenyl acetate, CAS Registry Number 1191-16-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-1-octanol, CAS Registry Number 106-21-8. (2017) (0)
RIFM fragrance ingredient safety assessment, 5,9-dimethyl-4,8-decadienal, CAS Registry Number 762-26-5. (2020) (0)
RIFM fragrance ingredient safety assessment, 10-undecenoic acid, CAS Registry Number 112-38-9. (2020) (0)
RIFM fragrance ingredient safety assessment diethyl succinate, CAS Registry Number 123-25-1. (2017) (0)
082 CD8+ IL-23R+ PD-1+ T cells in psoriatic skin possibly play a role in maintaining inflammation and disease recurrence (2019) (0)
Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with atopic dermatitis and psoriasis (1993) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 4,8-Dimethyl-3-7-nonadien-2-ol, CAS Registry Number 67845-50-5. (2018) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, methoxy dicyclopentadiene carboxaldehyde, CAS Registry Number 86803-90-9" [Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110826]. (2020) (0)
Announcements (2008) (0)
RIFM fragrance ingredient safety assessment, ethyl lactate, CAS Registry Number 97-64-3. (2020) (0)
RIFM fragrance ingredient safety assessment, p-(2,2-dimethoxyethoxy)toluene, CAS Registry Number 6324-78-3. (2018) (0)
RIFM fragrance ingredient safety assessment, 4-isopropyl-1-methyl-2-propenylbenzene, CAS Registry Number 14374-92-6. (2021) (0)
Long-term remission of metastatic malignant melanoma in association with development of systemic vitiligo (2010) (0)
The impact of antiviral therapy on renal function in herpes zoster patients: A multiple linear regression analysis of 211 cases (2016) (0)
RIFM fragrance ingredient safety assessment, 5,7-dihydro-2-methylthieno(3,4-d)pyrimidine, CAS Registry Number 36267-71-7. (2019) (0)
RIFM fragrance ingredient safety assessment, acetic acid, CAS Registry Number 64-19-7. (2019) (0)
RIFM fragrance ingredient safety assessment, nonyl acetate, CAS Registry Number 143-13-5. (2018) (0)
RIFM fragrance ingredient safety assessment, Octyl acetate, CAS Registry Number 112-14-1. (2018) (0)
RIFM fragrance ingredient safety assessment, dihydro-β-ionol, cas registry number 3293-47-8. (2017) (0)
RIFM fragrance ingredient safety assessment, benzaldehyde glyceryl acetal, CAS Registry Number 1319-88-6. (2021) (0)
RIFM fragrance ingredient safety assessment, diethyl malonate, CAS Registry Number 105-53-3. (2018) (0)
RIFM fragrance ingredient safety assessment, 4,5,6,7,8,9,10,11,12,13-decahydrocyclododecaoxazole, CAS Registry Number 38303-23-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-pentylcyclopentan-1-one, CAS Registry Number 4819-67-4. (2017) (0)
RIFM low-exposure fragrance ingredients safety assessment. (2021) (0)
RIFM fragrance ingredient safety assessment, octanal dimethyl acetal, CAS Registry Number 10022-28-3. (2018) (0)
RIFM fragrance ingredient safety assessment, S-isopropyl 3-methylthiobutyrate, CAS Registry Number 34322-06-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-2-pentylcyclopentan-1-one, CAS Registry Number 13074-63-0. (2017) (0)
RIFM fragrance ingredient safety assessment, 4-isopropyl-2-methoxy-1-methylbenzene, CAS Registry Number 6379-73-3. (2017) (0)
RIFM fragrance ingredient safety assessment, 2,5-diethyltetrahydrofuran, CAS Registry Number 41239-48-9. (2020) (0)
RIFM fragrance ingredient safety assessment, cinnamyl formate, CAS Registry Number 104-65-4. (2021) (0)
RIFM fragrance ingredient safety assessment, cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, trans- CAS Registry Number 23250-42-2. (2017) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-hexylacetoacetate, CAS Registry Number 29214-60-6. (2019) (0)
Tug-of-war between IFN-γ-producing CD8 + T cells and IL-4-producing CD4 + T cells destines the severity of muscle injury in dermatomyositis (2013) (0)
RIFM fragrance ingredient safety assessment, hydroxynonanoic acid, δ-lactone, CAS Registry Number 3301-94-8. (2021) (0)
RIFM fragrance ingredient safety assessment, cinnamyl benzoate, CAS Registry Number 5320-75-2. (2020) (0)
RIFM fragrance ingredient safety assessment, stearic acid, CAS Registry Number 57-11-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-isopropyl-5-methylcyclohexyl 2-methylbut-2-enoate, CAS Registry Number 67801-23-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl pivalate, CAS Registry Number 68039-45-2. (2018) (0)
280 Cell-to-cell contact with HTLV-1-infected T cells reduces dendritic cell immune functions and contributes to infection in trans (2016) (0)
RIFM fragrance ingredient safety assessment,1-(2,2,6-trimethylcyclohexyl)-3-hexanol, CAS Registry Number 70788-30-6. (2021) (0)
RIFM fragrance ingredient safety assessment, p-tolyl alcohol, CAS Registry Number 589-18-4. (2019) (0)
Controversies in Experimental Dermatology: Viewpoint 2 (2006) (0)
RIFM fragrance ingredient safety assessment, acetaldehyde cyclic propylene glycol acetal, CAS Registry Number 3390-12-3. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-2-butanol, CAS Registry Number 75-85-4. (2020) (0)
Corrigendum to "RIFM fragrance ingredient safety assessment, β,β,3-trimethyl benzenepropanol", CAS registry number 103694-68-4 [Food Chem. Toxicol. 130 Suppl. 1 (2019) 110650]. (2020) (0)
RIFM fragrance ingredient safety assessment, cis-6-nonen-1-ol, CAS Registry Number 35854-86-5. (2017) (0)
RIFM fragrance ingredient safety assessment, methyl 3-nonenoate, CAS Registry Number 13481-87-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 2,2,5-trimethyl-5-pentylcyclopentanone, CAS Registry Number 65443-14-3. (2017) (0)
Mini Book Reviews (1986) (0)
Cutaneous metastatic lung cancer manifesting multiple nodules on the scalp (2008) (0)
RIFM fragrance ingredient safety assessment, 2,4-dimethylcyclohexylmethyl acetate, CAS Registry Number 67634-22-4. (2020) (0)
143 High serum and epidermal extracellular levels of galectin-7 in atopic dermatitis (2017) (0)
RIFM fragrance ingredient safety assessment, pyridine, 4-decyl-, CAS Registry Number 1815-99-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 4,4a,5,9b-tetrahydroindeno[1,2-d]-1,3-dioxine, CAS Registry Number 18096-62-3. (2019) (0)
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-2,6-nonadien-1-al, CAS Registry Number 41448-29-7. (2020) (0)
RIFM fragrance ingredient safety assessment, S-2-butyl 3-methylbutanethioate, CAS Registry Number 2432-91-9. (2020) (0)
269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation (2017) (0)
RIFM fragrance ingredient safety assessment, tricyclodecenyl acetate, CAS Registry Number 5413-60-5. (2018) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-α-pentylfurfuryl acetate, CAS Registry Number 67634-08-6. (2020) (0)
RIFM fragrance ingredient safety assessment, 1-oxaspiro[4.5]deca-3,6-diene, 2,7-dimethyl-10-(1-methylethyl)-, CAS Registry Number 89079-92-5. (2020) (0)
RIFM fragrance ingredient safety assessment, phenylacetaldehyde, CAS Registry Number 122-78-1. (2020) (0)
RIFM fragrance ingredient safety assessment, amyl hexanoate, CAS Registry Number 540-07-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-methylbutyraldehyde, CAS Registry Number 96-17-3. (2021) (0)
RIFM fragrance ingredient safety assessment, 5-isopropenyl-2-methyl-2-vinyltetrahydrofuran, CAS registry number 13679-86-2. (2019) (0)
A case of giant extramammary Paget's disease (2006) (0)
Involvement of reactive oxygen species in contact photosensitization in mice. (1986) (0)
RIFM fragrance ingredient safety assessment, 2H-indeno[4,5b] furan, decahydro-2,2,6,6,7,8,8-heptamethyl, CAS Registry Number 476332-65-7. (2021) (0)
RIFM fragrance ingredient safety assessment, β-methylphenethyl alcohol, CAS Registry Number 1123-85-9. (2017) (0)
RIFM fragrance ingredient safety assessment, δ-dodecalactone, CAS Registry Number 713-95-1. (2021) (0)
RIFM fragrance ingredient safety assessment, styryl acetate, CAS Registry Number 10521-96-7. (2020) (0)
RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydro-5-methoxy-4,7-methano-1H-indene, CAS Registry Number 53018-24-9. (2019) (0)
RIFM fragrance ingredient safety assessment, xylene (mixed), CAS Registry Number 1330-20-7. (2021) (0)
RIFM fragrance ingredient safety assessment, isodecyl alcohol, CAS registry number 25339-17-7. (2017) (0)
RIFM fragrance ingredient safety assessment, benzene, 1,3,5-trimethoxy-, CAS Registry Number 621-23-8. (2020) (0)
Acute barrier disruption by acetone augments responsiveness of murine contact hypersensitivity (1994) (0)
Characterization of peripheral natural killer cells and their reduction in drug-induced hyper-sensitivity syndrome. (2012) (0)
102 Phenotypes of lymphocytes infiltrating in B16 melanoma (1997) (0)
RIFM fragrance ingredient safety assessment, 3-propylphenol, CAS Registry Number 621-27-2. (2020) (0)
ANALYSIS OF PHOTOTOXICITY AFTER PHOTOFRIN II-MEDIATED PHOTODYNAMIC THERAPY IN JAPANESE CANCER-BEARING PATIENTS (2000) (0)
RIFM fragrance ingredient safety assessment, pentyl acetate, CAS Registry Number 628-63-7. (2020) (0)
RIFM fragrance ingredient safety assessment, myrcenol, CAS Registry Number 543-39-5. (2020) (0)
New Year’s Greetings (2012) (0)
424 Sensitive skin is highly frequent in atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier assessments (2017) (0)
Combination Therapy of Mizoribine and Prednisolone for Autoimmune Bullous Diseases (2006) (0)
RIFM fragrance ingredient safety assessment, octyl formate, CAS Registry Number 112-32-3. (2018) (0)
276 Tumor cells suppress CRTAM expression on CD8+ T cells to evade host immunity in adult T cell leukemia/lymphoma (2017) (0)
RIFM fragrance ingredient safety assessment, alpha-methyl-4-(1-methylethyl)-cyclohexanemethanol, CAS Registry Number 63767-86-2. (2019) (0)
RIFM fragrance ingredient safety assessment, 3,12-Tridecadienenitrile CAS Registry Number 134769-33-8. (2017) (0)
Characterization of a malignant T‐cell line established from a rare case of CD8+CD56+ Sézary syndrome (2013) (0)
RIFM fragrance ingredient safety assessment, 2-methylbutyl butyrate, CAS Registry Number 51115-64-1. (2018) (0)
RIFM fragrance ingredient safety assessment, 10-undecenoic acid, heptyl ester, CAS Registry Number 68141-27-5. (2018) (0)
RIFM fragrance ingredient safety assessment, octyl butyrate, CAS Registry Number 110-39-4. (2018) (0)
586 New concept of cytokine balance in alopecia areata with atopic dermatitis (2019) (0)
RIFM fragrance ingredient safety assessment, diphenyl ether, CAS Registry Number 101-84-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane, CAS Registry Number 68398-18-5. (2019) (0)
RIFM fragrance ingredient safety assessment, isobutyl formate, CAS Registry Number 542-55-2. (2020) (0)
RIFM fragrance ingredient safety assessment,decane, CAS Registry Number 124-18-5. (2020) (0)
RIFM fragrance ingredient safety assessment, butyl lactate, CAS Registry Number 138-22-7. (2021) (0)
264 CCR5 blockade shows prevention of alopecia areata development as well as improvement of alopecia areata (2017) (0)
RIFM fragrance ingredient safety assessment Dimethyl succinate, CAS Registry Number 106-65-0. (2017) (0)
RIFM fragrance ingredient safety assessment, butanoic acid, 2-methyl-5-(1-methylethyl)cyclopentyl ester, CAS Registry Number 1266606-26-1. (2019) (0)
RIFM fragrance ingredient safety assessment, decanenitrile, CAS Registry Number 1975-78-6. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-cyclohexylcyclohexanone, CAS Registry Number 90-42-6. (2020) (0)
RIFM fragrance ingredient safety assessment, cyclopentanol, 2-(2-hexen-1-yl)-, CAS Registry Number 34686-67-4. (2019) (0)
Multicentric Castleman's disease presenting with cutaneous plasmacytosis (2020) (0)
RIFM fragrance ingredient safety assessment, benzoic acid, 2-[(1-oxopropyl)amino]-, methyl ester, CAS Registry Number 25628-84-6. (2017) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-2-(pentyloxy)cyclopent-2-en-1-one, CAS Registry Number 68922-13-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 3-octyl acetate, CAS Registry Number 4864-61-3. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-thiophenecarboxylic acid, ethyl ester, CAS Registry Number 2810-04-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 1-(3-methyl-2-benzofuranyl)ethanone, CAS Registry Number 23911-56-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4-propyl-1,3-oxathiane, CAS registry number 67715-80-4. (2020) (0)
RIFM fragrance ingredient safety assessment, p-cresyl benzoate, CAS Registry Number 614-34-6. (2019) (0)
Current Clinico-Epidemiological Characteristics of Adult T-Cell Leukemia-Lymphoma (ATL) Based on the 11th Nationwide Survey in Japan (2015) (0)
RIFM fragrance ingredient safety assessment, hexanoic acid, CAS Registry Number 142-62-1. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-methoxybenzyl ether, CAS Registry Number 64988-06-3. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-heptanone, CAS Registry Number 110-43-0. (2019) (0)
RIFM fragrance ingredient safety assessment, 3,5,6,6-tetramethyl-4-methyleneheptan-2-one, CAS Registry number 81786-75-6. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-heptanone, CAS Registry Number 106-35-4. (2019) (0)
RIFM fragrance ingredient safety assessment, 7,9-dimethylspiro[5.5]undecan-3-one, CAS Registry Number 83863-64-3. (2021) (0)
RIFM fragrance ingredient safety assessment, α-Isobutylphenethyl alcohol, CAS Registry Number 7779-78-4. (2017) (0)
RIFM fragrance ingredient safety assessment, 1-cyclohexylethanol, CAS Registry Number 1193-81-3. (2019) (0)
RIFM fragrance ingredient safety assessment, dodecanal dimethyl acetal, CAS Registry Number 14620-52-1. (2018) (0)
RIFM fragrance ingredient safety assessment, 1-naphthalenol, 1,2,3,4,4a,5,8,8a-octahydro-2,2,6,8-tetramethyl-, CAS Registry Number 103614-86-4. (2018) (0)
RIFM Fragrance ingredient safety assessment, methylheptenol, CAS Registry Number 1335-09-7. (2018) (0)
RIFM fragrance ingredient safety assessment, hexadeca-1,5-lactone, CAS Registry Number 7370-44-7. (2021) (0)
RIFM fragrance ingredient safety assessment, 4H-1,3-benzodioxin, hexahydro-4-methyl-2-(phenylmethyl)-, CAS Registry Number 1373821-23-8. (2020) (0)
RIFM fragrance ingredient safety assessment, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, CAS Registry Number 3658-77-3. (2020) (0)
IL-17A weakens the tight junction (TJ) barrier in a human-skin-equivalent model: A possible mechanism of impaired TJ in atopic dermatitis (2016) (0)
RIFM fragrance ingredient safety assessment, 3,3,5-trimethylcyclohexaneacetic acid, CAS Registry Number 3213-73-8. (2018) (0)
RIFM fragrance ingredient safety assessment, amyl alcohol, CAS Registry Number 71-41-0. (2019) (0)
Immunoglobulin A vasculitis in the oldest old (2015) (0)
Rifm fragrance ingredient safety assessment, 2-methylpentyl 2-methylvalerate, CAS Registry Number 90397-38-9. (2019) (0)
No Reduction in the Effect of Topical Steroids by Dilution with Topical Moisturizers-Assessment by Carrageenan-induced Edema- (2003) (0)
RIFM fragrance ingredient safety assessment, 2-hexanol, CAS Registry Number 626-93-7. (2020) (0)
RIFM fragrance ingredient safety assessment, p-mentha-8-thiol-3-one, CAS Registry Number 38462-22-5. (2021) (0)
RIFM fragrance ingredient safety assessment, δ-undecalactone, CAS Registry Number 710-04-3. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-pentanol, CAS Registry Number 6032-29-7. (2020) (0)
RIFM fragrance ingredient safety assessment, octane, 1,1-bis(octyloxy)-, CAS Registry Number 68527-82-2. (2019) (0)
RIFM fragrance ingredient safety assessment, 1-(2,4,4,5,5-pentamethyl-1-cyclopenten-1-yl)ethan-1-one, CAS Registry Number 13144-88-2. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-methylpropyl pentanoate, CAS Registry Number 10588-10-0. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-ethylbutyl acetate, CAS Registry Number 10031-87-5. (2019) (0)
RIFM fragrance ingredient safety assessment, 3-(m-tert-butylphenyl)-2-methylpropionaldehyde, CAS Registry Number 62518-65-4. (2020) (0)
My JDS, spicy but sweet task. (2020) (0)
RIFM fragrance ingredient safety assessment, ethanedioic acid, CAS Registry Number 144-62-7. (2021) (0)
Man's best friend? The effect of pet ownership on house dust microbial communities (2016) (0)
RIFM fragrance ingredient safety assessment, dodecanenitrile, CAS Registry Number 2437-25-4. (2018) (0)
RIFM fragrance ingredient safety assessment, 3-(hydroxymethyl)nonan-2-one, CAS Registry Number 67801-33-6. (2021) (0)
RIFM fragrance ingredient safety assessment, pinocarvyl acetate, CAS Registry Number 1078-95-1. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-undecanol, CAS Registry Number 1653-30-1. (2020) (0)
RIFM fragrance ingredient safety assessment, isobutyl cinnamate, CAS Registry Number 122-67-8. (2021) (0)
CXCL10 induces infiltrates of Th1/Tc1 cells in the acute alopecia areata followed by sustained Tc1 cell-accumulation in the chronic phase (2013) (0)
RIFM fragrance ingredient safety assessment, methyl 3-methylthiopropionate, CAS Registry Number 13532-18-8. (2020) (0)
Clinical course of the first Japanese family with Marie Unna hereditary hypotrichosis: a follow-up report (2018) (0)
RIFM fragrance ingredient safety assessment, benzyl methyl ether, CAS Registry Number 538-86-3. (2018) (0)
Inflammatory cytokine expression in the skin lesions of tumour necrosis factor receptor-associated periodic syndrome. (2012) (0)
Scleredema accompanied by IgG‐λ monoclonal gammopathy (2019) (0)
RIFM fragrance ingredient safety assessment, γ-valerolactone, CAS Registry Number 108-29-2. (2019) (0)
RIFM fragrance ingredient safety assessment, lactoscatone, CAS Registry Number 21280-29-5. (2019) (0)
RIFM fragrance ingredient safety assessment, amyl valerate, CAS Registry Number 2173-56-0. (2020) (0)
RIFM fragrance ingredient safety assessment 2-heptylcyclopentanone, CAS Registry Number 137-03-1. (2017) (0)
RIFM fragrance ingredient safety assessment, methyl undec-10-enoate, CAS Registry Number 111-81-9. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-4(2,2,3-trimethyl-3-cyclopentenyl)butanol, CAS Registry Number 72089-08-8. (2017) (0)
Higher frequency of sensitive skin in extrinsic type of atopic dermatitis than intrinsic type as assessed by lactic acid stinging test (2017) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate, CAS registry number 57934-97-1. (2019) (0)
RIFM fragrance ingredient safety assessment 4-(Isopropyl)cyclohexyl propionate, CAS Registry Number 63449-95-6. (2017) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-1-pentanol, CAS Registry Number 589-35-5. (2017) (0)
RIFM fragrance ingredient safety assessment, benzenemethanol, α-methylene-, acetate, CAS Registry Number 2206-94-2. (2020) (0)
RIFM fragrance ingredient safety assessment, isobutyl phenylacetate, CAS Registry Number 102-13-6. (2019) (0)
RIFM fragrance ingredient safety assessment, 3-mercaptohexanol, CAS Registry Number 51755-83-0. (2019) (0)
RIFM fragrance ingredient safety assessment, γ-decalactone, CAS Registry Number 706-14-9. (2019) (0)
RIFM fragrance ingredient safety assessment, carbonic acid, 2-hydroxypropyl (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, CAS Registry Number 260781-16-6. (2020) (0)
RIFM fragrance ingredient safety assessment, isobornyl methyl ether, CAS Registry Number 5331-32-8. (2019) (0)
Preferential suppression of Th17 infiltrate in psoriasis plaque by topical calcipotriol/corticosteroid combination: T cell propagation study (2016) (0)
Immunosuppressive states due to immunological senescence ( 1 ) or administration of immunosuppressants ( 2 ) occasionally cause (0)
RIFM fragrance ingredient safety assessment, ethyl 3-hydroxyhexanoate, CAS Registry Number 2305-25-1. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-nonyn-1-al dimethylacetal, CAS Registry Number 13257-44-8. (2019) (0)
RIFM fragrance ingredient safety assessment, ethyl 4-pentenoate, CAS Registry Number 1968-40-7. (2021) (0)
Phenobarbital- Induced Eruption Characterization of Drug-Specific T Cells in (2002) (0)
RIFM fragrance ingredient safety assessment, propanedioic acid, 1-(3,3-dimethylcyclohexyl) ethyl, ethyl ester, CAS Registry Number 478695-70-4. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT phenylethyl 2-methylbutyrate, CAS Registry Number 24817-51-4. (2018) (0)
Role of prostaglandin E2-EP2/EP4 signaling in the development of photosensitivity in pellagra (2013) (0)
RIFM fragrance ingredient safety assessment, cyclohexyl cyclopent-2-ene-1-acetate, CAS Registry Number 65405-69-8. (2019) (0)
RIFM fragrance ingredient safety assessment, cyclohexyl butyrate, CAS Registry Number 1551-44-6. (2019) (0)
398 Novel lymphocyte stimulation tests using ex-vivo expanded skin-infiltrating T cells from severe drug eruptions (2016) (0)
[Anti-fungal drug liranaftate suppresses fungal element-promoted production of IL-8 in normal human keratinocytes]. (2008) (0)
RIFM fragrance ingredient safety assessment, isophorol, CAS Registry Number 470-99-5. (2018) (0)
RIFM fragrance ingredient safety assessment, eugenyl acetate, CAS Registry Number 93-28-7. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 2-Methyl-2-hepten-6-ol, CAS Registry Number 1569-60-4. (2018) (0)
RIFM fragrance ingredient safety assessment, methyl 2-methylbutyrate, CAS Registry Number 868-57-5. (2019) (0)
RIFM fragrance ingredient safety assessment, undecane, CAS Registry Number 1120-21-4. (2020) (0)
364 Lymph node stromal cell-mediated deletional tolerance controls the development of GVHD-like skin lesion in newly generated involucrin-mOVA mice (2017) (0)
401 CD8+CD103+ skin resident memory T cells are a subpopulation of CD8+MDR-1+ cells in lesional skin of psoriasis and correlate with the clinical course (2018) (0)
RIFM fragrance ingredient safety assessment, S-1-methylethyl 3-methylbut-2-enethioate, CAS Registry Number 34365-79-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-methyl-2-pentenoic acid, CAS registry number 16957-70-3. (2018) (0)
RIFM fragrance ingredient safety assessment, butyrophenone, cas Registry Number 495-40-9. (2018) (0)
RIFM fragrance ingredient safety assessment, isobutyric acid, CAS Registry Number 79-31-2. (2020) (0)
Treatment and Prognosis in Patients with Adult T-Cell Leukemia-Lymphoma (ATL): A Nationwide Survey in Japan (2016) (0)
Genetic restriction of UVB-induced T-cell-suppressor factor in murine contact photosensitivity (1990) (0)
Papuloerythroderma in a patient with cutaneous T‐cell lymphoma infected with HTLV‐1 virus (2018) (0)
RIFM fragrance ingredient safety assessment, cyclododecaneethanol, β-methyl-, CAS Registry Number 118562-73-5. (2020) (0)
Activity to break plasmid DNA of sera from patients with various photosensitivity disorders —A new screening method for photoxity (1992) (0)
Calcipotriol increases intracellular cathelicidin LL-37 but not its extracellular form in IL-17/IL-22-stimulated human keratinocytes (2013) (0)
Two Cases of Chronic Expanding Hematoma (2007) (0)
Atypical large bullae caused by herpes simplex in a patient with thymoma. (2011) (0)
RIFM fragrance ingredient safety assessment, 2-methylhexanoic acid, CAS Registry Number 4536-23-6. (2018) (0)
Papuloerythroderma occurring in a patient with myelodysplastic syndrome (2018) (0)
RIFM fragrance ingredient safety assessment, p-tolyl 3-methylcrotonate, CAS Registry Number 24700-20-7. (2019) (0)
RIFM fragrance ingredient safety assessment, α,α,6,6-tetramethylbicyclo[3.1.1]hept-2-ene-2-propionaldehyde, CAS Registry Number 33885-52-8. (2021) (0)
RIFM fragrance ingredient safety assessment, methyl 3-hydroxyhexanoate, CAS Registry Number 21188-58-9. (2020) (0)
RIFM fragrance ingredient safety assessment, hexyl 2-methylbutyrate, CAS Registry Number 10032-15-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 4-methyloctanoic acid, CAS Registry Number 54947-74-9. (2019) (0)
RIFM fragrance ingredient safety assessment, p-cresyl salicylate, CAS Registry Number 607-88-5. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl 3-hydroxybutyrate, CAS Registry Number 5405-41-4. (2020) (0)
RIFM fragrance ingredient safety assessment, cinnamyl isobutyrate, CAS Registry Number 103-59-3. (2021) (0)
RIFM fragrance ingredient safety assessment, p-isopropylacetophenone, CAS Registry Number 645-13-6. (2019) (0)
RIFM fragrance ingredient safety assessment, decahydrospiro[furan-2(3H),5'-[4,7]methano[5H]indene], CAS Registry Number 68480-11-5. (2020) (0)
730 M2 macrophages promote wound induced hair neogenesis through the production of growth factors (2016) (0)
microRNA deep sequencing in Sezary Syndrome (2013) (0)
RIFM fragrance ingredient safety assessment benzyl 2,2-dimethylpropanoate, CAS Registry Number 2094-69-1. (2017) (0)
RIFM fragrance ingredient safety assessment, ethyl isobutyrate, CAS Registry Number 97-62-1. (2018) (0)
RIFM fragrance ingredient safety assessment, citronellyl isovalerate, CAS Registry number 68922-10-1. (2021) (0)
RIFM fragrance ingredient safety assessment, linalyl anthranilate, CAS Registry Number 7149-26-0. (2019) (0)
RIFM fragrance ingredient safety assessment, γ-undecalactone, CAS Registry Number 104-67-6. (2020) (0)
Mini-Symposium-Psoralen Photobiology and Photochemotherapy (1999) (0)
RIFM fragrance ingredient safety assessment, benzenepropanol, a,ß-dimethyl-, CAS Registry Number 56836-93-2. (2017) (0)
Lessons for Immunodermatology (I) : Basic Knowledge of Skin Immunity and Lymphocytes (2007) (0)
Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue (2016) (0)
RIFM fragrance ingredient safety assessment, bicyclo[3.1.0]hexan-3-one, 4-methyl-1-(1-methylethyl)-, CAS Registry Number 1125-12-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 1,3-Benzodioxole-5-propanol, α-methyl-, 5-acetate, CAS Registry Number 68844-96-2. (2018) (0)
RIFM fragrance ingredient safety assessment, 5-methyl-3-heptanone, CAS Registry Number 541-85-5. (2020) (0)
RIFM fragrance ingredient safety assessment, bis-(methylthio)methane, CAS Registry Number 1618-26-4. (2021) (0)
RIFM fragrance ingredient safety assessment, methyl 3,7-dimethyl-6-octenoate, CAS Registry Number 2270-60-2. (2019) (0)
RIFM fragrance ingredient safety assessment, palmitic acid, CAS Registry Number 57-10-3. (2019) (0)
RIFM fragrance ingredient safety assessment, lavandulyl acetate, CAS Registry Number 25905-14-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-hexanone, CAS Registry Number 589-38-8. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-phenylpropionaldehyde, CAS Registry Number 93-53-8. (2020) (0)
RIFM fragrance ingredient safety assessment, citronellyl phenylacetate, CAS Registry Number 139-70-8. (2018) (0)
RIFM fragrance ingredient safety assessment, β-naphthyl anthranilate, CAS Registry Number 63449-68-3. (2020) (0)
RIFM fragrance ingredient safety assessment, 2,6,8-trimethylnonan-4-one, CAS Registry Number 123-18-2. (2019) (0)
RIFM Fragrance ingredient safety assessment, 4-cyclohexyl-2-methyl-2-butanol, CAS Registry Number 83926-73-2. (2019) (0)
RIFM fragrance ingredient safety assessment, 4,8-dimethyl-4,9-decadienal, CAS Registry Number 71077-31-1. (2019) (0)
RIFM fragrance ingredient safety assessment, 2,6,6-trimethylcyclohex-2-ene-1,4-dione, CAS Registry Number 1125-21-9. (2021) (0)
RIFM fragrance ingredient safety assessment, terpinyl formate, CAS Registry Number 2153-26-6. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-Methylvaleric acid, CAS Registry Number 97-61-0. (2018) (0)
RIFM fragrance ingredient safety assessment, isobutyraldehyde, CAS Registry Number 78-84-2. (2021) (0)
458 An intuitive explanation of dermoscopic structures by digitally reconstructed pathological top-down view and 3D images (2019) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 2,6-Dimethylocta-2,4,6-triene, CAS Registry Number 673-84-7. (2018) (0)
RIFM fragrance ingredient safety assessment, 3,3,5,5-tetramethyl-4-ethoxyvinylcyclohexanone, CAS Registry Number 36306-87-3. (2020) (0)
Retraction (2012) (0)
RIFM fragrance ingredient safety assessment, 4-hexen-1-ol, 5-methyl-2-(1-methylethenyl)-, CAS Registry Number 58461-27-1. (2018) (0)
RIFM fragrance ingredient safety assessment, 3,3,5-trimethylcyclohexyl acetate, CAS Registry Number 67859-96-5. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl 3-phenylpropionate, CAS Registry Number 2021-28-5. (2019) (0)
RIFM fragrance ingredient safety assessment, 2-benzyl-2-methylbut-3-enenitrile, CAS Registry Number 97384-48-0. (2020) (0)
RIFM fragrance ingredient safety assessment, methyl 3,3-dimethylbicyclo[2.2.1]heptane-2-carboxylate, CAS Registry Number 52557-97-8. (2020) (0)
RIFM fragrance ingredient safety assessment cyclohexanecarboxylic acid, CAS Registry Number 98-89-5. (2018) (0)
Recurrent annular erythema after thymectomy. (2011) (0)
Greetings from the Editor‐in‐Chief, Journal of Cutaneous Immunology and Allergy (JCIA) (2018) (0)
Downmodulatory effect of epinastine on Th2 chemokine production by epidermal Langerhans cells (2007) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 2,2,4-trimethyl-4-phenyl-butane-nitrile CAS Registry Number 75490-39-0. (2017) (0)
Afloqualone photosensitivity: Induction of delayed-type hypersensitivity with afloqualone-photomodified epidermal cells in mice (1994) (0)
RIFM fragrance ingredient safety assessment, tricyclodecanyl acetate, CAS Registry Number 64001-15-6. (2018) (0)
RIFM fragrance ingredient safety assessment, 2-hydroxyethyl phenoxyacetate, CAS Registry Number 1984-60-7. (2020) (0)
RIFM fragrance ingredient safety assessment, methyl 2-methylthiobutyrate, CAS Registry Number 42075-45-6. (2019) (0)
RIFM fragrance ingredient safety assessment, 3,6-nonadien-1-ol, CAS registry number 76649-25-7. (2017) (0)
RIFM fragrance ingredient safety assessment, endo-1,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-ol, CAS Registry Number 28462-85-3. (2018) (0)
[Verification of the hygienic hypothesis by evaluating the regional incidence of eosinophilic pustular folliculitis]. (2013) (0)
RIFM fragrance ingredient safety assessment, propionic acid, CAS Registry Number 79-09-4. (2019) (0)
RIFM fragrance ingredient safety assessment, octahydro-4,7-methano-1H-indenemethyl acetate, CAS Registry Number 30772-69-1. (2018) (0)
RIFM fragrance ingredient safety assessment, methyl thiobutyrate, CAS Registry Number 2432-51-1. (2020) (0)
RIFM fragrance ingredient safety assessment, β-naphthyl isobutyl ether, CAS Registry Number 2173-57-1. (2020) (0)
RIFM fragrance ingredient safety assessment, alcohols, C8-10-iso-, C9-rich, CAS Registry Number 68526-84-1. (2017) (0)
RIFM fragrance ingredient safety assessment, benzyl isoamyl ether, CAS Registry Number 122-73-6. (2018) (0)
154 MDR1-expressing T cells accumulate in the resolved skin of psoriatic plaque after treatment with topical corticosteroid but not with anti-IL-17A mAb (2019) (0)
RIFM fragrance ingredient safety assessment, tetrahydro-2-methyl-4-methylene-6-phenyl-2H-pyrane, CAS Registry number 30310-41-9. (2019) (0)
RIFM fragrance ingredient safety assessment, pentanoic acid, 2-methylbutyl ester, CAS Registry Number 55590-83-5. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-butanone, CAS Registry Number 78-93-3. (2019) (0)
RIFM fragrance ingredient safety assessment, nonane, 1,1-diethoxy-, CAS Registry Number 54815-13-3. (2018) (0)
RIFM fragrance ingredient safety assessment, 1-heptanethiol, CAS Registry Number 1639-09-4. (2021) (0)
RIFM fragrance ingredient safety assessment, cyclohexanol, CAS Registry Number 108-93-0. (2021) (0)
RIFM fragrance ingredient safety assessment, p-tolyl isobutyrate, CAS Registry Number 103-93-5. (2021) (0)
RIFM fragrance ingredient safety assessment, methyl decanoate, CAS Registry Number 110-42-9. (2021) (0)
RIFM fragrance ingredient safety assessment, indole, CAS Registry Number 120-72-9. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-methylbutyl acetate, CAS Registry Number 624-41-9. (2018) (0)
RIFM fragrance ingredient safety assessment, acetaldehyde dihexyl acetal, CAS Registry Number 5405-58-3. (2021) (0)
RIFM fragrance ingredient safety assessment, phenol, CAS Registry Number 108-95-2. (2020) (0)
RIFM fragrance ingredient safety assessment, 2,7-nonadienal, (2E,7Z)-, CAS Registry Number 21662-22-6. (2021) (0)
RIFM fragrance ingredient safety assessment, lauric acid, CAS Registry Number 143-07-7. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl trans-2-decenoate, CAS Registry Number 7367-88-6. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-ethyl-1,3,3-trimethyl-2-norbornanol, CAS Registry Number 18368-91-7. (2021) (0)
RIFM fragrance ingredient safety assessment, dihydrocarvyl acetate, CAS Registry Number 20777-49-5. (2021) (0)
RIFM fragrance ingredient safety assessment, methyl phenylacetate, CAS Registry Number 101-41-7. (2018) (0)
RIFM fragrance ingredient safety assessment, 5,9-undecadien-2-ol,6,10-dimethyl-,acetate, CAS Registry Number 91482-37-0. (2018) (0)
TSLPR expressing CD4+ T cells produce enhanced IL-4 by directly responding to TSLP in AD (2016) (0)
Regulatory T cells prevent egress of activated T cells from lymph nodes after application of contact sensitizers via degradation of ATP (2014) (0)
RIFM fragrance ingredient safety assessment, α-Propylphenethyl alcohol, CAS Registry Number 705-73-7. (2017) (0)
A case of squamous cell carcinoma arising from perianal chronic pyoderma (2008) (0)
RIFM fragrance ingredient safety assessment, methyl 3,4,5,6-tetrahydro-7H-azepin-2-yl ether, CAS Registry Number 2525-16-8. (2020) (0)
RIFM fragrance ingredient safety assessment, 2-hydroxyacetophenone, CAS Registry Number 118-93-4. (2019) (0)
RIFM fragrance ingredient safety assessment, methoxy dicyclopentadiene carboxaldehyde, CAS Registry Number 86803-90-9. (2019) (0)
RIFM fragrance ingredient safety assessment, allyl cyclohexanepropionate, CAS Registry Number 2705-87-5. (2021) (0)
RIFM fragrance ingredient safety assessment, octahydro-4,7-methano-1h-indene-5-ol, CAS Registry Number 13380-89-7. (2018) (0)
RIFM fragrance ingredient safety assessment, [2-(cyclohexyloxy)ethyl]benzene, CAS Registry Number 80858-47-5. (2019) (0)
RIFM fragrance ingredient safety assessment, dihydroterpinyl acetate, CAS registry number 58985-18-5. (2018) (0)
RIFM fragrance ingredient safety assessment, sec-butyl ethyl ether, CAS Registry Number 2679-87-0. (2021) (0)
RIFM fragrance ingredient safety assessment, 4'-tert-butyl-2',6'-dimethylacetophenone, CAS Registry Number 2040-10-0. (2018) (0)
RIFM fragrance ingredient safety assessment, 1,2,3,4,4a,7,8,8a-octahydro-2,4a,5,8a-tetramethyl-1-naphthyl formate, CAS Registry Number 65405-72-3. (2018) (0)
Corrigendum to RIFM fragrance ingredient safety assessment, cinnamaldehyde, CAS Registry Number 104-55-2 [Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110710]. (2020) (0)
RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT, 1-Oxaspiro[4.5]decan-2-one, 8-(1-methylethyl)-, trans-, CAS Registry Number 4625-90-5. (2018) (0)
RIFM fragrance ingredient safety assessment, 4,8-undecadienenitrile, (4Z,8Z)-, CAS Registry Number 1882830-61-6. (2021) (0)
RIFM fragrance ingredient safety assessment, methyl cyclopentylideneacetate, CAS Registry Number 40203-73-4. (2020) (0)
RIFM fragrance ingredient safety assessment, ethyl 2-tert-butylcyclohexyl carbonate, CAS Registry Number 67801-64-3. (2017) (0)
RIFM fragrance ingredient safety assessment, cyclohexanone, CAS Registry Number 108-94-1. (2020) (0)
P21 Acanthotic epidermal keratinocytes in chronic eczematous skin diseases but not psoriasis vulgaris express P-cadherin (1996) (0)
RIFM fragrance ingredient safety assessment, 4-hydroxybutanoic acid lactone, CAS Registry Number 96-48-0. (2019) (0)
RIFM fragrance ingredient safety assessment, guaiyl acetate, CAS Registry Number 134-28-1. (2018) (0)
Therapies for aged patients with cutaneous lymphomas (2006) (0)
RIFM fragrance ingredient safety assessment, isobutyl butyrate, CAS Registry Number 539-90-2. (2018) (0)
RIFM fragrance ingredient safety assessment, acetal, CAS Registry Number 105-57-7. (2018) (0)
RIFM fragrance ingredient safety assessment, p-tert-butylacetophenone, CAS Registry Number 943-27-1. (2018) (0)
RIFM fragrance ingredient safety assessment, farnesal, CAS Registry Number 19317-11-4. (2021) (0)
RIFM fragrance ingredient safety assessment, 3a,7-methano-3ah-cyclopentacycloocten-3-ol, decahydro-1,1,7-trimethyl-, formate, CAS Registry Number 58096-47-2. (2018) (0)
RIFM fragrance ingredient safety assessment, 1-decen-3-ol, CAS Registry Number 51100-54-0. (2021) (0)
[Intestinal function tests and their limitations--clinical aspects]. (1967) (0)
Absorption of medium chain fatty acids and medium chain triglycerides, in vitro and in vivo, in comparison with long chain triglycerides (1970) (0)
Cutaneous lymphoma --1993-- (1994) (0)
Simultaneous fat-protein digestion-absorption test with131I-triolein and125I-risa (1969) (0)
Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells (2022) (0)
Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) (2022) (0)
009 Real-time in vivo imaging of CD8+ T cell-mediated keratinocyte apoptosis in a graft versus host disease-like murine model (2019) (0)
Lesions Coinfiltrating in Early B16 Melanoma T Cells b a T and d g Expressed on Th2-Type Molecules b T Cell Activities by MHC K Down-Regulation of Tumoricidal NK and NK (1998) (0)
My deepest condolences on the loss of former Editor-in-Chief, Professor Emeritus Hiroshi Shimizu (2021) (0)
In-vivo Imaging of CD8+ T cell-mediated Keratinocyte Apoptosis in Graft-Versus Host Disease-like Dermatitis in Involucrin-mOVA Mice. (2022) (0)
A Phenotypic Analysis of Involucrin–Membrane-Bound Ovalbumin Mice after Adoptive Transfer of Ovalbumin-Specific CD8+ T Cells (2022) (0)
Elevation of circulating neutrophil extracellular traps, interleukin (IL)‐8, IL‐22, and vascular endothelial growth factor in patients with venomous snake mamushi (Gloydius blomhoffii) bites (2021) (0)
Postpartum polymorphic eruption of pregnancy prominently occurring on striae distensae (2021) (0)
Paraphenylenediamine ingredient possibly contributes to granuloma formation in inflammatory tattoo (2021) (0)
095 CD8+CD103+ resident memory T cells with skewed TCR Vbeta usage infiltrate in the skin lesion of DIHS/DRESS (2022) (0)
Training and Retaining Physician‒Scientists in Dermatology: Japan (2021) (0)
Sensory irritation to methylparaben is caused by its low metabolism in the skin. (2023) (0)
Two cases of psoriasiform dermatitis arising during dupilumab therapy and successfully treated with delgocitinib ointment (2021) (0)
In chemico sequential testing strategy for assessing the photoallegic potential. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-cyclohexen-1-one, 2-methyl-5-propyl-, CAS Registry Number 1447712-18-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,6,6-trimethyl-1&2-cyclohexen-1-carboxaldehyde, CAS Registry Number 432-25-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,3,3-trimethylindanone, CAS registry number 54440-17-4. (2023) (0)
RIFM fragrance ingredient safety assessment, biphenyl, CAS Registry Number 92-52-4. (2022) (0)
RIFM fragrance ingredient safety assessment, p-menthan-2-one, CAS Registry number 499-70-7. (2021) (0)
RIFM fragrance ingredient safety assessment, dihydrocarveol (isomer unspecified), CAS Registry Number 619-01-2. (2022) (0)
RIFM fragrance ingredient safety assessment, citronellyl valerate, CAS Registry Number 7540-53-6. (2021) (0)
RIFM fragrance ingredient safety assessment, trans-2-nonenal, CAS Registry Number 18829-56-6. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-decenal, CAS registry number 3913-71-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-hexylidenecyclohexan-1-one, CAS Registry Number 16429-07-5. (2021) (0)
RIFM fragrance ingredient safety assessment, 1,6-octadien-3-ol, 3,7-dimethyl-, acid-isomerized, CAS Registry Number 73018-51-6. (2022) (0)
RIFM fragrance ingredient safety assessment, dihydromyrcene, CAS Registry Number 2436-90-0. (2021) (0)
RIFM fragrance ingredient safety assessment, piperidine, CAS Registry Number 110-89-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 3,7-dimethyloct-1-en-3-ol, CAS Registry Number 18479-49-7. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, hexyl 2-methylbutyrate, CAS Registry Number 10032-15-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 4,7-methano-1H-inden-5-ol, 3a,4,5,6,7,7a-hexahydrodimethyl-, CAS Registry Number 79771-15-6 (2021) (0)
RIFM fragrance ingredient safety assessment, hexanenitrile, CAS Registry Number 628-73-9. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl 2-furoate, CAS Registry Number 611-13-2. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl phenethyl ether, CAS Registry Number 3558-60-9. (2021) (0)
RIFM fragrance ingredient safety assessment, ethyl isovalerate, CAS Registry Number 108-64-5 (2021) (0)
RIFM fragrance ingredient safety assessment, propyl 2-methylbutyrate, CAS Registry Number 37064-20-3. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-pentenoic acid, 2-methyl-, (3Z)-3-hexen-1-yl ester, CAS Registry Number 76649-17-7. (2021) (0)
RIFM fragrance ingredient safety assessment, butanoic acid, 2-methyl-, 5-hexen-1-yl ester, CAS Registry Number 155514-23-1. (2021) (0)
RIFM fragrance ingredient safety assessment, benzoic acid, 2-[[(4-methoxyphenyl)methylene]amino]-, methyl ester, CAS Registry Number 14735-72-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 5-cyclotetradecen-1-one, 3-methyl-,(5E)-, CAS Registry Number 259854-70-1. (2022) (0)
RIFM fragrance ingredient safety assessment, methyl propionate, CAS Registry Number 554-12-1. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, hexyl isobutyrate, CAS Registry Number 2349-07-7. (2022) (0)
RIFM fragrance ingredient safety assessment, cedrol, CAS Registry Number 77-53-2. (2022) (0)
RIFM fragrance ingredient safety assessment, cinnamyl propionate, CAS Registry Number 103-56-0. (2021) (0)
RIFM fragrance ingredient safety assessment, isoeugenyl ethyl ether, CAS Registry Number 7784-67-0. (2022) (0)
RIFM fragrance ingredient safety assessment, cyclohexadecanone, CAS Registry Number 2550-52-9. (2021) (0)
RIFM fragrance ingredient safety assessment, 3-propylidenephthalide, CAS Registry Number 17369-59-4. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methylbutyl 3-methylbutanoate, CAS Registry Number 2445-77-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 8-nonenal, CAS Registry number 39770-04-2. (2022) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-2-(n-pentanyl)-2-cyclopenten-1-one, CAS Registry Number 1128-08-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 3-methyl-5-phenylpent-2-enenitrile, CAS registry number 93893-89-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 3 and 4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carboxaldehyde, CAS registry number 31906-04-4. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-phenylethyl valerate, CAS Registry Number 7460-74-4. (2022) (0)
RIFM fragrance ingredient safety assessment, cyclohexadecenone, CAS Registry Number 88642-03-9. (2021) (0)
Update to RIFM fragrance ingredient safety assessment, 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol, CAS Registry Number 67801-20-1. (2022) (0)
RIFM fragrance ingredient safety assessment, 2-dodecenal, CAS registry number 4826-62-4. (2022) (0)
RIFM fragrance ingredient safety assessment, n-hexane, CAS Registry Number 110-54-3. (2022) (0)
RIFM fragrance ingredient safety assessment, tetrahydrolinalool, CAS Registry Number 78-69-3. (2022) (0)
RIFM fragrance ingredient safety assessment, γ-hexalactone, CAS Registry Number 695-06-7. (2022) (0)
RIFM fragrance ingredient safety assessment, 4,8-decadienal, (4Z,8Z)-, CAS Registry Number 1958027-35-4. (2021) (0)
RIFM fragrance ingredient safety assessment, 4-(methylthio)-4-methyl-2-pentanone, CAS Registry Number 23550-40-5. (2022) (0)
RIFM fragrance ingredient safety assessment, 3,5,5-trimethyl-1-hexanol, CAS Registry Number 3452-97-9. (2022) (0)
RIFM fragrance ingredient safety assessment, octyl isobutyrate, CAS Registry Number 109-15-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 2,3-dihydro-1,1-dimethyl-1H-indene-ar-propanal, CAS Registry Number 300371-33-9. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, isoamyl octanoate, CAS registry number 2035-99-6. (2023) (0)
RIFM fragrance ingredient safety assessment, 13-methyloxacyclopentadecan-2-one, CAS Registry Number 868846-58-6. (2022) (0)
Update to RIFM fragrance ingredient safety assessment, cis-3-octenyl propionate, CAS Registry Number 94134-03-9. (2022) (0)
RIFM fragrance ingredient safety assessment, 4,9-dodecadienenitrile, (4Z,9Z)-, CAS Registry Number 1882830-66-1. (2021) (0)
RIFM fragrance ingredient safety assessment, 2-methylpentanal, CAS Registry Number 123-15-9. (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yoshiki Tokura?

Yoshiki Tokura is affiliated with the following schools:

Hamamatsu University
University of Occupational and Environmental Health Japan
Hamamatsu University School of Medicine

Yoshiki Tokura's Academic­Influence.com Rankings

Why Is Yoshiki Tokura Influential?

Yoshiki Tokura's Published Works

Published Works

What Schools Are Affiliated With Yoshiki Tokura?

Yoshiki Tokura's AcademicInfluence.com Rankings